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are  separated  by  a  hyphen.  E.g.:  
WAH-­‐‑1  
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are  separated  by  a  hyphen.  E.g.:  
wah-­‐‑1  
  
Vertebrate  proteins  are  written  as  a   three-­‐‑   to   four-­‐‑letter  code   in  CAPITAL   letters.  No  
separation  between  letters  and  digits.  E.g.:  
AIF  
  
Vertebrate  genes  are  written  as  a   three-­‐‑   to   four-­‐‑letter   code  with   the   first   letter  CAPI-­‐‑
TAL  and  the  other  letters  in  lower  case.  No  separation  between  letters  and  digits.  E.g.:  
Aif  
  
Human  proteins  are  written  as  a  three-­‐‑  to  four-­‐‑letter  code  in  CAPITAL  letters.  No  sep-­‐‑
aration  between  letters  and  digits.  E.g.:  
AIFM1  
  
Human  genes  are  written  as  a   three-­‐‑   to   four-­‐‑letter   code   in  CAPITAL   letters   in   italics.  
No  separation  between  letters  and  digits.  E.g.:  
AIFM1  

Summary   1  
  1  Summary  
Mitochondria  are  organelles  in  the  cytoplasm  of  almost  all  eukaryotic  cells.  They  
supply  large  quantities  of  energy  in  the  form  of  adenosine  triphosphate  (ATP)  and  are  
involved   in   cell   signalling,  differentiation  and   cell  death.  Mutations   in  mitochondrial  
genes   cause   organelle   dysfunction   and   lead   to   a   heterogeneous   group   of   disorders.  
Apoptosis   Inducing   Factor   (AIF)   is   a  mitochondrial   protein   required   for   the  mainte-­‐‑
nance   of   respiratory   complex   subunits   and   efficient   oxidative   phosphorylation  
(OXPHOS).  Altered  AIF   function   causes   severe   human  pathologies   and   recapitulates  
the  majority   of   features   commonly   observed   in   other  mitochondrial   disorders.   There  
are  no  available  treatments  for  mitochondrial  disorders.  
The   present   study  demonstrates   that  AIF   (or  WAH-­‐‑1   in   nematodes)   deficiency  
results  in  electron  transport  chain  (ETC)  defects  in  Caenorhabditis  elegans.  Consequently,  
impaired  OXPHOS   leads   to  defective  mitochondrial   function  and   shortens  nematode  
lifespan.  Conversely,  reduced  insulin/IGF-­‐‑1  signalling  elicits  a  compensatory  response  
that   results   in   lifespan  extension   independent  of   the  downstream   transcription   factor  
DAF-­‐‑16/FOXO.   Compromised   OXPHOS   and   decreased   insulin/IGF-­‐‑1   signalling   pro-­‐‑
mote  stress  response,  AMPK/AAK-­‐‑2  activation  and  autophagy.  Importantly,  enhancing  
AMPK/AAK-­‐‑2  activity  is  sufficient  to  extend  the  survival  of  AIF/WAH-­‐‑1  impaired  an-­‐‑
imals  and  requires  autophagy.    
The   identified   cellular   response   mechanisms   result   in   metabolic   remodelling,  
protect  from  altered  mitochondrial  respiration  and  ultimately  lead  to  increased  surviv-­‐‑
al  of  animals  with  compromised  OXPHOS.  These  results  may  contribute  to  the  devel-­‐‑
opment  of  novel  strategies  for  the  treatment  of  mitochondrial  disorders.  
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  2  Introduction  
  2.1  Mitochondria  
Mitochondria  are  highly  abundant  organelles  present  in  the  vast  majority  of  eu-­‐‑
karyotic  cells.  Their  number  and  morphology  can  differ  greatly,  depending  on  the  cell  
type   and   its   bioenergetic   demands.   The   primary   function   of  mitochondria   is   energy  
production.  They  provide   the  vast  majority  of   cellular  adenosine   triphosphate   (ATP).  
ATP  is  the  fuel  of  any  cell  and  often  rhetorically  referred  to  as  the  “cellular  currency”.  
The  transfer  of  phosphate  residues  from  ATP  to  proteins  and  enzymes  is  indispensable  
for   all   cellular  processes   that   require   energy.  Mitochondria  produce  ATP   through  an  
intricate   process   termed   oxidative   phosphorylation   (OXPHOS).   This  metabolic   path-­‐‑
way  produces  ATP  through  a  series  of  redox  reactions  catalysed  by  the  mitochondrial  
electron  transport  chain  (ETC).  In  addition  to  energy  production,  mitochondria  are  the  
central  orchestrator  of  metabolism  and  execute  crucial  chemical  reactions  and  functions  
for   the   cell,   such   as   the   tricarboxylic   acid   (TCA)   cycle   (Krebs,   1979),   fatty   acid   β-­‐‑
oxidation  (Houten  &  Wanders,  2010),  Ca2+  uptake  (Rottenberg  &  Scarpa,  1974)  as  well  
as   iron  and  metal  homeostasis   (Lill  &  Muhlenhoff,   2008).   Furthermore,  mitochondria  
take  part   in  apoptotic  cell  death,  a  process  which   is  essential   for  proper  development  
and  health  (Green  &  Reed,  1998).  
  2.1.1  Morphology  
Mitochondria   are   hypothesised   to   have   evolved   from   an   ancestral   α-­‐‑
proteobacterium   that   infiltrated   cells   and   was   engulfed   as   an   endosymbiont   (Gray,  
2012).  Therefore,  mitochondria  still  carry  part  of  their  own  genome,  termed  mitochon-­‐‑
drial  DNA  (mtDNA),  which  encodes  for  a  subset  of  electron  transport  chain  (ETC)  pro-­‐‑
teins   (Chapter  2.1.2   ).  The  remaining  ETC  proteins  are  encoded  by  nuclear  DNA  and  
imported   into  mitochondria.  Due  to   their  proteobacterial  origin,  mitochondria  consist  
of  an  outer  membrane  (OM),  an  intermembrane  space  (IMS),  an  inner  membrane  (IM)  
and  the  mitochondrial  matrix.  
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The  OM  contains  membrane  proteins  that  control  mitochondrial  import  and  export  of  
proteins,  molecules   and   ions   (Gellerich   et   al.,   2000).   These   transport  mechanisms   are  
crucial  for  the  import  of  the  nuclear  encoded  ETC  proteins  and  metabolites  that  are  re-­‐‑
quired  for  mitochondrial  energy  production.  
The  IMS  is  a  reservoir  for  hydrogen  ions  that  contains  a  variety  of  proteins  and  mole-­‐‑
cules   that   assist   in   the   function   of   the   respiratory   chain   and   ensure   efficient   energy  
production  (Saraste,  1999).  
The  IM  is  a  highly  folded  membrane  that  shapes  the  mitochondrial  matrix  into  cristae.  
This  morphology  ensures  an  efficient  ratio  between  volume  and  surface  area,  as  many  
of   the   crucial  mitochondrial   reactions   occur   along   the   IM.   The   homeostasis   between  
components   in   the  mitochondrial   IMS  and  the  matrix   is   regulated  by   transmembrane  
proteins  in  the  IM.  Importantly,  many  proteins  of  the  ETC  are  integrated  in  the  IM.  
The  mitochondrial  matrix   contains   the  mitochondrial   genome.  Proteins,   such   as  ETC  
subunits,   are   produced   and   assembled   in   this   compartment.   Furthermore,   important  
metabolic   processes   such   as   the   tricarboxylic   acid   (TCA)   cycle   and   fatty   acid   β-­‐‑
oxidation  take  place  in  the  matrix.  
Altogether,   proteins  within   the   different  mitochondrial  membrane   spaces   exert  
diverse  and  specialised  functions.  Since   the  single  mitochondrial  compartments  serve  
as  rather  isolated  reaction  spaces,  an  interconnected  network  of  proteins  and  signalling  
processes  is  indispensable  for  mitochondrial  function.  
  2.1.2  Electron  Transport  Chain  
The  ETC  is  a  functional  series  of  proteins  that  produce  ATP  by  OXPHOS.  To  this  
end,  mitochondria  shuttle  electrons  in  the  form  of  hydride  protons  (H+)  along  the  res-­‐‑
piratory  chain.  NADH  and  FADH2,  which  are  produced  during  the  TCA  cycle,  glycol-­‐‑
ysis,  β-­‐‑oxidation  and  other  catabolic  processes,  serve  as  an  electron  source  to  fuel   the  
OXPHOS   process.   The   respiratory   chain   is   comprised   of   5   individual   complexes   an-­‐‑
chored  to  the  IM.  Two  mobile  electron  carriers  in  the  IMS,  ubiquinone-­‐‑10  (Q10)  and  cy-­‐‑
tochrome   c   (Cyt   c),   assist   in   the   transport   of   electrons   through   the   ETC.  During   this  
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process  other  hydrogen  ions  are  transported  into  the  IMS.  This  produces  a  H+  proton  
gradient   between   the   IMS   and   the  matrix   across   the   IM.  The  proton  gradient   is   ulti-­‐‑
mately  utilised   for   the   formation   of  ATP   from  ADP   and   free  phosphate   in   the  mito-­‐‑
chondrial  matrix.  
For   efficient   OXPHOS   the   electron   transfer   follows   regulated   redox   reactions  
through  the  ETC  complexes:  
• NADH-­‐‑ubiquinone  oxidoreductase         (complex  I  or  C  I)  
C  I   is  an  integral  protein  of  the  electron  transport  chain  that  receives  hydride  ions  
from  NADH  and  passes  the  electrons  on  to  ubiquinone.  
• Succinate  dehydrogenase                 (complex  II  or  C  II)    
C  II   is   a  peripheral  protein   that   receives   electrons   from  succinate,  which   is   an   in-­‐‑
termediate  metabolite  of  the  TCA  cycle.  C  II  uses  these  electrons  to  reduce  the  pros-­‐‑
thetic  group  of  FAD  to  FADH2  to  subsequently  pass  the  electrons  to  ubiquinone.  
• Ubiquinone  (Q10)  
Ubiquinone  is  a  mobile  protein  that  can  diffuse  across  the  membrane.  Upon  reduc-­‐‑
tion  by  C  I  and  C  II,  ubiquinol  (the  reduced  form  of  ubiquinone)  shuttles  electrons  
to  C  III.  
• Cytochrome  c  reductase                    (complex  III  or  C  III)  
C  III  then  passes  electrons  on  to  Cyt  c.  C  III  receives  electrons  via  Q10  not  only  from  
C  I   and   C  II   but   also   from   glycerol-­‐‑3-­‐‑phosphate   dehydrogenase   and   the   electron  
transfer  flavoprotein  (ETF).  
• Cytochrome  c  oxidase                    (complex  IV  or  C  IV)  
C  IV  receives  electrons  from  Cyt  c.  These  electrons  are  then  transferred  to  oxygen,  
and  produce  water  within  the  mitochondrial  matrix.    
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• ATP  synthase                         (ATPase  or  complex  V  or  C  V)  
C  V   is   ultimately   responsible   for   the   generation   of  ATP.  During   electron   transfer  
along  C  I,  C  III  and  C  IV,  H+  protons  are  actively  translocated  across  the  IM  into  the  
mitochondrial  IMS.  This  creates  a  proton  gradient  and  an  electrochemical  potential  
across  the  membrane.  ATPase  utilises  the  reflux  of  protons  into  the  matrix  to  drive  
a  mechanical   rotor.   The   energy   from   this   rotor   is   used   to   phosphorylate  ADP   to  
ATP.   This   process   is   termed   oxidative   phosphorylation   (OXPHOS)   (Mitchell   &  
Moyle,  1967)  
  
  2.1.3  ETC  subunits  
The  membrane  potential  that  is  generated  by  the  proton  gradient  is  required  for  
many  mitochondrial  processes.  Apart  from  ATP  generation  it  plays  an  important  role  
for  Ca2+   homeostasis   (Rottenberg  &  Scarpa,   1974),   transport   of  metabolites   across   the  
IM   (Eilers   et   al.,   1987)   and   apoptosis   (Zamzami   et   al.,   1995).   Therefore,   efficiency   of  
OXPHOS  and  ETC  complex  function  is  crucial  for  mitochondrial  and  cellular  health.  
Correct   shuttling   of   electrons   through   the   protein   complexes   and   pumping   of  
protons  into  the  IMS  ultimately  depends  on  the  stability  of  the  ETC  complexes.  As  the  
name   already   suggests,   ETC   complexes   are   comprised   of   several   different   subunits.  
These  subunits  are  specific  to  each  ETC  complex.  Nuclear  genes  encode  for  the  majori-­‐‑
ty  of   the  90  subunits   that  comprise   the  ETC  complexes.  However,  13  proteins  are  en-­‐‑
coded   by  mtDNA   and   provide   subunits   for   all   complexes   except   C  II.   Furthermore,  
mtDNA  encodes  for  other  working  units  such  as  ribosomal  RNA  (rRNA)  and  transfer  
RNAs  (tRNAs).  They  are  required  for  the  translation  of  mitochondrial  genes  and  con-­‐‑
sequently   for  mitochondrial   function.  Therefore,   the   correct   assembly  of   the   subunits  
from  different  sources  to  functional  complexes  requires  intricate  regulation  and  strate-­‐‑
gy.  
The  stability  of  ETC  complexes   is  promoted  by  two  main  mechanisms:  The  for-­‐‑
mation  of  supercomplexes  and  proteins  that  contribute  to  the  stabilisation.  Unlike  the  
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classical  textbook  view  of  the  ETC  as  a  fluid-­‐‑state  model,  ETC  complexes  are  capable  of  
forming  supercomplexes.  For  instance,  the  supercomplex  comprised  of  various  stoichi-­‐‑
ometries  of  C  I,  C  III  and  C  IV  builds  a  functional  electron-­‐‑channelling  unit  (Bianchi  et  
al.,  2004;  Schagger,  2001).  This  respirasome  has  been  proposed  to  increase  the  efficiency  
of  the  respiratory  chain  by  bringing  the  electron  carriers  in  close  proximity  (Chance  &  
Williams,   1955;   Schafer   et   al.,   2006).   Another   supercomplex,   comprised   of   dimeric  
ATPase,  is  crucial  for  the  folding  of  the  inner  membrane  and  formation  of  cristae  (Rabl  
et  al.,  2009;  Saddar  et  al.,  2008).  Furthermore,  dimers  of  ATPase  form  the  mitochondrial  
permeability  transition  pore,  a  key  effector  of  cell  death  (Giorgio  et  al.,  2013).  Addition-­‐‑
al  proteins  and  factors  can  also  stabilise  respiratory  complexes  and  comply  protective  
functions.  For   instance,   the  assembly  of   the  biggest   complex  of   the   respiratory  chain,  
C  I,   relies  on  a  variety  of   factors  such  as  C3orf1,  TMEM126B  and  Ndufaf1   (McKenzie  
2010).  
  2.2  Mitochondrial  dysfunction,  pathology  and  disease  
Owing  to  the  highly  diverse  mitochondrial  function,  impairment  of  the  organelle  
can   lead  to  drastic  cellular  consequences.  Oxidative  stress  and  subsequent  damage  of  
cellular  components  was  hypothesised  to  substantially  contribute  to  biological  decline  
(Droge  &  Schipper,   2007;  Romano   et   al.,   2010).   In   fact,   aged  mitochondria  display   re-­‐‑
duced  OXPHOS  and  ATP  production  but  increased  reactive  oxygen  species  (ROS)  lev-­‐‑
els  (Gomez  et  al.,  2009;  Gouspillou  et  al.,  2014;  Sgarbi  et  al.,  2014).  Impaired  ETC  func-­‐‑
tion   is   the   primary   source   for   increased  ROS  production   (Bratic  &  Trifunovic,   2010).  
The  mitochondrial  theory  of  ageing  suggests  a  vicious  cycle  of  the  accumulation  of  ox-­‐‑
idative  damage  to  proteins,  DNA  and  lipids  by  ROS  (Gutierrez  et  al.,  2006;  Pamplona  &  
Barja,  2006;  Radak  et  al.,  2011).  As  a  result,  damaged  mitochondria  generate  even  more  
ROS.  Nevertheless,  ROS  are  not  just  harmful  by-­‐‑products  of  (impaired)  mitochondrial  
function.   They   are   rather   important   cellular   signalling   molecules   (D'ʹAutreaux   &  
Toledano,  2007).  
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  2.2.1  Mitochondrial  diseases  
Dysfunction   of   mitochondrial   activity,   dynamics,   trafficking   and   transport   as  
well  as  altered  morphology  may  cause  or  contribute  to  neuronal  loss  (Douglas  &  Dillin,  
2010;  Gkikas   et  al.,  2014;  Parashos   et  al.,  2014;  Sgarbi   et  al.,  2014).  Consequently,  mito-­‐‑
chondria  are  implicated  in  the  pathophysiology  of  late-­‐‑onset,  progressive  neurodegen-­‐‑
erative   diseases   such   as   Alzheimer`s,   Parkinson`s   and   Huntington`s   disease,   amyo-­‐‑
trophic   lateral   sclerosis   (ALS)   or   Charcot-­‐‑Marie-­‐‑Tooth   (Cassereau   et   al.,   2011;   Lin   &  
Beal,  2006).  Furthermore,  due  to  the  complexity  of  mitochondria,  impaired  function  of  
many  mitochondrial  proteins  can  lead  to  clinically  heterogeneous  syndromes,  also  re-­‐‑
ferred  to  as  “mitochondrial  diseases”.  Many  of  the  diseases  arise  as  a  result  of  ETC  dys-­‐‑
functions   and  may   present   at   any   age   (Chinnery,   2014;   Zeviani  &  Di  Donato,   2004).  
Whereas   acquired  mitochondrial   disorders  manifest   from  accumulation   of  mitochon-­‐‑
drial   damage   over   time,   inherited   disorders   are   caused   by   mutations   in   nuclear   or  
mtDNA  genes.   Furthermore,   the  unique   character   of  mitochondrial   genetics  displays  
maternal   and   autosomal   variations,   making   genetic   counselling   challenging.   While  
some  mitochondrial  disorders  only  affect  single  organs,  many  involve  multiple  organ  
systems  and  often  present  with  progressive  neuronal  decline  and  myopathic   features  
(Venna,  2004)  (Figure  2-­‐‑1).    
  
Figure   2-­‐‑1:  Organ   systems   commonly   affected  by  mitochondrial   dysfunction.   Inherited   and  
spontaneous  mutations  in  mitochondrial  genes  encoded  by  nuclear  or  mitochondrial  DNA  can  
cause   severe  mitochondrial   dysfunction.   The   resulting   syndromes   can   be   very   heterogeneous  
and  a  variety  of  organs  may  be  affected.  
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Accordingly,  cells  with  high-­‐‑energy  expenditure  such  as  neurons,  myocytes  and  
cardiomyocytes   are   most   vulnerable   to   changes   in   mitochondrial   function.   Conse-­‐‑
quently,  most   syndromes,   e.g.  Leigh   syndrome;  neuropathy,   ataxia,   retinopathia  pig-­‐‑
mentosa  (NARP);  mitochondrial  myopathy,  encephalopathy,  lactic  acidosis,  and  stroke  
(MELAS);   myoclonic   epilepsy   myopathy   sensory   ataxia   (MEMSA);   Leber   hereditary  
optic   neuropathy   (LHON);   myoclonic   epilepsy   with   ragged   red   fiber   (MERRF)   and  
chronic   progressive   external   ophthalmoplegia   (CPEO)   display   common   pathological  
phenotypes  such  as  neuronal  degeneration,  muscular  atrophy  and  vision  impairments  
(Schapira,  2012).  However,  even  tissues  with  a  relatively  low  metabolic  demand  can  be  
affected,   including   peripheral   nerves,   sensory   organs,   kidneys   and   endocrine   tissues  
(DiMauro,  2004).  
The   complexity   of   the   mitochondrial   system   and   variability   of   symptoms   and  
genetic   mutations   make   both   diagnosis   and   treatment   of   mitochondrial   disorders   a  
challenge.  No  effective   treatments  have  been  developed  so   far  and   therapy   is  mainly  
limited   to   the   amelioration   of   the   specific   symptoms   (Benit   et   al.,   2008).  Affected  pa-­‐‑
tients   are   commonly   treated   by   dietary   intervention.   Furthermore,   individuals   with  
ETC  deficiency  may  benefit  from  administration  of  riboflavin  or  coenzyme  Q10.  How-­‐‑
ever  a  cure  is  not  available.  In  part,  this  can  be  attributed  to  the  lack  of  suitable  animal  
models  for  research.  
  2.2.2  Animal  models  of  mitochondrial  disease  
Many   mitochondrial   diseases   result   from   mutations   in   mtDNA.   The   develop-­‐‑
ment   of   mouse   models   that   carry   mutations   in   the   mitochondrial   genome   has   been  
challenging.   Due   to   the   non-­‐‑Mendelian   inheritance   of  mtDNA,  mitochondrial  muta-­‐‑
tions  are   transmitted  maternally  and   therefore  only   inherited   from   the  mother   to  her  
children   (Dogan   &   Trifunovic,   2011).   Furthermore,   each   cell   contains   hundreds   of  
mtDNA  copies.  This   results   in  mtDNA  heteroplasmy,  describing   the  presence  of  dif-­‐‑
ferent  mtDNA   variants   in   a   single   cell.   Dependent   on   the   cellular   energy   demands,  
heteroplasmy  leads  to  a  threshold  effect  where  a  critical  level  of  a  pathogenic  mutation  
needs  to  be  present  to  cause  a  deleterious  effect  (Bourgeron  et  al.,  1993;  Chomyn  et  al.,  
1992;  Hanna  et  al.,  1995).  Consequently,  mutations  often  affect  only  some  mitochondria,  
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leaving   others   unimpaired.  Whereas   for   patients   suffering   from   a  mitochondrial   dis-­‐‑
ease   the   threshold   effect   is   an   important   factor   for   the   severity  of   the   symptoms,   the  
inconsistency   of   affected   mitochondria   aggravates   the   research   in   mouse   models   of  
mtDNA  dysfunction.    
The   first   “mito-­‐‑mouse”  was   generated   by   the   introduction   of   exogenous  mito-­‐‑
chondria   carrying   an  mtDNA  deletion   into  mouse   zygotes   (Inoue   et   al.,   2000).  Mito-­‐‑
mice  exhibit  some  symptoms  correlated  with  mitochondrial  disease  such  as  low  body  
weight,  lactic  acidosis,  systemic  ischemia,  hearing  loss  and  male  infertility  (Inoue  et  al.,  
2000;  Nakada   et   al.,   2006).  However,   the   overall   phenotype  mimics  more   specifically  
human  early-­‐‑onset  Pearson  syndrome  that  is  caused  by  a  single  heteroplasmic  mtDNA  
deletion.  To  overcome  specificity  of  mutations  introduced  into  mtDNA,  the  restriction  
endonuclease  PstI  was  expressed  in  mitochondria  of  mouse  skeletal  muscle  (Srivastava  
&   Moraes,   2001).   This   leads   to   double-­‐‑strand brakes and subsequent depletion of 
mtDNA, which ultimately results in mitochondrial   myopathy.   mtDNA  maintenance  
and   gene   expression   is   dependent   on   proteins   encoded   by   nuclear   DNA.   Therefore,  
disruption  of  nuclear-­‐‑encoded  genes  can  ultimately  lead  to  mtDNA  damage  and  mito-­‐‑
chondrial   dysfunction.   Various   models   have   been   generated   by   disruption   of   these  
genes,  including  the  mitochondrial  transcription  factor  A  (TFAM,  (Larsson  et  al.,  1998),  
thymidine   kinase   2   (TK2,   (Akman   et   al.,   2008;   Zhou   et   al.,   2008)   and   mitochondrial  
DNA  polymerase  subunit  gamma  (POLG,   (Kujoth   et   al.,   2005;  Trifunovic   et   al.,   2004).  
Although,  the  different  models  show  specific  phenotypes,  they  all  suffer  from  myopa-­‐‑
thies  and  premature  death.  
Nevertheless,  mitochondrial  diseases  are  not   restricted   to  mutations   in  mtDNA  
as  only  13  protein  subunits  of  the  respiratory  chain  are  encoded  by  the  mitochondrial  
genome.  Diseases  caused  by  mutations  in  nuclear  encoded  genes  are  a  very  heteroge-­‐‑
neous  group.  Nuclear  DNA  encodes  for  both  structural  proteins  of   the  OXPHOS  sys-­‐‑
tem  and  proteins  required  for  their  import  and  assembly  in  the  mitochondria.  Defects  
in   any  of   these  proteins   can   lead   to   functionally   impaired  OXPHOS  and   therefore   to  
mitochondrial  disease.  Germ  line  and  tissue-­‐‑specific  knockout  mice  have  been  generat-­‐‑
ed   for   a   number   of   mitochondrial   proteins.   These   include   the   adenine   nucleotide  
transporter   (Ant1,   (Graham   et   al.,  1997),   the  antioxidant  genes  glutathione  peroxidase  
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(GPx1)  and  superoxide  dismutase  (Sod2,  (de  Haan  et  al.,  1998;  Esposito  et  al.,  2000);  (Li  
et   al.,   1995;  Melov   et   al.,   1999)   and   Frataxin   (FRDA),   involved   in  mitochondrial   iron  
homeostasis   (Puccio   et  al.,  2001).  Again,   these  mice  display  features  of  myopathy  and  
die  early.  Nevertheless,  to  date,  no  mouse  models  have  been  successfully  created  that  
recapitulate  defects  in  the  respiratory  chain  protein  subunits  (Hance  &  Larsson,  2005).  
  2.2.3  Mitochondrial  dysfunction  in  the  harlequin  mouse  
A  mitochondrial  disorder   that  primarily  affects  brain  and  muscle   tissue  and  re-­‐‑
sults  in  severe  muscle  atrophy  and  progressive  neurodegeneration  has  been  associated  
with  the  mitochondrial  protein  apoptosis-­‐‑inducing  factor  (AIF;  Chapter  2.3  ).  Patients  
carrying  a  deletion  of   the  AIFM1   arginine   residue  R201  suffer   from  severe  mitochon-­‐‑
drial   encephalomyopathy,   characterised  by  delayed  psychomotor  development,  mus-­‐‑
cle  atrophy,   sensory  neuropathy,   seizures  and  respiratory   insufficiency   (Ghezzi   et   al.,  
2010).  The  pathology  results  from  impaired  ETC  function  and  decreased  levels  of  mito-­‐‑
chondrial  C  I.  Accordingly,  a  reduction  of  C  I  has  also  been  demonstrated  in  harlequin  
mice  (Benit  et  al.,  2008;  Vahsen  et  al.,  2004).  Harlequin  mice  show  up  to  80  %  reduction  in  
AIF  protein  levels  due  to  a  pro-­‐‑viral  insertion  in  the  regulatory  region  of  the  gene  and  
display  features  of  progressive  neurodegeneration,  ataxia  and  muscle  atrophy.  There-­‐‑
fore,   the   harlequin  mouse   is   one   of   the   few  models   that   show   a   defect   in   respiratory  
chain  complex  function.  Consequently,  the  harlequin  mouse  might  serve  as  a  model  to  
identify   molecular   mechanisms   of   impaired   OXPHOS   and   provide   valuable   infor-­‐‑
mation  of  potential  targets  for  the  development  of  treatments  for  mitochondrial  diseas-­‐‑
es  (Benit  et  al.,  2008).    
  2.2.4  C.  elegans  as  a  model  organism  for  mitochondrial  dysfunction  
Nevertheless,   the  mouse   is   a   rather   complex   organism   and   entails   some  draw-­‐‑
backs  as  an  in  vivo  model.  Therefore,  a  simpler  organism  such  as  C.  elegans  might  pro-­‐‑
vide  a  suitable  tool  for  the  study  of  underlying  pathways  and  mechanisms.  In  fact,  var-­‐‑
ious  C.  elegans  mutant  strains  of  ETC  dysfunction  display  OXPHOS  deficiency  that  ul-­‐‑
timately  affects  C.  elegans  phenotype  and  lifespan.   Important  models  of  ETC  dysfunc-­‐‑
tion   include  mutations   in   the   ETC   subunit   genes   gas-­‐‑1,  nuo-­‐‑1,   nuo-­‐‑2   and  nuo-­‐‑6   (C   I),  
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mev-­‐‑1   (C   II),   isp-­‐‑1,   cyc-­‐‑1   and  ucr-­‐‑2.3   (C   III),   cco-­‐‑1   (C   IV)  and  atp-­‐‑3   (C  V)   (Dancy   et   al.,  
2015;  Tsang  &  Lemire,  2003).  Furthermore,  clk-­‐‑1  encodes  for  a  demethyloxyubiquinone  
monoxygenase  necessary  for  the  synthesis  of  ubiquinone  that  serves  as  an  electron  car-­‐‑
rier  from  CI/CII  to  CIII.  Notably,  although  all  these  mutations  affect  ETC  function  and  
lead   to   impaired   OXPHOS,   the   effect   on   the   nematodes   lifespan   is   heterogeneous.  
Whereas  gas-­‐‑1   and  mev-­‐‑1  mutations   significantly   decrease   their   lifespan,   other  muta-­‐‑
tions  have  no  effect  or  even  promote  longevity,  such  as  nuo-­‐‑6  and   isp-­‐‑1   (Baruah  et  al.,  
2014).  Despite  the  different  effect  on  lifespan,  C.  elegans  ETC  mutants  serve  as  genetic  
models  to  study  underlying  pathways  of  impaired  OXPHOS.  Nevertheless,  the  lack  of  
mouse   model   equivalents   to   these   invertebrate   mutants   make   translational   research  
challenging.  To  this  end,  a  C.  elegans  model  of  AIF  deficiency  might  provide  an  inver-­‐‑
tebrate  model  of  ETC  deficiency  that  recapitulates  the  phenotype  observed  in  harlequin  
mice  to  study  underlying  mechanisms  of  OXPHOS  impairment.  
  2.3  Apoptosis  Inducing  Factor  
The  stability  and  function  of  the  ETC  depends  on  the  correct  assembly  of  the  res-­‐‑
piratory  complexes   subunits.  Moreover,   stabilisation  of   the  maturated  proteins   is   im-­‐‑
portant  for  OXPHOS  function  and  provides  structural  rigidity  against  adverse  events.  
Mitochondrial  C  I  assembly  is  an  intricate  dynamic  process  that  involves  various  pro-­‐‑
teins  and  prosthetic  groups  (McKenzie  &  Ryan,  2010).  A  protein  that  has  been  associat-­‐‑
ed  with  ETC  stability  and  C  I  assembly  is  the  mitochondrial  flavoprotein  AIF.  
  2.3.1  AIF  in  apoptosis  
The  name  of  AIF  derives  from  its  original  discovery  as  a  protein  that  plays  a  key  
role  in  triggering  apoptotic  cell  death  (Daugas  et  al.,  2000)  (Figure  2-­‐‑2).  It  was  primarily  
found   to   be   an   integral   protein   located   in   the   IMS,   anchored   to   the   IM   (Susin   et   al.,  
1999),  and  later  to  the  OM  (Yu  et  al.,  2009).  Upon  cytotoxic  insult,  mature  AIF  is  cleaved  
and  truncated  AIF  (tAIF)  is  released  from  mitochochondria  to  the  cytosol  (Polster  et  al.,  
2005;  Yuste  et  al.,  2005).  Together  with  cyclophilin  A  (CypA)  and  CPS-­‐‑6/endonuclease  
G  (EndoG),  tAIF  is  eventually  translocated  to  the  nucleus  (Cande  et  al.,  2004).  Whereas  
CypA  promotes  nuclear  translocation  of  AIF,  the  heat  shock  protein  Hsp70  inhibits  re-­‐‑
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localisation   (Gurbuxani   et   al.,   2003).  Hsp70   is   a   chaperone   that   is   expressed  upon   in-­‐‑
duced   stress   (Daugaard   et   al.,   2007).  As   a  primary   stress   response,   chaperones   aid   in  
the   structural   reassembly  of  proteins   in  affected  organelles   to  prevent  organellar  and  
cellular  damage.  Therefore,  Hsp70  inhibits  nuclear  tAIF  translocation  to  prevent  prem-­‐‑
ature  cell  death  (Matsumori  et  al.,  2005).  However,  when  the  protein  enters  the  nucleus,  
tAIF  recruits  CypA  and  associates  with  histone  H2AX  (Artus  et  al.,  2010).  This  interac-­‐‑
tion  induces  chromatinolysis  and  DNA  degradation  (Artus   et  al.,  2010;  Baritaud   et  al.,  
2010).   In  C.  elegans,   tAIF   and  EndoG   trigger   chromatin   condensation   and  DNA   frag-­‐‑




Figure  2-­‐‑2:  Functions  of  AIF  in  cell  survival  and  apoptosis.  Mature  AIF  is  located  in  the  inter-­‐‑
membrane   space   (IMS)   of   mitochondria   and   important   for   stabilising   the   electron   transport  
chain   (ETC)   in  non-­‐‑apoptotic   conditions.  Upon   induced  apoptosis,  AIF   is   cleaved  by  calpains  
and  cathepsins.  Truncated  AIF  (tAIF)  is  released  from  the  mitochondria,  recruits  cyclophilin  A  
(CypA)  and  translocates  to  the  nucleus.  In  the  nucleus,  tAIF  forms  a  complex  with  CypA,  endo-­‐‑
nuclease  G   (EndoG)  and  Histone  H2AX  and   induces   chromatin   condensation  and  DNA   frag-­‐‑
mentation.  
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  2.3.2  AIF  in  ETC  stabilisation  
Importantly,   AIF   is   involved   in   the   assembly   of   C  I   and   indispensible   for   cell  
survival.   For   instance,  C  I   subunit   levels   (NDUFA9,  NDUFS7   and  NDUFB6   in  mam-­‐‑
mals)   are   reduced   in   cells   lacking  AIF   and   the   harlequin   mouse   brain   (Vahsen   et   al.,  
2004).  AIF  exhibits  NADH  and  NADPH  oxidase  activity  (Miramar  et  al.,  2001)  and  can  
form  stable  NADH-­‐‑associated  dimers  (Churbanova  &  Sevrioukova,  2008),  suggesting  a  
possible   role   in   redox-­‐‑dependent   substrate   delivery   to  C  I   (McKenzie  &  Ryan,   2010).  
Furthermore,  AIF   interacts  with   the  dynamin-­‐‑related  GTPase   optic   atrophy   1   (Opal),  
located   in   the   IM  (Cipolat   et   al.,   2004;  Meeusen   et   al.,   2006).  Opal   is   implicated   in   the  
fusion  of   the  mitochondrial   IM  and  critical  during  apoptosis  signalling.  Nevertheless,  
the  role  of  AIF  in  C  I  biogenesis  remains  elusive  as  no  direct  association  with  any  struc-­‐‑
tural  subunits,  assembly  intermediates,  or  mature  C  I  has  been  found.  
  2.4  Stress  response  mechanisms  and  ageing  
Pathophysiological  conditions  such  as  impaired  ETC  function,  for  instance  by  C  I  defi-­‐‑
ciency,   may   induce   strong   mitochondrial   stress.   However,   also   under   physiological  
conditions  temporal  cellular  and  mitochondrial  stress  can  occur.  For  example,  physical  
activity  increases  energy  expenditure,  temperature  and  the  generation  of  ROS  (Di  Meo  
&  Venditti,  2001).  To  prevent  cellular  damage,  cells  respond  to  a  wide  variety  of  stress-­‐‑
es   through   the   transcriptional   activation  of  protective  genes.  Organelle-­‐‑specific   stress  
can   induce   retrograde   signalling   specific   to   the   subcellular   compartments.   The  mito-­‐‑
chondria-­‐‑specific   stress   response   is   termed  mitochondrial   unfolded   protein   response  
(UPRmt).  
  2.4.1  Mitochondrial  Unfolded  Protein  Response  (UPRmt)  
Mitochondrial  stress  commonly  leads  to   loss  of  membrane  potential  and  results  
in  disturbed  organelle  homeostasis  (Satoh  et  al.,  1997).  This  homeostatic  imbalance  af-­‐‑
fects  the  equilibrium  of  newly  synthesised  mitochondrial  proteins  and  chaperones  that  
assist   in   correct  protein   folding   (Haynes  &  Ron,  2010).  As  a   consequence,  proteins   in  
the  mitochondrial  matrix   become  misfolded   or   even   unfolded.   These   non-­‐‑functional  
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proteins  are  recognised  by  the  cell  and  cleaved  by  the  mammalian  mitochondrial  ma-­‐‑
trix  protease  ClpP  orthologue  CLPP-­‐‑1  in  C.  elegans  (Benedetti  et  al.,  2006;  Haynes  et  al.,  
2007)  (Figure  2-­‐‑3).  The  peptide  products  are  then  exported  from  the  matrix  to  the  cyto-­‐‑
sol  by  the  mitochondrial  half-­‐‑molecule  ATP-­‐‑binding  cassette  (ABC)  transporter  (HAF-­‐‑
1).  In  the  cytosol,  the  peptide  products  originating  from  mitochondrial  proteins  induce  
formation   of   a   protein   complex   between   the   homeodomain-­‐‑containing   transcription  
factor  defective  proventriculus   (in  drosophila)   homolog   (SatB2/DVE-­‐‑1)   and   the   small  
ubiquitin-­‐‑like  protein  Ubl5/UBL-­‐‑5   (Benedetti   et   al.,   2006).   This   complex   is   then   redis-­‐‑
tributed   to   the   nucleus  where   it   binds   to   the   promoters   of  mitochondrial   chaperone  
genes  and  enhances  their  expression  (Haynes  et  al.,  2007).  These  chaperones  (e.g.  HSP-­‐‑6  
and  HSP-­‐‑60)  are  transported  back  to  mitochondria  and  assist  in  the  folding  of  proteins  
to  restore  mitochondrial  homeostasis  (Martinus  et  al.,  1996;  Ryan  &  Hoogenraad,  2007;  
Zhao   et   al.,   2002).  This   reaction   to  mitochondrial   stress  was   identified  as   the   classical  
pathway  of  UPRmt.    
  
  
Figure  2-­‐‑3:  Schematic  overview  of  the  mitochondrial  unfolded  protein  response  (UPRmt).  (A)  
The  transcription  factor  ATFS-­‐‑1  is  constantly  translated  in  the  cytosol  of  the  cell  and  contains  a  
nuclear   localisation   sequence   (NLS)   and   a   mitochondrial   targeting   sequence   (MTS).   Under  
normal  conditions  ATFS-­‐‑1   is   translocated  into  the  mitochondrial  matrix  and  degraded  by  Lon  
protease.   (B)  When  mitochondria   are   stressed,   newly   synthesised  mitochondrial   proteins   be-­‐‑
come  misfolded  or  unfolded  and  are  cleaved  by  Clp  protein  (ClpP)  into  small  peptides.  These  
peptides   are   then   exported   through   the  HAF-­‐‑1   transporter   and   activate  UBL-­‐‑5   and   the   tran-­‐‑
scription  factor  DVE-­‐‑1.  DVE-­‐‑1/UBL-­‐‑5  translocate  to  the  nucleus  and  induce  expression  of  heat-­‐‑
shock   proteins   (HSP-­‐‑6   and  HSP-­‐‑60)   that   are   transported   to  mitochondria   and   aid   in   protein  
folding.   Furthermore,  mitochondrial   stress   affects   the  membrane   potential   and   impairs  mito-­‐‑
chondrial  import  proteins.  Hence,  ATFS-­‐‑1  translocates  into  the  nucleus  and  induces  expression  
of  HSPs.  
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However,   a   second   potent  mediator   of   the   UPRmt   that   operates   in   parallel   to  
DVE-­‐‑1/UBL-­‐‑5  was  identified  thereafter.  Activating  transcription  factor  associated  with  
stress  (ATFS-­‐‑1)  is  a  bZip  transcription  factor  that  acts  downstream  of  HAF-­‐‑1  and  medi-­‐‑
ates  the  expression  of  the  heat  shock  proteins  HSP-­‐‑6  and  HSP-­‐‑60  (Haynes  et  al.,  2010).  
However,   later   it   was   demonstrated   that   ATFS-­‐‑1   is   not   activated   by   exported  mito-­‐‑
chondrial  peptides  but  rather  depends  on  the  import  efficiency  of  mitochondrial  trans-­‐‑
porters  (Nargund  et  al.,  2012).  ATFS-­‐‑1  is  permanently  produced  in  the  cytosol  and  con-­‐‑
tains   both   a   mitochondrial   targeting   sequence   (MTS)   and   a   nuclear   localisation   se-­‐‑
quence  (NLS).  Under  normal  conditions,  ATFS-­‐‑1  is  transported  into  the  mitochondria  
where   it   is   immediately  degraded  by  Lon  protease   (Nargund   et   al.,   2012).  Both  mito-­‐‑
chondrial  stress  and  altered  mitochondrial  membrane  potential  lead  to  impairment  of  
mitochondrial   transporters,   which   finally   fail   to   channel   ATFS-­‐‑1   into   the   matrix.  
Hence,  ATFS-­‐‑1   accumulates   in   the   cytosol   and   is   imported   into   the  nucleus  where   it  
induces  the  expression  of  chaperones  that  restore  mitochondrial  protein  folding  capaci-­‐‑
ty  (Rauthan  et  al.,  2013).  Therefore,  the  UPRmt  is  an  important  mechanism  in  the  quali-­‐‑
ty  control  and  stress  response  of  mitochondria  and  contributes   to   the  health  of  a  cell.  
Furthermore,  UPRmt  has  been  implicated  in  ageing  and  plays  an  important  role  for  the  
lifespan  of  long-­‐‑lived  C.  elegans  mutants  (Durieux  et  al.,  2011).  
  2.4.2  Ageing  and  pathology  
Ageing  is  an  enigmatic  fate  of  all  organisms.  Many  pathological  syndromes  from  
cardiovascular  disease,  cancer,  atherosclerosis,  impaired  vision,  diabetes  (type  2),  oste-­‐‑
oporosis   and   sarcopenia   to  neurodegenerative  diseases  manifest   at   an   advanced   age.  
For  instance,  the  relentless  neuronal  degeneration  associated  with  Alzheimer’s  disease  
(AD)  and  related  forms  of  dementia  affects  an  estimated  44  million  people  worldwide,  
set  to  almost  double  by  2030  (Huttin,  2014).  With  the  overall  increase  in  the  age  of  the  
world’s  population,  numbers  of  age-­‐‑related  disease  patients  are  expected  to  grow  ex-­‐‑
ponentially.  The  tremendous  number  of  individuals  affected  holds  an  enormous  chal-­‐‑
lenge   for   health   care   and   physicians   and   has   an   enormous   impact   on   societies.   The  
group   of   ageing-­‐‑associated   diseases   can   affect   almost   any   organ   and   encompasses   a  
variety  of  harmful  and  in  some  cases  fatal  syndromes.  This  is  due  to  increased  vulner-­‐‑
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ability  of   the  patients  caused  by  decline  in  fitness,  decrease  of  protective  mechanisms  
and   low   regenerative   capacities.   Although   the  mechanisms   that   lead   to   some   of   the  
age-­‐‑related   disorders   like   atherosclerosis   are   rather   well   characterised,   very   little   is  
known  about   the   causes  of  others,   such  as  AD  and  ALS.  For  a   long   time,  ageing  has  
been  characterised  as  a  passive  process.  However,  whereas  the  processes  of  deteriora-­‐‑
tion  may  partially  be   the   result   of   the  persistent   exposure   to   extrinsic   environmental  
and  physiological  cues,  ageing  itself  is  a  risk  factor  for  the  development  of  disease.    
Studies  on  ageing  have  demonstrated  that  a  variety  of  different  cellular  processes  
affect  the  senescence  of  an  organism.  Hallmarks  that  have  been  implicated  with  ageing  
include   telomere   length,   epigenetic   alterations,   development,   growth   factors,   hor-­‐‑
mones,  stress  response  and  diet.  Importantly,  also  mitochondria,  metabolism  and  insu-­‐‑
lin/IGF-­‐‑1  signalling  are  important  factors  in  the  ageing  process  (Lopez-­‐‑Otin  et  al.,  2013;  
Tosato  et  al.,  2007).  The  number  of  factors  involved  in  senescent  decline  and  their  het-­‐‑
erogeneous   functions   display   the   complexity   of   ageing.  Nevertheless,  many   of   these  
processes  underlie  classic  cell  signalling.  More  precisely,  like  any  other  biological  pro-­‐‑
cess,  classical  cellular  signalling  pathways  and  transcription  factors  can  influence  age-­‐‑
ing.   The   regulation   of   these   pathways   is   subject   to   environmental   and   physiological  
signals.  This  finding  reveals  that  in  fact,  ageing  is  not  just  the  coincident  and  indispen-­‐‑
sable  result  of  environmental  stress  but  also  a  genetically  inherited  trait  of  active  regu-­‐‑
lation  and  programmed  cellular  death.  Consequently,  genes  and  proteins  involved  can  
be   specifically   targeted  and  manipulated  by  genetic   or  pharmacological   intervention.  
This   finding   is   important   for   the  understanding  of   the  ageing  process  and   the  devel-­‐‑
opment  of  strategies  to  counteract  senescent  decline.  
  2.5  Insulin/IGF-­‐‑1  signalling  
  2.5.1  Insulin/IGF-­‐‑1  signalling  and  lifespan  
Many   pathways   that   extend   lifespan   have   been   discovered   through   studies   in  
nematodes.   These   include   the   longevity   effect   of   caloric   restriction   and  mechanisms  
involving   genes   that   affect   the   rate   of   development   and   behaviour   in   C.   elegans  
(Lakowski  &  Hekimi,   1998).   Insulin/insulin-­‐‑like   growth   factor   (IGF-­‐‑1)   signalling   (IIS)  
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has  been  identified  to  be  the  single  most  important  pathway  to  regulate  lifespan.  Muta-­‐‑
tions  that  decrease  the  activity  of  DAF-­‐‑2  or  other  proteins  involved  in  the  IIS  can  dou-­‐‑
ble  the  lifespan  of  the  animals  (Kenyon  et  al.,  1993;  Kimura  et  al.,  1997).  Importantly,  the  
role  of   the   IIS   is  conserved  across  species  and  downregulation  of   the  signalling  path-­‐‑
way   or   activation   of   downstream   targets   such   as   abnormal   dauer   formation-­‐‑
16/forkhead-­‐‑box-­‐‑protein  (DAF-­‐‑16/FOXO,  Chapter  2.5.3  )  has  been  demonstrated  to  ex-­‐‑
tend   the   lifespan   in   various   organisms   (Bartke,   2008).   Thus,   IIS   reduction   hyperac-­‐‑
tivates   downstream   transcription   factors   that   create   stress   response   and   long-­‐‑lived  
worms  (Kenyon,  2005).  The  transcription  factors  cooperatively  regulate  pathways  that  
adapt  metabolism  and  growth  to  environmental  conditions  (Jasper,  2008).  
In  the  fruitfly  Drosophila  melanogaster,  inhibiting  IIS  results  in  similar  consequenc-­‐‑
es   for   the   organism   as   observed   in   nematodes   (Giannakou  &   Partridge,   2007).   Both,  
systemic  and  tissue-­‐‑specific  downregulation  leads  to  increased  lifespan,  providing  evi-­‐‑
dence   for   cell  non-­‐‑autonomous  signalling.   In  mice,   low   levels  of   IGF-­‐‑1  correlate  with  
increased  stress  resistance  (Holzenberger  et  al.,  2003).  Mutations  in  genes  encoding  for  
the  insulin  and  IGF-­‐‑1  receptor  as  well  as  inhibition  or  activation  of  upstream  regulators  
and   downstream   targets   can   extend   lifespan   (Bartke,   2008;  Holzenberger   et   al.,   2003;  
Kappeler   et   al.,   2008;   Selman   et   al.,   2008;  Yuan   et   al.,   2009).   Even   in   dogs   it   has   been  
demonstrated   that   a   mutation   that   decreases   IGF-­‐‑1   levels   results   in   an   extension   of  
lifespan  (Greer  et  al.,  2011;  Kraus  et  al.,  2013).  The  finding  that  mutations  in  IIS  lead  to  a  
long   life   is   intriguing,  given   that   it   is   such  an  evolutionarily   conserved  pathway   that  
exerts   critical   cellular   functions.   Predictably,   the   idea   that   any   given   IIS   mutation  
would   increase   stress   resistance   and   lead   to   an   extension  of   lifespan  does  not   apply.  
For  example,   the  knockout  of  the  gene  encoding  for   insulin/IGF-­‐‑1  in  the  liver  of  mice  
causes   diabetes   (Yakar   et   al.,   2001).  Nevertheless,   the   consistent   effect   of   a   variety   of  
mutations  on  longevity,  consistent  across  species,  makes  IIS  an  attractive  target  for  the  
development  of  potential  treatment  in  humans.  In  fact,  even  in  humans  IIS  seems  to  be  
an  important  mechanism  of  lifespan  regulation.  The  genetic  analysis  of  various  human  
populations   around   the   globe   has   unveiled   common   functions   of   IIS   as   well   as   up-­‐‑
stream  and  downstream  effectors  (van  Heemst  et  al.,  2005).  Strikingly,  the  comparison  
of  human  cohort  subpopulations  displayed  an  overrepresentation  of  mutations  known  
Introduction  18  
to   impair   IGF-­‐‑1   receptor   function   in   long-­‐‑lived   individuals   (Kojima   et   al.,   2004;  Paw-­‐‑
likowska   et  al.,  2009;  Suh   et  al.,  2008).  Noteworthy,  many  other  human  cohort  studies  
also  underline  the  important  role  of  downstream  targets.  Throughout  the  world,  vari-­‐‑
ants  of   IGF-­‐‑1  downstream  target  genes  have  been   linked   to   longevity   (Anselmi   et   al.,  
2009;  Flachsbart  et  al.,  2009;  Li  et  al.,  2009;  Lunetta  et  al.,  2007;  Willcox  et  al.,  2008).  It  is  
worth  mentioning  that  these  populations  also  show  a  significantly  lower  risk  of  devel-­‐‑
oping  common  age-­‐‑related  diseases.  
Hence,   there   is   emerging   evidence   that   manipulating   the   ageing   process   is   a  
promising   strategy   aimed   at   postponing   the  manifestation   of   late-­‐‑onset   neurodegen-­‐‑
erative  disorders  and  to  slow  their  progression  once  emerged  (Morimoto,  2006).  Reduc-­‐‑
ing   the  activity  of   IIS  protects  worms  from  proteotoxicity  of  various  aggregative  pro-­‐‑
teins   associated   with   neurodegenerative   diseases.   These   include   the   AD-­‐‑associated  
amyloid   beta   (Aβ)   peptide   (Link,   1995)   and   the   Huntington’s   disease   (HD)-­‐‑linked  
polyQ40  peptide  (Morley  et  al.,  2002).  Similarly,  reduction  of  IGF-­‐‑1  signalling  protects  
mice   from  AD-­‐‑like  diseases   (Cohen   et  al.,  2009).  Furthermore,  pharmacological   IIS   in-­‐‑
hibitors  have  been  reported  to  mediate  efficient  reduction  of  the  signalling  cascade  and  
protect   nematodes   from  AD-­‐‑   and  HD-­‐‑associated   proteotoxicity   (El-­‐‑Ami   et   al.,   2014).  
Moreover,   they   promote   stress   resistance   and   are   used   in   clinical   trials   for   cancer  
treatment  (Weroha  &  Haluska,  2008).  Results  like  these  prove  that  IIS  inhibition  has  a  
therapeutic   potential   as   a   treatment   for   neurodegenerative   maladies   (Cohen,   2011).  
Furthermore,  manipulation   of   ageing-­‐‑related   pathways  might   have   beneficial   effects  
for  other  pathologies.  
  2.5.2  The  insulin/IGF-­‐‑1  signalling  pathway  
In  mammals,  the  insulin-­‐‑like  growth  factor  1  receptor  (IGF1R)  is  present  on  vari-­‐‑
ous  cell  types  in  many  tissues  (van  Heemst,  2010).  Ligand  binding  initiates  intracellular  
IIS.   The   activated   receptor   phosphorylates   several   intracellular   substrates,   inducing  
two  major  signalling  pathways:  The  PI-­‐‑3K-­‐‑  PKB/AKT  pathway  is  a  central  regulator  of  
cell  metabolism,  whereas  the  Ras-­‐‑MAPK  pathway  has  been  shown  primarily  to  regu-­‐‑
late   cell   proliferation   (Taniguchi   et   al.,   2006).   The  C.   elegans   receptor   abnormal  dauer  
formation-­‐‑2  (DAF-­‐‑2)  is  the  sole  IGF1R  homolog  in  nematodes  (Lin  et  al.,  2001).  Interest-­‐‑
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ingly,  nematodes  express  40  insulin/IGF-­‐‑1-­‐‑like  peptides,  agonists  and  antagonists  that  
affect  IIS  function  (Pierce  et  al.,  2001).  Mediated  by  a  receptor  tyrosine  kinase,  the  bind-­‐‑
ing  of  agonist  peptides  activates  several  downstream  kinases  via  a  cascade  of  sequen-­‐‑
tial  phosphorylation  events  (Figure  2-­‐‑4):  
• phosphoinositide  3-­‐‑kinase  (AGE-­‐‑1/PI3K)  
• pyruvate  dehydrogenase  lipoamide  kinase  isozyme  (PDK-­‐‑1)  
• Akt  kinase  family  1  and  2  (AKT-­‐‑1  and  AKT-­‐‑2)  
• serine/threonine-­‐‑protein  kinase  (SGK-­‐‑1)  
  
  
Figure  2-­‐‑4:  Schematic  overview  of  insulin/IGF-­‐‑1  signalling.  (A)  Active  insulin/IGF-­‐‑1  signalling  
(IIS)   induces   a   PI3K-­‐‑dependent   phosphorylation   cascade   that   ultimately   phosphorylates   the  
transcription   factors   DAF-­‐‑16   and   SKN-­‐‑1   and   keeps   them   in   the   cytosol.   Furthermore,   heat-­‐‑
shock  factor  1  (HSF-­‐‑1)  is  inactivated  by  the  incorporation  in  a  complex  with  DDL-­‐‑1  and  DDL-­‐‑2.  
Activation  of  HSF-­‐‑1  requires  phosphorylation  of  DDL-­‐‑1/2,  which  is   inhibited  by  active  IIS.  (B)  
Upon   impairment   of   IIS,  DDL-­‐‑1/2   become   phosphorylated   and   release  HSF-­‐‑1,  which   translo-­‐‑
cates   into   the  nucleus   and   induces   expression  of   stress   response  genes.   Furthermore,  DAF-­‐‑16  
and  SKN-­‐‑1  are  no  longer  phosphorylated  by  AKT-­‐‑1/2  and  GSK-­‐‑3,  respectively,  and  also  drive  
the  expression  of  stress  response  genes.  
Ultimately,  active  PDK-­‐‑1,  AKT  and  SGK-­‐‑1  phosphorylate  the  FOXO  transcription  
factors  DAF-­‐‑16  and  nuclear   factor   (erythroid-­‐‑derived)-­‐‑like   /   skinhead  1   (NRF/SKN-­‐‑1)  
(Lee  et  al.,  2001;  Paradis  &  Ruvkun,  1998;  Tullet  et  al.,  2008).  The  phosphorylation  pre-­‐‑
vents  the  translocation  of  the  transcription  factors  to  the  nucleus  and  the  proteins  are  
kept   in   the   cytosol.   Thereby   transcription   of   target   genes   is   blocked   (Wolff  &  Dillin,  
2006).  Similarly,  IIS  negatively  regulates  heat  shock  factor  1  (HSF-­‐‑1)  by  preventing  the  
phosphorylation   of   ‘DAF-­‐‑16-­‐‑dependent   longevity’   DDL-­‐‑1   and   DDL-­‐‑2   (Chiang   et   al.,  
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2012).  DDL-­‐‑1/2  proteins  interact  with  HSF-­‐‑1  and  collaboratively  form  a  complex.  Upon  
phosphorylation  DDL-­‐‑1/2  detach  from  HSF-­‐‑1,  allowing  the  protein  to  enter  the  nucle-­‐‑
us.  There,  the  transcription  factor  promotes  expression  of  chaperones  that  assist  in  pro-­‐‑
tein  folding,  targeting  damaged  proteins  for  degradation  and  inducing  other  responses  
associated  with   the   protection   from   cellular   damage   (Hartl,   1996;   Jolly  &  Morimoto,  
2000).  
  2.5.3  DAF-­‐‑16  
IIS   regulates  a  variety  of   transcription   factors  and  co-­‐‑regulators   that   induce   the  
expression  of  a  diverse  set  of  genes  that  act  in  a  cumulative  way  to  promote  resistance  
to   various   stresses   and   ultimately   increase   lifespan   (Hsu   et   al.,   2003;   Murphy   et   al.,  
2003;  Wolff   et   al.,   2006).  The   forkhead-­‐‑box   transcription   factor  DAF-­‐‑16/FOXO  plays  a  
key   role   in   this   pathway   and   can   translocate   from   the   cytosol   to   the   nucleus.   There,  
DAF-­‐‑16/FOXO  induces  the  expression  of  a  diverse  set  of  antioxidant,  metabolic,  chap-­‐‑
erone  and  antimicrobial  target  genes  that  are  functionally  important  to  promote  stress  
resistance  (Wang  et  al.,  2008).  
However,   DAF-­‐‑16/FOXO   is   not   only   regulated   by   the   insulin/IGF-­‐‑1   receptor-­‐‑
DAF-­‐‑2.  Several  other  mechanisms  promote  DAF-­‐‑16/FOXO  nuclear  localisation,  increas-­‐‑
ing   the  regulatory  capacities  and  complexity  of   the  pathway.  Phosphatase  and   tensin  
homolog   (DAF-­‐‑18/PTEN)   dephosphorylates   and   inhibits   AGE-­‐‑1/PI3K,   preventing  
DAF-­‐‑16/FOXO  phosphorylation  (Ogg  &  Ruvkun,  1998);  c-­‐‑Jun  N-­‐‑terminal  kinase  (JNK-­‐‑
1)   stimulates   DAF-­‐‑16   nuclear   translocation   by   alternate   phosphorylation   (Oh   et   al.,  
2005);   and   type   I   protein   arginine   methyltransferase   (PRMT-­‐‑1)   promotes   nuclear  
maintenance  of  DAF-­‐‑16   (Takahashi   et   al.,   2011).   Furthermore,   the   transcription   factor  
SKN-­‐‑1  can  act   together  with  DAF-­‐‑16  and  regulate  stress  resistance  and  detoxification  
genes  downstream  of  DAF-­‐‑2  (Tullet  et  al.,  2008).  Among  others,  these  factors  modulate  
DAF-­‐‑16/FOXO   activity   and   regulate   the   transcriptional   response   to   specific   environ-­‐‑
mental   and   physiological   signals.   The   extensive   regulatory   opportunities   of   DAF-­‐‑
16/FOXO  point  to  a  diverse  cellular  effect  when  the  transcription  factor  is  activated.  In  
fact,   gene   expression   profiling   of   daf-­‐‑2   mutants   has   identified   hundreds   of   DAF-­‐‑16-­‐‑
regulated  genes  (Halaschek-­‐‑Wiener  et  al.,  2005;  McElwee  et  al.,  2003;  Murphy,  2006).  In  
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C.  elegans   these   genes   are   responsible   for   the   twofold   lifespan   extension   in   the   long-­‐‑
lived  daf-­‐‑2  mutants  (Kenyon  et  al.,  1993).  
  2.6  HIF-­‐‑1  
Another  factor  that  is  co-­‐‑regulated  by  IIS  is  the  hypoxia-­‐‑inducible  factor  (HIF-­‐‑1).  
Oxygen  plays  a  central  role  for  the  survival  of  multicellular  organisms  since  they  rely  
on  oxidative  respiration  (Lane  &  Martin,  2010).  Low  O2  levels  or  the  generation  of  reac-­‐‑
tive  oxygen  species  (ROS)  that  react  with  cellular  macromolecules  can  lead  to  oxidative  
stress  and  result   in  cell  dysfunction  or  death.  As  a  consequence,  metazoan  organisms  
have   developed   elaborate   cellular   systems   that   maintain   oxygen   homeostasis  
(Semenza,   2012).   HIF-­‐‑1   activates   glycolytic   enzymes   and   is   critical   for   the  metabolic  
adaptation   to   hypoxic   condition   (Loenarz   et   al.,   2011).   It   acts   like   a  metabolic   switch  
that   shunts   glucose  metabolites   from   the  mitochondria   to   the   cytoplasm   in   order   to  
maintain  ATP  production  by  glycolysis  and  promote  longevity  (Kim  et  al.,  2006).  
HIF-­‐‑1  consists  of   two  subunits:  HIF-­‐‑1α  and  HIF-­‐‑1β.  Both  subunits  contain  basic  
helix-­‐‑loop-­‐‑helix  domains  (bHLH)  (Ema  et  al.,  1997;  Wang  et  al.,  1995)  and  work  only  as  
a  heterodimer.  While  ubiquitous  HIF-­‐‑1β  is  present  in  excess  and  heterodimerises  with  
other   bHLH   proteins,   HIF-­‐‑1α   protein   levels   determine  HIF-­‐‑1   transcriptional   activity  
(Semenza  et  al.,  1996).  Under  normoxic  conditions,  HIF-­‐‑1α  is  bound  to  the  von  Hippel-­‐‑
Lindau  (VHL)  protein  (Figure  2-­‐‑5).  VHL  recruits  an  ubiquitin  ligase  that  targets  HIF-­‐‑1α  
for  proteasomal  degradation   (Kaelin  &  Ratcliffe,   2008).  VHL  binding  depends  on  hy-­‐‑
droxylation,   mediated   by   prolyl   hydroxylase   domain   proteins   (PHD1-­‐‑3,   homolog   in  
C.  elegans:   EGL-­‐‑9).   The   hydroxylation   of   specific   proline   residues   in  HIF-­‐‑1α   by   EGL-­‐‑
9/PHD  requires  molecular  O2  as  a  substrate,  and   thus,   this  process   is   inhibited  under  
hypoxic  conditions  (Epstein  et  al.,  2001).  As  a  consequence,  HIF-­‐‑1α  and  HIF-­‐‑1β  translo-­‐‑
cate   into   the   nucleus   and   heterodimerise.   Subsequently,   the   complex   binds   to   DNA  
and  induces  the  transcription  of  more  than  100  genes  crucial  for  adaptation  to  hypoxia  
(Jiang   et   al.,  1996;  Semenza  &  Wang,  1992).   In  addition   to   the  enzymatic   inhibition  of  
EGL-­‐‑9/PHD,  increasing  levels  of  cytoplasmic  ROS  can  control  HIF-­‐‑1.  ROS  are  generat-­‐‑
ed  by  perturbed  mitochondrial  ETC  and  alter  the  oxidation  state  of  Fe2+  (a  co-­‐‑factor  for  
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PHD  activity)  to  Fe3+.  Such  oxidised  ions  cannot  be  utilised,  inhibiting  EGL-­‐‑9/PHD  ac-­‐‑
tivity  and  promoting  HIF-­‐‑1α  stabilisation  (Simon,  2006).  Nevertheless,  the  role  of  ROS  
in  hypoxia  and  HIF-­‐‑1   regulation  remains  controversial  owing   to  discrepancies   in  dif-­‐‑
ferent  model   systems   as  well   as   the   debate   over   tools   for   accurate   detection   of   ROS  
(Yee  Koh  et  al.,  2008).  Furthermore,  various  other  factors  have  been  implicated  in  HIF-­‐‑1  
regulation  independent  of  VHL-­‐‑1  or  PHD  (Berchner-­‐‑Pfannschmidt  et  al.,  2004;  Epstein  
et   al.,   2001;  Lando   et   al.,   2002;  Mahon   et   al.,   2001;  Nakayama  &  Ronai,   2004).   In   sum-­‐‑
mary,  the  regulation  of  HIF-­‐‑1α  protein  levels  is  complex.  It  involves  multiple  pathways  
and  regulatory  factors  that  are  oxygen-­‐‑independent  and  rely  on  posttranslational  regu-­‐‑
lation  and  other  signalling  pathways,  some  yet  to  be  fully  characterised  (Arnesen  et  al.,  
2005;   Arsham   et   al.,   2002;   Bae   et   al.,   2004;   Baek   et   al.,   2007;   Carbia-­‐‑Nagashima   et   al.,  
2007;  Cheng  et  al.,  2007;  Jung  et  al.,  2006;  Koritzinsky  et  al.,  2006;  Li  et  al.,  2005;  Liu  et  al.,  
2007a;  Liu  et  al.,  2007b;  Mottet  et  al.,  2003;  Shao  et  al.,  2004;  Sonenberg  &  Hinnebusch,  
2007;  Stiehl  et  al.,  2002;  Toker  &  Newton,  2000;  van  den  Beucken  et  al.,  2006).  
  
Figure   2-­‐‑5:   Schematic   overview   of   HIF-­‐‑1   signalling.  Under   normoxic   conditions,   HIF-­‐‑1α   is  
bound   to   the  von  Hippel-­‐‑Lindau   (VHL)  protein  mediated  by  prolyl  hydroxylase  domain  pro-­‐‑
teins   (PHD1-­‐‑3).   The   complex   recruits   an   ubiquitin   ligase   and   targets  HIF-­‐‑1α   for   proteasomal  
degradation.  VHL-­‐‑1  binding  is  inhibited  under  hypoxic  conditions  and  HIF-­‐‑1α  translocates  into  
the  nucleus  along  with  ubiquitously  expressed  HIF-­‐‑1β.  Subsequently,  the  two  subunits  dimerise  
and  induce  gene  expression.  
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  2.7  AMP-­‐‑activated  Kinase  (AMPK)  
  Similar  to  HIF-­‐‑1,  AMP-­‐‑activated  Kinase  (AMPK,  AAK-­‐‑2  in  C.  elegans)  is  a  meta-­‐‑
bolic   sensor   that   efficiently   controls   energy   metabolism,   cellular   housekeeping   and  
stress   resistance.  AMPK/AAK-­‐‑2  promotes   food   intake  and   influences  energy  metabo-­‐‑
lism  on  the  organism  level.  The  metabolic  sensor  is  activated  upon  low  energy  condi-­‐‑
tions  and  primarily  promotes  catabolism  over  anabolic  reactions  (Ferrer  et  al.,  1985;  Yeh  
&  Kim,  1980;  Yeh  et  al.,  1980).  Reduced  energy  levels  result   in  decreased  ATP  and  in-­‐‑
creased  AMP  levels.  This  high  AMP/ATP  ratio  activates  AMPK/AAK-­‐‑2,  which  conse-­‐‑
quently  switches  off  anabolic  pathways  (Lee  et  al.,  2008).  For  example,  energy  produc-­‐‑
tion  from  glucose  and  fatty  acids  is  stimulated,  whereas  energy  consumption  for  pro-­‐‑
tein,   cholesterol,   triglyceride   and   glycogen   synthesis   is   inhibited   (Hardie,   2011b;  
Steinberg  &  Kemp,  2009).  Furthermore,  transcription  processes  that  consume  ATP  are  
downregulated   (Shin   et   al.,   2011).   In   contrast,   catabolic   pathways   that   generate  ATP,  
such  as   fatty  acid  oxidation  and  glycolysis  are  switched  on.  Consequently,   caloric   re-­‐‑
striction   stimulates   AMPK/AAK-­‐‑2   activity   whereas   nutritional   overload   impairs  
AMPK/AAK-­‐‑2  function  (Salminen  &  Kaarniranta,  2012).    
Although   the  name  AMP-­‐‑activated  protein  kinase   implicates  AMP  as   the  main  
and  potentially  exclusive  activator  of  AMPK/AAK-­‐‑2,  other  kinases  have  been  discov-­‐‑
ered  that  can  activate  AMPK/AAK-­‐‑2  independently  from  cellular  AMP  levels  (Witters  
et  al.,  2006).  AMPK/AAK-­‐‑2  is  a  serine/threonine  protein  kinase,  comprised  of  a  catalytic  
α-­‐‑subunit  and  regulatory  β-­‐‑  and  γ-­‐‑subunits.  Whereas   the  functional  role  of  β-­‐‑  and  γ-­‐‑  
subunit  phosphorylation   is   relatively  poor  understood,   the  phosphorylation  of   the  α-­‐‑  
subunit  regulates  AMPK/AAK-­‐‑2  activity.  The  phosphorylation  of  Thr-­‐‑172  in  the  activa-­‐‑
tion  loop  of  the  α-­‐‑  subunit  catalytic  domain  (Hawley  et  al.,  1996)  is  induced  by  the  ser-­‐‑
ine/threonine   kinase   LKB-­‐‑1   (Hawley   et   al.,   2003;   Shaw   et   al.,   2004),   Calmodulin-­‐‑
dependent  kinase  kinase  β  (CaMKKβ)  (Hawley  et  al.,  2005;  Hawley  et  al.,  1995;  Hurley  
et  al.,  2005)  and  transforming  growth  factor-­‐‑β-­‐‑activated  kinase  (TAK-­‐‑1)  (Momcilovic  et  
al.,  2006;  Xie  et  al.,  2006).  The  circumstances  under  which  AMPK/AAK-­‐‑2  is  activated  is  
dependent   on   the   developmental   and   environmental   situation   (Mantovani   &   Roy,  
2011)  as  well  as  physiological  and  pathological  conditions  such  as  exercise  (Richter  &  
Ruderman,   2009)   and   several   diseases   (Steinberg   &   Kemp,   2009).   Activation   of   the  
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metabolic   sensor   has   been   identified   to   extend   lifespan   via   an   integrated   signalling  
network.  For  example,  DAF-­‐‑16/FOXO  (Chapter  2.5.3   )   is   regulated  by  AMPK/AAK-­‐‑2.  
Moreover,   AMPK/AAK-­‐‑2   promotes   autophagy   via   mechanistic   target   of   rapamycin  
(mTOR)  inhibition  and  serine/threonine-­‐‑protein  kinase  ULK1  activation  (Chapter  2.8  ).  
In  contrast,  AMPK/AAK-­‐‑2  can  be  inactivated  by  protein  phosphatases  (Gimeno-­‐‑
Alcaniz   &   Sanz,   2003;   Marley   et   al.,   1996;   Voss   et   al.,   2011).   However,   chronic  
AMPK/AAK-­‐‑2   inactivation   induces   insulin/IGF-­‐‑1   resistance   in   various   tissues  
(Ruderman   et   al.,   2013).   As   an   effect,   the   incidence   of  metabolic   syndromes   such   as  
obesity,  diabetes  and  cardiovascular  diseases  is  promoted  (Lage  et  al.,  2008).  
Since  AMPK/AAK-­‐‑2  plays  a  diverse  role  in  the  response  to  stressful  insults  and  
its   activation   has   beneficial   consequences   for   the   cell,   it   is   believed   that   novel  
AMPK/AAK-­‐‑2  activators  might  contribute  as  an  important  milestone  to  the  therapy  of  
metabolic   and   neurodegenerative   diseases   (Hardie,   2011c;   Zhou   et   al.,   2009).   The   5-­‐‑
aminoimidazole-­‐‑4-­‐‑carboxamide   riboside   (AICAR)   is   an   AMP   analogue   and   a   potent  
activator  of  AMPK/AAK-­‐‑2.  AICAR  has  been  used  clinically  to  treat  and  protect  against  
ischemic  injury  (Corton  et  al.,  1995;  Idrovo  et  al.,  2015;  Lempiainen  et  al.,  2012).  Similar-­‐‑
ly,   metformin,   statins,   thiazolidinediones   and   many   phytochemicals,   e.g.   berberine,  
quercetin  and  resveratrol,  are  clinically  used  drugs  that  have  been  reported  to  activate  
AMPK/AAK-­‐‑2   signalling   (Hwang   et   al.,   2009;   Steinberg   &   Kemp,   2009;   Zhou   et   al.,  
2009).  
  2.8  Autophagy  
  2.8.1  Autophagy  in  cell  homeostasis,  disease  and  lifespan  
  AMPK/AAK-­‐‑2  regulates  a  versatile  response  at  low  energy  conditions  and  upon  
mitochondrial   damage   that   is   beneficial   for   the   function   and   survival   of   a   cell.   One  
process  that  has  been  implicated  with  disease,  ageing  and  the  response  to  AMPK  acti-­‐‑
vation  is  macroautophagy,  or  simply  autophagy.  Autophagy  merely  means  self-­‐‑eating  
and  has  originally  been  defined  as  a  form  of  programmed  cell  death.  In  fact,  autophagy  
primarily   has   a   pro-­‐‑survival   function   and   promotes   cellular   and   organismal   health  
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(Levine  &  Kroemer,  2009).  AMPK/AAK-­‐‑2  activates  autophagy,  which  sequesters  cyto-­‐‑
solic  materials  and  damaged  organelles  and  targets  them  to  lysosomes  for  degradation  
(Egan   et  al.,  2011;  Kim   et  al.,  2011).   In   this  way,  autophagy  generates  macromolecular  
building  blocks,   increases  cellular  energy   levels  and  clears   the  cell   from  damaged  or-­‐‑
ganelles  (Yen  &  Klionsky,  2008).    
Notably,  autophagy  plays  an  important  role  for  lifespan  extension  under  various  
conditions  and  is  also  linked  to  changes  in  metabolism  (Hansen  et  al.,  2008;  Hars  et  al.,  
2007;  Jia  &  Levine,  2007;  Lim  et  al.,  2014;  Melendez  et  al.,  2003;  Toth  et  al.,  2008).  For  ex-­‐‑
ample,  upon  mammalian  starvation  autophagy  generates  fatty  acids  and  amino  acids,  
which   are   catabolized   to   yield   energy   and   drive   gluconeogenesis   and   ketogenesis  
(Rabinowitz  &  White,  2010).  Genetic  manipulations  that  increase  lifespan  in  model  or-­‐‑
ganisms  often  stimulate  autophagy  (Juhasz  et  al.,  2007;  Pyo  et  al.,  2013).  In  contrast,  its  
inhibition  compromises  the  longevity-­‐‑promoting  effects  of  caloric  restriction,  inhibition  
of   insulin/IGF-­‐‑1   and   Sirtuin   1   activation,   or   by   administration   of   survival-­‐‑promoting  
drugs   (Hansen   et   al.,   2008).  Furthermore,  genetic   inhibition  of  autophagy   induces  de-­‐‑
generative   changes   in   mammalian   tissues   (Cecconi   &   Levine,   2008).   These   resemble  
pathologies  commonly  associated  with  ageing.    
  2.8.2  The  autophagic  process  
When  initiated,  autophagy  is  primed  by  the  formation  of  an  isolation  membrane,  
or  phagophore,   that  begins  with   the  engulfment  of   cytoplasmic  material.  The  phago-­‐‑
phore  membrane  is  then  further  elongated  until  its  edges  fuse  to  close  the  autophago-­‐‑
some.  The  cytoplasmic  material   is  now  sequestered  within  double-­‐‑membrane  vesicles  
and  delivered  to  lysosomes  for  bulk  degradation.  The  outer  membrane  of  the  autopha-­‐‑
gosome  fuses  with   the   lysosome  and  forms  the  autolysosome.  The  material   in   the   lu-­‐‑
men,  including  the  internal  membrane,  is  then  degraded  (Rubinsztein  et  al.,  2011).  Sub-­‐‑
sequently,   the  digested  products   are   released   through  permeases  and   recycled   in   the  
cytosol  (Ravikumar  et  al.,  2010).  Thus,  autophagy  is  the  mechanism  through  which  the  
cytoplasmic  parts  of  the  cell  can  be  recycled.  
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Four  enzymatic  complexes  are  required  for  autophagosome  formation:  
• A   serine/threonine   protein   kinase   complex   (LET-­‐‑363   (target   of   rapamycin   –  
TOR),  UNC-­‐‑51  (in  neurons))  that  induces  autophagic  activity,  
• a  class   III  phosphatidylinositol  3-­‐‑kinase   (PI3K)  complex   (LET-­‐‑512,  BEC-­‐‑1)   that  
acts  in  vesicle  nucleation,  
• ubiquitin-­‐‑like   conjugation   pathways   (ATG-­‐‑3,  ATG-­‐‑4,  ATG-­‐‑5,  ATG-­‐‑7,  ATG-­‐‑16,  
LGG-­‐‑1  and  LGG-­‐‑3)  that  lead  to  vesicle  expansion  and  completion  and    
• a  protein  retrieval  system  (ATG-­‐‑9  from  the  phagophore  assembly  site  (PAS)  in-­‐‑
volves  ATG-­‐‑2  and  ATG-­‐‑18).  
  
Key   signalling   mechanisms   for   regulating   autophagy   include   AMPK/AAK-­‐‑2,  
TOR,  class   I  and  class   III  PI3Ks,   the   insulin/IGF-­‐‑1   receptor,  and   the  Ras/Raf/mitogen-­‐‑
activated  protein  kinase  kinase  1/2  (MEK1/2)  (Codogno  &  Meijer,  2005;  Meijer  &  Codo-­‐‑
gno,   2004).   When   nutrients   and   growth   factors   are   abundant,   the   TOR   and   Class   I  
PI3Ks   pathways   inhibit   autophagic   function   (Chang   et   al.,   2009).   Class   III   PI3K   and  
MEK1/2   positively   regulate   autophagy   under   impaired   cellular   conditions   (Chen   &  
Karantza-­‐‑Wadsworth,  2009).  Both  TOR  and  AMPK/AAK-­‐‑2  regulate  autophagy  by  con-­‐‑
trolling   the   activity   of   essential   components   of   the   autophagic   machinery,   such   as  
UNC-­‐‑51  or  BEC-­‐‑1  (Lapierre  &  Hansen,  2012).  
  2.8.3  Autophagy  and  mitochondria    
Mitochondria  play  a  central  role  in  ageing-­‐‑related  pathologies  and  autophagy  is  
a  critical  regulator  of  organelle  homeostasis.  Autophagy  is  required  for  the  clearance  of  
mitochondrial  debris   such   as  damaged  proteins   and  apparently   also   for   the   selective  
removal  of  whole  damaged  mitochondria,  specifically  referred  to  as  mitophagy.  Under  
normal  conditions,  the  PTEN-­‐‑induced  putative  kinase  protein  1  (PINK1)  is  imported  to  
the   inner  mitochondrial  membrane   (Youle  &  Narendra,  2011).  Subsequently,   the  pro-­‐‑
tein   is   cleaved   and   proteolytically   degraded   (Deas   et   al.,   2011;  Meissner   et   al.,   2011).  
Dysfunctional   mitochondria   often   lose   their   membrane   potential,   leading   to   an   im-­‐‑
paired  mitochondrial  membrane  transport  and  increased  probability  to  generate  toxic  
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ROS  and  release  pro-­‐‑apoptotic  mediators.  This  loss  of  membrane  potential  prevents  the  
import   of   PINK1,   leading   to   the   accumulation   of   unprocessed   PINK1   on   the   outer  
membrane   surface.   This   induces   recruitment   of   the   cytosolic   E3   ligase   Parkin  
(Narendra  et  al.,  2010).  Subsequently,  Parkin  mediates  ubiquitination  of  mitochondrial  
membrane   proteins   which   recruits   the   damaged   mitochondria   to   autophagosomes  
(Greene  et  al.,  2012;  Kim  et  al.,  2008;  Lazarou  et  al.,  2012;  Rubinsztein  et  al.,  2011;  Shiba  et  
al.,   2009).  Such   tagged  mitochondria  can  be  cleared   from  the  cell  while  healthy  mito-­‐‑
chondria  are  spared.  Thus,  the  delivery  function  of  autophagy  is  an  important  mecha-­‐‑
nism  by  which  the  cell  rids  itself  of  potentially  harmful  constituents.  This  adaptive  cel-­‐‑
lular   housekeeping  mechanism  helps   to  maintain   normal   functioning   of   the   cell   and  
protects  against  ageing,  neurodegenerative  diseases  as  well  as  infections  and  other  cel-­‐‑
lular  insults  (Arroyo  et  al.,  2014).  
  2.8.4  Autophagy  and  metabolism  
Autophagy  digests  large-­‐‑scale  protein  structures  and  even  whole  organelles  as  a  
rapid  mobilisation  of  endogenous  reserves.  The  subsequent  degradation  of  macromol-­‐‑
ecules  supplies  the  cell  with  energy  and  basic  modules  for  the  initiation  of  essential  an-­‐‑
abolic  reactions  and  generation  of  new  macromolecules  (Singh  &  Cuervo,  2011).  There-­‐‑
fore,  autophagy  ultimately  affects  cellular  and  mitochondrial  metabolism  and  results  in  
metabolic  changes  that  influence  biologic  function  and  determine  cellular  fate  (Guo  et  
al.,  2011;  Houtkooper  et  al.,  2012;  Kim  &  Lee,  2014;  Settembre  et  al.,  2013;  Shimobayashi  
&  Hall,  2014).  
Vice   versa,  metabolism   also   affects   the  process   of   autophagy.   The   signal   trans-­‐‑
duction  cascades  are  mainly  regulated  by  upstream  stress  and  energy  sensors,  which  
are  intricately  coordinated  to  adapt  to  environmental  changes.  The  diversity  of  sensors  
that   affect   autophagy   also   reflect   the   variety   of   regulatory   signals,   such   as   AMPK  
(AMP/ATP,  glucose  and  NADH/NAD+),  TOR  (amino  acids),  sirtuins  (acetyl-­‐‑CoA)  and  
eukaryotic  translation  initiation  factor  2a  (eIF2a)  kinases  (lipids)  (Galluzzi  et  al.,  2014).  
However,   some   molecules   may   directly   favour   the   formation   of   autophagosomes  
without   the  signalling  of  additional   factors,   such  as   the  accumulation  of   lipids  or   the  
depletion  of  iron.  
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  2.9  Metabolism  
Despite  the  many  functions  of  mitochondria,  energy  production  and  the  control  
of  metabolism  remain  their  pivotal  role.  For  example,  dietary  restriction  results  in  met-­‐‑
abolic   rewiring  and  has  an  extensive   impact  on   the  organism.   IIS,  HIF-­‐‑1,  AMPK  and  
autophagy  control  cellular  metabolism  and  are  potent  mediators  of  cellular  health.  Co-­‐‑
operatively,   these   factors   promote   survival   of   the   organism   and   ultimately   regulate  
lifespan.  
  Mutations  in  genes  that  are  involved  in  metabolism  can  cause  a  variety  of  devel-­‐‑
opmental  symptoms,  seizures,  mental  retardation,  liver  and  kidney  failure,  visual  loss  
and  other  pathologies  (Saudubray  et  al.,  2006).  Affected  patients  are  commonly  treated  
by  dietary  intervention.  Despite  the  fact  that  supplementation  of  specific  metabolites  or  
changes   in  diet  might  not  cure   the  disease,   the  simplicity  of   the   treatment  provides  a  
strategy  with  great  potential  for  the  therapy  of  other  syndromes  that  effect  metabolism,  
such  as  mitochondrial  diseases.  
However,  metabolism   is   complex.   For   instance,   changes   in   the  TCA   cycle,   glu-­‐‑
cose  metabolism,  amino  acids  and  lipids  are  only  some,  although  potentially  the  most  
important   key   players.   Nevertheless,   the   networks   that   control   dietary   responses   in  
vivo   remain  largely  elusive  and  transcription  factors  and  proteins   involved  are  still   to  
be   further   characterised.  However,   Acyl   CoA   dehydrogenase   1   (ACDH-­‐‑1),   a   dietary  
sensor   that  has   recently  been   linked   to  global  changes   in  C.  elegans  metabolism  could  
help   in   the   identification   of   signals   that   alter   the   metabolic   footprint   in   nematodes  
(Watson  et  al.,  2013).  acdh-­‐‑1  encodes  for  a  mitochondrial  acetyl  CoA  dehydrogenase  en-­‐‑
zyme.  The  protein  is  predicted  to  catalyse  the  first  step  of  fatty  acid  β-­‐‑oxidation.  Fur-­‐‑
thermore,   it   is   implicated   in   the  breakdown  of  branched-­‐‑chain  amino  acids   (BCAAs).  
However,  apart  from  its  enzymatic  function,  ACDH-­‐‑1  has  been  characterised  as  a  po-­‐‑
tent  sensor  for  broad  shifts  in  metabolism  (Watson  et  al.,  2013).  
In  summary,  metabolism  plays  a  central  role   in  ageing,  health  and  disease.  The  
understanding  of  the  intricate  signalling  pathways  that  underlie  the  control  of  metabol-­‐‑
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ic  networks  could  ultimately  aid  in  the  development  of  strategies  to  treat  mitochondri-­‐‑
al  impairments.     
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  2.10  Aim  of  the  study  
Mitochondria  are  essential  organelles   for   cellular   function  and  health  of   the  or-­‐‑
ganism.  Consequently,  mitochondrial  dysfunction  is  associated  with  common  diseases  
such  as  neurodegeneration  and  metabolic  syndrome,  as  well  as  ageing.  Mitochondrial  
complex  I  deficiency  is  causally  linked  to  over  thirty  per  cent  of  human  mitochondrial  
diseases   (Hangen   et   al.,   2010).   Yet,   the   underlying   mechanisms   and   cellular   conse-­‐‑
quences  of  the  diseases  are  not  fully  investigated  and  no  treatment  is  available.  
A   fundamental   problem   for   understanding   common  mechanisms   of  mitochon-­‐‑
drial   disorders   is   the   lack   of   good   model   organisms   that   resemble   pathologies   and  
symptoms  of  patients  affected  by  mitochondrial  disease  (Wallace,  2002).  Desirably,  the  
model  organism  is  closely  related  to  humans  and  the  protein  of  interest  associated  with  
disease   is   conserved   across   species.  However,   at   close   relation,   organism   complexity  
and   ethical   boundaries   increase.   Furthermore,   the   number   of   research   techniques  
available  decreases  while  time  and  costs  increase.  The  nematode  C.  elegans  has  a  short  
life  cycle,   fast  development  and  allows  for  easy  genetic  modification.   Importantly,  an  
estimated  60–80  %  of  human  genes  have  a  counterpart  in  the  worm  (Harris  et  al.,  2004;  
Sonnhammer  &  Durbin,   1997).   Therefore,  C.   elegans   serves   as   a   valuable   research  or-­‐‑
ganism.  
  In  this  study,  I  present  a  nematode  model  of  mitochondrial  disorder  that  is  char-­‐‑
acterised  by  ETC  dysfunction  and   impaired  OXPHOS.  For   this  purpose,   I  downregu-­‐‑
lated  the  mitochondrial  protein  AIF/WAH-­‐‑1  in  the  nematode  C.  elegans.  Low  levels  of  
the  protein   lead   to  a  decrease   in  C  I   levels  and  progressive  mitochondrial  encephalo-­‐‑
myopathies  in  humans  and  the  harlequin  mouse  model.  Consequently,  AIF/WAH-­‐‑1  de-­‐‑
ficiency  allows  for  the  study  of  impaired  ETC  function  and  the  pathways  that  ultimate-­‐‑
ly   lead   to  disease.   Furthermore,   this   study   aimed   to   identify   signalling   cascades   that  
protect   from   the   detrimental   consequences   of   OXPHOS   deficiency.   Impaired   insu-­‐‑
lin/IGF-­‐‑1  signalling  protects   from  cellular  stress  and  promotes  survival   in  various  or-­‐‑
ganisms.  Therefore,   I   reduced  IIS   to  promote  survival   in  AIF/WAH-­‐‑1  deficient  nema-­‐‑
todes.  I  identified  that  AMPK  and  autophagy  play  a  central  role  in  the  protection  from  
Introduction   31  
detrimental  effects  by  wah-­‐‑1  downregulation.  Finally,  the  present  study  points  to  a  cen-­‐‑
tral  role  of  metabolism  in  the  adaption  to  cellular  stress  induced  by  ETC  deficiency.  
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  3  Results  
  3.1  wah-­‐‑1  downregulation  results  in  mitochondrial  deficiency  and  
reduced  lifespan  in  C.  elegans  
Alteration  of  ETC  activity  and  OXPHOS  determine  mitochondrial   function  and  
lifespan   in   various   organisms.   AIF/WAH-­‐‑1   has   been   demonstrated   to   play   an   im-­‐‑
portant  role  in  the  stabilisation,  maintenance  and  function  of  the  ETC.  To  test  whether  
downregulation  of  wah-­‐‑1  affects  mitochondrial  activity  in  nematodes  and  might  serve  
as  a  model  for  mitochondrial  disease,  I  tested  the  impact  of  AIF/WAH-­‐‑1  deficiency  on  
mitochondria  in  C.  elegans.  
To   this   end,  wah-­‐‑1   was   downregulated   by   targeted   RNAi   knockdown   and   the  
lifespan  of  the  nematodes  was  observed.  The  reduction  of  WAH-­‐‑1  caused  a  decrease  in  
the  mean  survival  by  about  20  %  (Figure  3-­‐‑1  A).  However,  it  was  not  clear  whether  the  
reduction   in   lifespan   was   caused   by   impaired   ETC   function   or   other   factors   down-­‐‑
stream  of  wah-­‐‑1  deficiency.  Therefore,  I  performed  an  epistasis  analysis  using  the  mito-­‐‑
chondrial  mutant  gas-­‐‑1(fc21).  gas-­‐‑1  encodes  for  a  49  kDa  subunit  of  C  I  and  a  mutation  
in   the  gene   results   in   a   short   lifespan   (Kayser   et   al.,   1999).  Additional   knockdown  of  
wah-­‐‑1  did  not  alter   the   lifespan  of  gas-­‐‑1  animals,   indicating   that   the  survival  of  wah-­‐‑1  
deficient  animals  was  dependent  on  ETC  function  (Figure  3-­‐‑1  B).  
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Figure  3-­‐‑1:  Downregulation  of  WAH-­‐‑1  shortens  C.  elegans  lifespan  and  affects  mitochondrial  
morphology  and  function.  Survival  curves  represent  the  lifespan  of  a  nematode  population.  y-­‐‑
axis   shows   the   percentage   of   animals   remaining   alive   plotted   over   time.  black:   control,   red:  
wah-­‐‑1   (RNAi).   (A)   Depletion   of   WAH-­‐‑1   shortens   the   lifespan   of   wild   type   N2   animals.   (B)  
Knockdown  of  wah-­‐‑1  does  not  affect  the  lifespan  of  the  C  I  mutant  gas-­‐‑1(fc21).  (C)  STED  micros-­‐‑
copy   on   worms   expressing   mitochondrial   GFP   in   animals   grown   on   wah-­‐‑1(RNAi).   (D)   Im-­‐‑
munoblot  of  ETC  complexes  C  I,  C  IV,  C  V  and  pDH  in  control  and  wah-­‐‑1  (RNAi)  treated  wild  
type   animals.   (E)  Oxygen   consumption   rates   (OCR)   analysed  by   SeaHorse  XF24   and   (F)  ATP  
levels  measured  with  the  Luminescent  ATP  Detection  Assay  Kit   (abcam)   in  control  and  wah-­‐‑1  
(RNAi)  animals.  (C:  control,  W:  wah-­‐‑1  (RNAi)  treatment.  Results  are  means  ±  S.E.M.,  ***p-­‐‑value  
















































































Since   AIF   is   an   important   protein   for   mitochondrial   function,   mitochondrial  
morphology  was   examined   in   transgenic   lines   carrying   a  mitochondria-­‐‑targeted  GFP  
reporter  driven  by  the  muscle-­‐‑specific  myo-­‐‑3  promoter.  This  allowed  for  non-­‐‑invasive  
analysis  of  mitochondrial  morphology  by  STED  microscopy.  Adult,  WAH-­‐‑1  deficient  
C.  elegans  exhibited  altered  mitochondrial  morphology  with  irregular,  swollen  appear-­‐‑
ance  (Figure  3-­‐‑1  C).  To  further  investigate  whether  low  wah-­‐‑1  levels  affected  OXPHOS  
components,  I  performed  western  blot  analysis  of  ETC  subunits.  Similar  to  the  observa-­‐‑
tions  in  AIF  deficient  mice,  wah-­‐‑1  RNAi  strongly  reduced  CI  protein  levels  (Figure  3-­‐‑1  
D)   (Bouaita   et   al.,   2012;   Vahsen   et   al.,   2004).   Furthermore,  wah-­‐‑1   downregulation   in-­‐‑
creased  ATPase  protein   levels,  whereas  C  IV  was  not  affected.  Pyruvate  dehydrogen-­‐‑
ase  (pDH)  was  upregulated.  To  confirm  OXPHOS  impairment  at  the  functional  level,  I  
assessed  oxygen  consumption   rates   (OCR)   in   living  animals.  wah-­‐‑1   (RNAi)   treatment  
significantly   decreased  C.  elegans   respiration   (Figure   3-­‐‑1   E).   Consequently,   ATP   pro-­‐‑
duction  was  decreased  as  demonstrated  by  the  measurement  of  ATP  levels  (Figure  3-­‐‑1  
F).  
Mitochondria  play  an  important  role  for  many  cellular  functions  and  are  crucial  
during   nematode   development.   Consequently,   dysfunctions   in   OXPHOS   result   in  
common  C.  elegans  phenotypes  (Dillin  et  al.,  2002).  Similarly  to  other  mitochondrial  mu-­‐‑
tants,   low  respiration  rates   in  WAH-­‐‑1  deficient  nematodes  resulted   in  altered  growth  
rate,  body  size,  body  thrashing  in  liquid  as  a  marker  of  motility,  pharyngeal  pumping,  
fertility  and  a  slow  defecation  rhythm  (Figure  3-­‐‑2).  
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Figure   3-­‐‑2:  Downregulation   of  WAH-­‐‑1   affects  C.   elegans   phenotype.   Phenotypic   analysis   of  
body  length,  body  volume,  body  thrashing  (body  movements  in  M9  buffer  per  minute),  phar-­‐‑
yngeal   pumping,   number   of   laid   eggs   and   the   defecation   cycle   in   wah-­‐‑1   (RNAi)   treated  
C.  elegans.  (C:  control,  W:  wah-­‐‑1  (RNAi)  treatment.  Results  are  means  ±  S.E.M.,  ***p-­‐‑value  <0.001,  
two-­‐‑tailed  unpaired  Student’s  t-­‐‑test).  
In   conclusion,   these   data   demonstrate   the   evolutionarily   conserved   role   of  
AIF/WAH-­‐‑1  in  the  assembly  and/or  stabilisation  of  the  mitochondrial  ETC.  Its  loss  se-­‐‑
verely   compromised   mitochondrial   C  I   and   impaired   OXPHOS,   which   led   to   mito-­‐‑
chondrial  dysfunction  that  ultimately  shortened  the  lifespan  of  C.  elegans.  Importantly,  
this  impairment  of  the  ETC  by  low  wah-­‐‑1  levels  and  the  resulting  mitochondrial  defects  
in  nematodes  resemble  the  mitochondrial  consequences  observed  in  AIF  deficient  mice  
and  even  patients  suffering  from  mitochondrial  encephalomyopathies.  Therefore,  wah-­‐‑
1   (RNAi)   in  C.  elegans   is  a  suitable  model   for  studying  mechanisms   that  underlie  dis-­‐‑
ease  related  ETC  deficiencies.  
  3.2  Mitochondrial  deficiency  leads  to  stress  response  activation  
and  reduced  ROS  
Eukaryotic  cells  respond  to  impaired  mitochondrial  function  by  relaying  signals  
to  the  nucleus  and  other  organelles  and  robustly  induce  expression  of  detoxifying  sys-­‐‑
tems.  Therefore,  I  measured  the  expression  levels  of  genes  that  play  a  role  in  the  innate  

































































































GFP  controlled  by  the  promoter  of  the  respective  stress  response  gene  with  the  COPAS  
Biosorter.   wah-­‐‑1   downregulation   activated   gene   expression   of   gst-­‐‑4   (glutathione-­‐‑S-­‐‑
transferase),  an  enzyme  involved  in  the  cellular  detoxification  of  xenobiotic  and  endo-­‐‑
biotic   compounds  and   sod-­‐‑3   (superoxide  dismutase),   a  mitochondrial   superoxide  dis-­‐‑
mutase   that  might  defend   against   oxidative   stress   (Figure   3-­‐‑3  A),   indicating   induced  
mitochondrial  stress  and  activated  stress  response.  
Altered  respiration  and  induced  stress  response  has  been  linked  to  increased  ox-­‐‑
idative  stress  in  some  mitochondrial  mutant  nematodes  (Hekimi  et  al.,  2011).  I  hypoth-­‐‑
esized  that  wah-­‐‑1  downregulation  could  alter  ROS  homeostasis  as  a  consequence  of  mi-­‐‑
tochondrial  dysfunction.  To  asses  ROS  levels   in  vivo,   I   incubated  RNAi  treated  nema-­‐‑
todes  with  the  cell  permeate  reagent  6-­‐‑carboxy-­‐‑2'ʹ,7'ʹ-­‐‑dichlorodihydrofluorescein  diace-­‐‑
tate   (DCF-­‐‑DA),  which  becomes   fluorogenic  when  oxidised.  Surprisingly,  WAH-­‐‑1   loss  
resulted  in  a  decrease  of  fluorescent  signals  (Figure  3-­‐‑3  B).  Although,  DCF-­‐‑DA  is  one  of  
the  most  widely   used   techniques   for   directly  measuring   the   redox   state   of   cells   and  
nematodes   (Eruslanov  &  Kusmartsev,  2010),  detection  of  ROS  and  oxidative   stress   in  
vivo   remains   a   strongly   debated   challenge.   Given   that  wah-­‐‑1   downregulation   might  
lead   to  potential  differences   in   cellular  uptake  of   the  drug,   an  alternative  genetic   ap-­‐‑
proach   for  monitoring  ROS  was   used.   To   this   end,   two   strains   expressing   the   redox  
sensitive  biosensors  Hyper  and  roGFP  were  subjected  to  wah-­‐‑1  RNAi  and  fluorescence  
was  measured  by  spinning  disc  microscopy  (Knoefler  et  al.,  2012).  These  strains  change  
their  fluorescent  spectrum  when  mitochondria  are  oxidised.  As  demonstrated  by  DCF-­‐‑
DA  staining,  wah-­‐‑1  (RNAi)  treatment  of  nematodes  resulted  in  decreased  H2O2  (Hyper)  
and  GSH  (roGFP)  signals  (Figure  3-­‐‑3  C).  As  a  positive  control,   the  ETC  mutant  strain  
mev-­‐‑1   was   used   since   it   exhibits   increased   ROS   levels   (Dingley   et   al.,   2010;   Senoo-­‐‑
Matsuda  et  al.,  2001).  The  mev-­‐‑1  mutation  increased  the  oxidation  of  Hyper  but  did  not  
show  an  effect  on  roGFP   fluorescence  compared   to  control  animals.  As  an  additional  
control,  ROS  levels  were  measured  at  different  age  of  the  nematodes  as  oxidative  stress  
increases  with  age  (Back  et  al.,  2012).  Supportingly,  the  measurement  of  control  animals  
by  Hyper  and  roGFP  at  day  4  and  day  7  showed  an  increase  in  ROS  levels.  However,  
animals  subjected  to  wah-­‐‑1  (RNAi)  showed  a  decrease  in  ROS  levels  compared  to  con-­‐‑
trol  animals  at  both  time  points  (Figure  3-­‐‑3  D).    
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Taken   together,  wah-­‐‑1   (RNAi)   alters   mitochondrial   function   and   results   in   ex-­‐‑
pression   of   stress   response   genes.  However,  mitochondrial   stress   response   is   not   in-­‐‑
duced  by  excessive  ROS  production,  as  their  levels  are  decreased  in  wah-­‐‑1  (RNAi)  ani-­‐‑
mals.  
  
Figure  3-­‐‑3:  wah-­‐‑1  (RNAi)  induces  stress  response  and  decreases  ROS  production.  (A)  Fluores-­‐‑
cence  analysis  with  the  COPAS  Biosorter  of  genes  encoding  for  the  detoxifying  enzymes  GST-­‐‑4  
and  SOD-­‐‑3  fused  to  GFP.  (B)  Measurement  of  ROS  by  DCF-­‐‑DA  staining.  (C)  Spinning  disc  mi-­‐‑
croscopy  of  worms  expressing   jrIs1   [Prpl-­‐‑17::Hyper]  and   jrIs2   [Prpl-­‐‑17::Grx-­‐‑1-­‐‑roGFP2]   in   life  C.  
elegans  on  day  7  in  control,  wah-­‐‑1  (RNAi)  and  mev-­‐‑1(kn-­‐‑1)  animals.  (D)  Microscopy  of  jrIs1  [Prpl-­‐‑
17::Hyper]  and  jrIs2  [Prpl-­‐‑17::Grx-­‐‑1-­‐‑roGFP2]  in  live  C.  elegans  on  day  4  and  day  7  in  control  and  
wah-­‐‑1  (RNAi)  animals.  (C:  control,  W:  wah-­‐‑1  (RNAi)  treatment.  Mean  ±  S.E.M.,  ***p<  0.001,  **p<  
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  3.3  Reduced  WAH-­‐‑1  levels  induce  the  mitochondrial  Unfolded  
Protein  Response  (UPRmt)  
Organelle  stress  can  induce  the  activation  of  protective  mechanisms  that  restore  
organelle   function   and   cell   homeostasis.   In  mitochondria,   the  UPRmt   can   counteract  
disturbed  mitochondrial   function.  Upon  mitochondrial   stress,   the  expression  of   small  
interfering   heat   shock   proteins   and   chaperones   is   induced   and  molecules   are   trans-­‐‑
ported  to  the  mitochondria.  A  marker  for  the  induction  of  the  UPRmt  is  the  expression  
of   the   heat   shock   protein  HSP-­‐‑6.   To   analyse  whether  wah-­‐‑1   deficiency   in   nematodes  
also  induced  the  UPRmt,  I  analysed  mRNA  expression  levels  of  hsp-­‐‑6  by  qRT-­‐‑PCR.  hsp-­‐‑
6   levels  were  increased  by  2  fold  in  wah-­‐‑1  deficient  conditions  (Figure  3-­‐‑4  A).  To  con-­‐‑
firm   the   induction   of   the  UPRmt   by  wah-­‐‑1   (RNAi),   I   assessed   the   expression   of  GFP  
under   control   of   the   hsp-­‐‑6  promoter  with   the  COPAS  Biosort   system.   Furthermore,   I  
tested  hsp-­‐‑60  expression   levels,   another   chaperone   activated  by   the  UPRmt.  GFP   sig-­‐‑
nals  for  both  HSPs  increased  when  nematodes  were  treated  with  wah-­‐‑1  (RNAi)  (Figure  
3-­‐‑4  B).  To  assess  weather  the  induced  stress  response  was  mitochondria-­‐‑specific  or  also  
affected  other  cellular  organelles,  I  tested  the  potential  influence  of  mitochondrial  dys-­‐‑
function   on   the   ER   stress   response   (UPR)   by   hsp-­‐‑4   mRNA   levels.   HSP-­‐‑4   is   an   ER-­‐‑
specific   heat   shock   protein   in   C.  elegans   and   the   homologue   of   mammalian   binding  
immunoglobulin   protein   (BiP)   that   is   important   for   folding   and   oligomerisation   of  
newly  synthesised  proteins.  Fluorescence  analysis  with   the  COPAS  Biosort   system  of  
an  hsp-­‐‑4p::GFP   strain  displayed  no  difference   in  GFP   signal  when   treated  with  wah-­‐‑1  
(RNAi),  indicating  no  increase  in  ER  stress  (Figure  3-­‐‑4  C).  However,  mitochondria  play  
an  important  role  for  the  general  health  of  an  organism.  Their  dysfunction  can  lead  to  
severe  consequences  for  the  whole  cell.  Therefore,  I  measured  the  expression  levels  of  
the  cytosolic  heat  shock  protein  hsp-­‐‑16.2  (Figure  3-­‐‑4  D).  However,  decreased  wah-­‐‑1  lev-­‐‑
els  did  not  affect  unfolded  protein  response  mechanisms  other  than  the  mitochondria-­‐‑
specific  UPRmt.  
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Figure   3-­‐‑4:  wah-­‐‑1   (RNAi)   induces  UPRmt.   (A)  Quantitative   real-­‐‑time   analysis   of  hsp-­‐‑6   levels  
after  wah-­‐‑1(RNAi)   treatment.   (B)   COPAS   Biosort  measurement   of   hsp-­‐‑6::GFP   and   hsp-­‐‑60::GFP  
strains  after  wah-­‐‑1   (RNAi)   treatment.   (C)  COPAS  Biosort  measurement  of   the  endoplasmic  re-­‐‑
ticulum  UPR  in  hsp-­‐‑4::GFP  animals.  (D)  qRT-­‐‑PCR  for  the  cytosolic  UPR  gene  hsp-­‐‑16.2.  (C:  con-­‐‑
trol,  W:  wah-­‐‑1  (RNAi)  treatment.  Mean  ±  S.E.M.,  ***p<  0.001,  two-­‐‑tailed  Student’s  t  test)  
In  C.  elegans,  the  original  discovery  of  the  UPRmt  suggested  that  disturbed  mito-­‐‑
chondrial  function  results  in  the  increase  of  un-­‐‑  or  misfolded  proteins  in  the  mitochon-­‐‑
drial  matrix  due  to  insufficient  chaperone  activity.  Misfolded  proteins  are  then  digest-­‐‑
ed   into   small  peptides,   exported   through   the  HAF-­‐‑1   transporter   into   the   cytosol   and  
activate  UBL-­‐‑5  and  the  transcription  factor  DVE-­‐‑1  (Haynes  &  Ron,  2010).  In  turn,  UBL-­‐‑
5/DVE-­‐‑1   translocates   into   the   nucleus   and   induces   the   expression   of   heat   shock  pro-­‐‑
teins.  To  test  whether  wah-­‐‑1  also  activated  the  UPRmt  via  this  classic  pathway,  I  meas-­‐‑
ured  hsp-­‐‑6  expression  levels  in  haf-­‐‑1  mutants,  which  lack  the  mitochondrial  transporter  
that  is  important  for  the  export  of  peptides.  Surprisingly,  haf-­‐‑1  mutants  also  displayed  
increased  hsp-­‐‑6  levels  (Figure  3-­‐‑5  A).  To  test,  whether  a  reduction  of  wah-­‐‑1  actually  in-­‐‑
duced  UPRmt  via  UBL-­‐‑5/DVE-­‐‑1,   I  analysed  UBL-­‐‑5   levels   in  a   transgenic  worm  strain  
expressing  UBL-­‐‑5  fused  to  GFP,  driven  by  the  ubl-­‐‑5  promoter.  Indeed,  wah-­‐‑1  downreg-­‐‑
ulation   resulted   in   increased   ubl-­‐‑5   expression   compared   to   control   animals,  whereas  



























































































Figure   3-­‐‑5:  UPRmt   in  WAH-­‐‑1  deficient   animals   is  not   activated   through   the   classical  DVE-­‐‑
1/UBL-­‐‑5   route.   (A)  qRT-­‐‑PCR  of   the  UPRmt  marker  hsp-­‐‑6   in  mutant  C.  elegans   for   the  peptide  
exporter  HAF-­‐‑1.  (B)  COPAS  Biosort  analysis  of  the  UPRmt  marker  strain  ubl-­‐‑5p::ubl-­‐‑5::GFP.  (C)  
Spinning  disc  microscopy  of   the   cellular   localisation  of  dve-­‐‑1p::dve-­‐‑1::GFP   signal.   (C:   control,  
W:  wah-­‐‑1   (RNAi),  U:  ubl-­‐‑5   (RNAi),  W;U:  wah-­‐‑1;ubl-­‐‑5   (RNAi)   treatment.  Means   ±   S.E.M.,   ***p<  
0.001,  two-­‐‑tailed  Student’s  t  test)  
Nevertheless,  even  low  expression  levels  of  the  protein  might  be  sufficient  to  ac-­‐‑
tivate  chaperone  expression,  as  the  determining  factor  for  stress  response  activation  is  
the  nuclear  translocation  of  the  transcription  factor  DVE-­‐‑1  from  the  cytosol.  In  order  to  
assess  the  nuclear  translocation  of  DVE-­‐‑1,  I  studied  its  localisation  by  microscopy  using  
the   dve-­‐‑1p::dve-­‐‑1::gfp   reporter   strain.   In   untreated   animals,   DVE-­‐‑1::GFP   signal   is   ob-­‐‑
served   in   the   cytosol   of  C.  elegans   cells   (Figure   3-­‐‑5   C).   As   a   positive   control   for   the  
translocation  of  DVE-­‐‑1,  worms  were   treated  with   the  mtDNA   intercalating  drug  eth-­‐‑
idium  bromide  (EtBr).  EtBr  is  a  well-­‐‑known  mitochondrial  stressor  and  is  widely  used  
to   induce  UPRmt   (Addo   et   al.,   2010).   The   treatment   of  dve-­‐‑1p::dve-­‐‑1::gfp   animals  with  
50  µμg/ml   EtBr   resulted   in   pronounced   nuclear   translocation.  However,  wah-­‐‑1   (RNAi)  
A ubl-5p::ubl-5::GFP
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treated  animals  did  not  display  nuclear  GFP  foci,   indicating  that  UBL-­‐‑5/DVE-­‐‑1  might  
not  be  involved  in  wah-­‐‑1  (RNAi)  dependent  UPRmt  induction.  
Additionally,   fluorescent   signals   of   hsp-­‐‑60p::GFP   animals   were   measured   after  
wah-­‐‑1  downregulation  and  simultaneous  block  of  UBL-­‐‑5  or  DVE-­‐‑1  by  RNAi.   Interest-­‐‑
ingly,  increased  HSP  expression  in  wah-­‐‑1  (RNAi)  treated  animals  was  not  abrogated  by  
ubl-­‐‑5  knockdown  (Figure  3-­‐‑6  A).  Remarkably,  also  DVE-­‐‑1  downregulation  did  not  af-­‐‑
fect   the  wah-­‐‑1   (RNAi)-­‐‑induced  mitochondrial   stress   response.  A   second   route   of  UP-­‐‑
Rmt   induction   is   the   activation   of   ATFS-­‐‑1.   ATFS-­‐‑1   is   a   transcription   factor   that  was  
identified   to  work   independently   from  DVE-­‐‑1/UBL-­‐‑5.  Therefore,   I   tested   the   involve-­‐‑
ment  of  ATFS-­‐‑1   in  the  wah-­‐‑1   (RNAi)  dependent   induction  of  UPRmt  by  the  measure-­‐‑
ment  of  HSP  expression  levels.  In  fact,  atfs-­‐‑1  mutant  animals  neither  showed  induction  
of  hsp-­‐‑60p::gfp  protein  expression  levels  (Figure  3-­‐‑6  B),  nor  increased  hsp-­‐‑6  mRNA  lev-­‐‑
els  after  knockdown  of  wah-­‐‑1  (Figure  3-­‐‑6  C).  
  
Figure  3-­‐‑6:  UPRmt  is  activated  by  the  transcription  factor  atfs-­‐‑1.  (A)  Analysis  of  hsp-­‐‑60p::GFP  
levels  by  the  COPAS  Biosorter  after  downregulation  of  wah-­‐‑1  (W),  ubl-­‐‑5  (U),  wah-­‐‑1;ubl-­‐‑5  (W;U),  
dve-­‐‑1   (D)   and  wah-­‐‑1;dve-­‐‑1   (W;D).   (B)   Biosorter   fluorescence  measurement   of   hsp-­‐‑60::GFP   and  
atfs-­‐‑1(tm4525);hsp-­‐‑60p::GFP   animals.   (C)   qRT-­‐‑PCR   for   hsp-­‐‑6   in  wild   type  N2   and  mutant   atfs-­‐‑
1(tm4525)  nematodes.  (C:  control,  W:  wah-­‐‑1  (RNAi)  treatment.  Mean  ±  S.E.M.,  ***p<  0.001,  two-­‐‑
tailed  Student’s  t  test)  
A hsp-60p::GFP








































































Together,  these  data  demonstrate  the  activation  of  the  mitochondria-­‐‑specific  UP-­‐‑
Rmt  by  wah-­‐‑1  (RNAi).  Furthermore,  the  experiments  unravel  that  the  UPRmt  activation  
requires  ATFS-­‐‑1,  while  the  DVE-­‐‑1/UBL-­‐‑5  axis  is  dispensable.  
  3.4  Impaired  insulin/IGF-­‐‑1  signalling  extends  the  lifespan  of  
wah-­‐‑1  deficient  nematodes  
ETC  deficiency  and  impaired  mitochondrial  function  is  observed  in  many  mito-­‐‑
chondrial   disorders.   However,   to   date,   no   effective   treatment   is   available   to   restore  
OXPHOS  function  caused  by  inherited  or  acquired  genetic  mutations.  Therefore,  I  used  
wah-­‐‑1  downregulation   in  C.   elegans   as   a  model   to   study  human  pathology   caused  by  
mutations  in  the  AIFM1  gene.  The  aim  was  to  investigate  genetic  ways  to  protect  from  
the  detrimental  effects  of  mitochondrial  deficiency  caused  by  WAH-­‐‑1  loss.  Insulin/IGF-­‐‑
1  signalling  is  a  fundamental  and  conserved  regulator  of  survival  and  metabolism.  In  
C.   elegans,   DAF-­‐‑2   is   the   sole   insulin/IGF-­‐‑1   like   receptor   that   negatively   regulates   the  
forkhead   transcription   factor   DAF-­‐‑16/FOXO   through   a   phosphorylation   cascade   in-­‐‑
volving  AGE-­‐‑1/PI3K  and  AKT-­‐‑1/2  kinases  (Kenyon  et  al.,  1993;  Ogg  et  al.,  1997).  A  re-­‐‑
duction  of   IIS   in  nematodes  dramatically  extends  the   lifespan  of   the  organism.  To  as-­‐‑
sess  whether  IIS  deficiency  could  counteract  wah-­‐‑1   (RNAi)-­‐‑induced  mitochondrial  de-­‐‑
fects,  I  analysed  the  effect  of  wah-­‐‑1  (RNAi)  on  the  lifespan  of  insulin/IGF-­‐‑1/DAF-­‐‑2  defi-­‐‑
cient  nematodes.    
In  contrast  to  wild  type  animals,  loss  of  DAF-­‐‑2  did  not  only  abolish  the  reduction  
of   lifespan   caused   by   wah-­‐‑1   (RNAi)   but   rather   extended   it   significantly   by   ~15  %  
(Figure  3-­‐‑7  A).  Interestingly,  the  extension  of  the  mean  lifespan  of  insulin/IGF-­‐‑1  mutant  
animals   was   independent   of   the   downstream   DAF-­‐‑16/FOXO   transcription   factor  
(Figure  3-­‐‑7  B).  This  suggests,  that  the  protective  effect  of  reduced  IIS  was  not  only  me-­‐‑
diated  by  global  effects  of   lifespan  extension,  but  elicited   its   capabilities   through  dis-­‐‑
tinctive  alterations  in  cellular  homeostasis.  Activated  DAF-­‐‑16  induces  the  expression  of  
diverse  stress  response  genes  that   influence  cellular  function  and  homeostasis.  As  the  
IIS  pathway  is  complex  and  the  transcription  factor  DAF-­‐‑16  was  not  responsible  for  the  
lifespan  extending  effect  in  wah-­‐‑1  deficient  animals,  further  experiments  were  conduct-­‐‑
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ed  in  daf-­‐‑16;daf-­‐‑2  double  mutant  animals  that  lack  both  the  insulin/IGF-­‐‑1/DAF-­‐‑2  recep-­‐‑
tor   and   the   transcription   factor   DAF-­‐‑16/FOXO.   This   allowed   investigating   the   path-­‐‑
ways   that  were  responsible   for   the   lifespan  extension  of  wah-­‐‑1   (RNAi)  nematodes  ex-­‐‑
cluding  DAF-­‐‑16-­‐‑dependent  influences.    
  
Figure   3-­‐‑7:  Reduced   insulin/IGF-­‐‑1   signaling   extends   the   lifespan   of  WAH-­‐‑1   deficient   ani-­‐‑
mals.  Downregulation  of  WAH-­‐‑1  extends  the  lifespan  of  (A)  daf-­‐‑2  mutants,  (B)  independently  
of  the  transcription  factor  DAF-­‐‑16/FOXO.  black:  control,  red:  wah-­‐‑1  (RNAi).  (C)  Immunoblot  of  
mitochondrial  ETC  complexes  C  I,  C  IV,  C  V  and  pDH  in  daf-­‐‑16(mu86);daf-­‐‑2(e1370)  animals.  (D)  
Oxygen  consumption  rates  and  (E)  ATP  levels  in  daf-­‐‑16(mu86);daf-­‐‑2(e1370)  mutants.  (C:  control,  
W:  wah-­‐‑1  (RNAi)  treatment.  Mean  ±  S.E.M.,  ***p  value  <0.001,  two-­‐‑tailed  unpaired  Student’s  t-­‐‑
test).  
To   test   whether   impaired   IIS   protected   nematodes   from   the   adverse   effects   of  
low  wah-­‐‑1  levels  through  a  stabilisation  of  OXPHOS,  I  analysed  ETC  complexes  in  daf-­‐‑
16;daf-­‐‑2  mutants  by  western  blot  analysis.  Similar  to  wild  type  animals,  wah-­‐‑1  silencing  
significantly   reduced  C  I   protein   levels   (Figure   3-­‐‑7  C).  ATP   synthase,  C  IV   and  pDH  
levels  were  not  significantly  affected.   In   line  with  the  changes   in   the  ETC  subunits  of  
wild  type  and  mutant  nematodes,  animals  displayed  similarly  reduced  mitochondrial  
respiration  (Figure  3-­‐‑7  D).  Furthermore,  ATP  levels  were  also  decreased  (Figure  3-­‐‑7  E).  
As  observed  in  wild  type  N2  animals,  the  downregulation  of  wah-­‐‑1  also  decreased  ROS  
levels  in  the  daf-­‐‑16;daf-­‐‑2  mutant  background  (Figure  3-­‐‑8  A),  indicating  that  ROS  signal-­‐‑
A daf-16;daf-2













































































ling  does  not  play  a  role  in  the  opposing  effect  on  lifespan.  Since  loss  of  wah-­‐‑1  caused  
ETC  impairment,  I  performed  epistasis  analysis  in  daf-­‐‑16;daf-­‐‑2;gas-­‐‑1  triple  mutants  that  
already   carry   a  mutation   impairing  CI   (Figure   3-­‐‑8  B).  Notably,  wah-­‐‑1   (RNAi)   did  not  
affect  the  survival  of  the  triple  mutant.  However,  the  daf-­‐‑16;daf-­‐‑2  mutation  significantly  
extended  the  lifespan  of  nematodes  with  a  loss-­‐‑of-­‐‑function  mutation  in  the  gas-­‐‑1  gene  
in  control  conditions,  similarly  to  wah-­‐‑1  silencing.  
  
Figure   3-­‐‑8:  wah-­‐‑1   (RNAi)   reduces   ROS   in   insulin/IGF-­‐‑1   mutants   and   does   not   affect   the  
lifespan   of   daf-­‐‑16;daf-­‐‑2;gas-­‐‑1   triple   mutants.   (A)   Measurement   of   ROS   in   daf-­‐‑16(mu86);daf-­‐‑
2(e1370)  animals  by  DCF-­‐‑DA  staining.  (B)  Lifespan  analysis  of  daf-­‐‑16(mu86);daf-­‐‑2(e1370)  and  daf-­‐‑
16(mu86);daf-­‐‑2(e1370);gas-­‐‑1(fc21)  mutants  on  control  and  wah-­‐‑1   (RNAi)  bacteria.  Black:   control,  
red:  wah-­‐‑1   (RNAi).   (C:   control,  W:  wah-­‐‑1   (RNAi)   treatment.  Mean   ±   S.E.M.,   ***p<   0.001,   two-­‐‑
tailed  Student’s  t  test)  
  
In  conclusion,   impaired  IIS  signalling  significantly  extends  the  lifespan  of  wah-­‐‑1  
deficient  animals   in  a  daf-­‐‑16   independent  manner.   Importantly,   low  IIS   increases  sur-­‐‑
vival  also  in  other  C  I  mutants  such  as  gas-­‐‑1.  This  observation  is  important  for  the  eval-­‐‑
uation  of   reduced   IIS  as  a  protective  mechanism  for  a  broader   spectrum  of  OXPHOS  
dysfunction  and  mitochondrial  diseases  that  are  independent  of  WAH-­‐‑1.  
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  3.5  Impaired  insulin/IGF-­‐‑1  signalling  leads  to  metabolic  rewiring  
in  wah-­‐‑1  treated  nematodes  
OXPHOS   deficiency   can   dramatically   affect   cellular   metabolism.   However,   IIS  
plays  a  central  role  in  the  metabolic  homeostasis  of  the  cell.  Consequently,  impaired  IIS  
could  no  longer  operate  as  an  orchestrator  of  metabolism  when  mitochondrial  function  
is  affected.  Therefore,  the  metabolism  of  wah-­‐‑1  deficient  wild  type  and  daf-­‐‑16;daf-­‐‑2  mu-­‐‑
tant  C.  elegans  could  be  different  and  cause  an  opposing  effect  on  nematode  lifespan.  
It  has  been  demonstrated  that  inhibition  of  the  ETC  can  stimulate  the  switch  from  
cellular   respiration   to   glucose  metabolism   (Koopman,   2013;   Koopman,   2012).   There-­‐‑
fore,   I   tested  whether   loss  of  AIF/WAH-­‐‑1  could   lead   to  a  metabolic  shift   in   favour  of  
alternative  pathways  that  do  not  rely  on  mitochondrial  energy  production.  To  this  end,  
I  measured  mRNA  expression  of  different  metabolic  markers  by  qRT-­‐‑PCR.  Interesting-­‐‑
ly,   qRT-­‐‑PCR  analysis   of   the  glycolytic   enzyme  glyceraldehyde  3-­‐‑phosphate  dehydro-­‐‑
genase   (gpd-­‐‑3)   revealed   a   significant   upregulation   in   both  wild   type   and   daf-­‐‑16;daf-­‐‑2  
mutants  treated  with  wah-­‐‑1  (RNAi)  (Figure  3-­‐‑9  A).  In  comparison,  qRT-­‐‑PCR  analysis  of  
phosphoenolpyruvate   carboxykinase   (PEPCK),  which   catalyses   the   conversion   of   ox-­‐‑
aloacetate  to  phosphoenolpyruvate  during  gluconeogenesis  (McElwee  et  al.,  2006),  was  
not  affected  when  animals  were  treated  with  wah-­‐‑1  (RNAi)  (Figure  3-­‐‑9  B).    
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Figure   3-­‐‑9:  WAH-­‐‑1   deficiency   affects   glucose   metabolism.   mRNA   expression   levels   of   (A)  
glyceraldehyde   3-­‐‑phosphate   dehydrogenase   (gpd-­‐‑3)   and   (B)   phosphoenolpyruvate   carboxyki-­‐‑
nase  (pck-­‐‑1)  in  wild  type  animals  and  daf-­‐‑16(mu86);daf-­‐‑2(e1370)  mutants.  (C)  Fluorescence  analy-­‐‑
sis  of  2-­‐‑NBDG  stained  wild  type  and  daf-­‐‑16;daf-­‐‑2  animals.  (D)  Calorimetric  measurement  of  glu-­‐‑
cose-­‐‑6-­‐‑phosphate   dehydrogenase   (G-­‐‑6-­‐‑PDH)   activity   after   wah-­‐‑1   downregulation   by   RNAi.  
(Mean  ±  S.E.M.,  ***p<  0.001,  **p<  0.01,  *p<  0.05,  ns:  not  significant,  two-­‐‑tailed  Student’s  t  test)  
Although,  both  wild  type  and  mutant  animals  display  increased  glycolytic  activi-­‐‑
ty,  glucose  uptake  of  the  cells  could  be  different.  To  this  end,  I  measured  glucose  up-­‐‑
take  of  C.  elegans  cells  in  vivo.  Surprisingly,  upon  wah-­‐‑1  downregulation,  wild  type  and  
daf-­‐‑16;daf-­‐‑2   cells   displayed   decreased   glucose   uptake   as   demonstrated   by   incubation  
with  the  fluorescent  glucose  analogue  2-­‐‑(N-­‐‑(7-­‐‑Nitrobenz-­‐‑2-­‐‑oxa-­‐‑1,3-­‐‑diazol-­‐‑4-­‐‑yl)Amino)-­‐‑
2-­‐‑Deoxyglucose   (2-­‐‑NBDG)   (Figure   3-­‐‑9  C).   Furthermore,   also   glucose-­‐‑6-­‐‑phosphate  de-­‐‑
hydrogenase  (G-­‐‑6-­‐‑P-­‐‑DH)  levels  were  decreased  in  both  backgrounds,  as  measured  by  
qRT-­‐‑PCR  (Figure  3-­‐‑9  D).  Thus,  altered  glucose  metabolism  does  not  explain  the  differ-­‐‑
ent  lifespan  of  wah-­‐‑1   (RNAi)  treated  wild  type  and  IIS  mutant  animals  as  neither  gly-­‐‑
colysis  and  gluconeogenesis  nor  glucose  uptake  were  differentially  affected  in  the  ge-­‐‑
netic  backgrounds.  Hence,   cellular  metabolism  might  have   switched   to  glucose   inde-­‐‑
pendent  energy  sources.  
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Therefore,   I  measured  other  metabolite   levels   in  whole  body  extracts   from  wild  
type  and  daf-­‐‑16;daf-­‐‑2  mutant  nematodes   treated  with  wah-­‐‑1   (RNAi).  Lactate  dehydro-­‐‑
genase  (LDH)  activity,  fumarate  and  branched  chain  amino  acids  (BCAA)  levels  were  
analysed  with  specific  calorimetric  test  kits.  However,  decreased  WAH-­‐‑1  levels  did  not  
affect  fumarate  levels  (Figure  3-­‐‑10  A),  whereas  BCAA  levels  (Figure  3-­‐‑10  B)  and  LDH  
activity  (Figure  3-­‐‑10  C)  were  slightly  decreased  in  wild  type  and  daf-­‐‑16;daf-­‐‑2  nematodes  
without  significant  difference  between  the  strains.  
  
Figure   3-­‐‑10:  Decreased   insulin/IGF-­‐‑1   signalling   shifts   expression   of   the   metabolic   marker  
acdh-­‐‑1.  (A)  Calorimetric  metabolite  analysis  of  (A)  fumarate,  (B)  lactate  dehydrogenase  (LDH)  
activity  and  (C)  branched  chain  amino  acids  (BCAA)  in  C.  elegans  full  body  lysates.  (D)  mRNA  
expression   levels   of   (C)   acyl-­‐‑CoA   dehydrogenase   (acdh-­‐‑1)   in   wild   type   animals   and   daf-­‐‑
16(mu86);daf-­‐‑2(e1370)   mutants   by   qRT-­‐‑PCR.   (D)  Lifespan   analysis   of   daf-­‐‑16(mu86);daf-­‐‑2(e1370)  
mutants  after  wah-­‐‑1  (RNAi)  and  additional  downregulation  of  acdh-­‐‑1  by  RNAi.  (C:  control,  W:  
wah-­‐‑1  (RNAi)  treatment.  Mean  ±  S.E.M.,  ***p<  0.001,  *p<  0.05,  two-­‐‑tailed  Student’s  t  test)  
Results  48  
In  C.  elegans,  acdh-­‐‑1  encodes  a  mitochondrial  short-­‐‑chain  acyl-­‐‑CoA  dehydrogen-­‐‑
ase  that  catalyses  fatty  acid  β-­‐‑oxidation  and  thus  plays  a  key  role  in  energy  production  
(Taubert  et  al.,  2006).  Moreover,  ACDH-­‐‑1  has  also  been  identified  as  a  marker  of  global  
metabolic  network  perturbation  (Watson  et  al.,  2013).  Therefore,  I  tested  acdh-­‐‑1  expres-­‐‑
sion  levels  in  wah-­‐‑1  deficient  wild  type  and  daf-­‐‑16;daf-­‐‑2  mutant  animals.  Although,  the  
expression  of  this  gene  was  slightly  increased  in  wild  type  animals,  WAH-­‐‑1-­‐‑loss  had  a  
strong  impact  on  acdh-­‐‑1  levels  in  conditions  of  low  IIS  and  increased  the  expression  up  
to   6-­‐‑fold   (Figure   3-­‐‑10  D).  Despite  ACDH-­‐‑1   being   an   important  metabolic   sensor,   the  
increase   in   its   activity  was   not   causative   for   the   lifespan   extension   as   knockdown  of  
acdh-­‐‑1   in  wah-­‐‑1   (RNAi)   treated  daf-­‐‑16;daf-­‐‑2  mutants  did  not   affect   the  nematodes   sur-­‐‑
vival  (Figure  3-­‐‑10  E).  
In  summary,  ETC  deficiency  induced  by  wah-­‐‑1  downregulation  reduced  the  en-­‐‑
ergy   production   through  OXPHOS.   Consequently,   cells   adapted  metabolism   accord-­‐‑
ingly   and   induced  oxygen-­‐‑independent  glucose  metabolism.  However,  differences   in  
glucose  metabolism  could  not  explain  the  opposing  effect  of  wah-­‐‑1  downregulation  in  
wah-­‐‑1  (RNAi)  treated  wild  type  and  IIS  mutant  animals.  In  both  backgrounds,  glucose  
metabolism  was   similarly   affected.  Nevertheless,   expression   of   the  metabolic  marker  
acdh-­‐‑1  was  highly  increased  in  daf-­‐‑16;daf-­‐‑2  mutants  but  not  in  wild  type  animals.  These  
data   indicate   a   strong   involvement   of  metabolism   upon   reduction   of  WAH-­‐‑1   levels.  
However,  it  was  not  clear  how  the  cells  would  control  the  changes  in  metabolism.  
  3.6  HIF-­‐‑1,  AMPK  and  autophagy  mediate  metabolic  rewiring  
Upon  cellular  stress  and  energy  deprivation,  nutrient  sensors  and  metabolic  pro-­‐‑
cesses  are  activated  that  tune  metabolism  and  protect  the  cell  from  detrimental  conse-­‐‑
quences.  HIF-­‐‑1,  AMPK  and  autophagy  are   important   factors   in   this  cellular  stress  re-­‐‑
sponse.   I  demonstrated   that   impaired   IIS  extended   the   lifespan  of  OXPHOS  deficient  
animals  and  induced  the  expression  of  acdh-­‐‑1.  Therefore,  I  first  asked  whether  this  ex-­‐‑
pression  was  dependent  on  HIF-­‐‑1  and  AMPK.  To  this  end,  I  downregulated  wah-­‐‑1  by  
RNAi  in  triple  mutant  IIS  strains,  i.e.  daf-­‐‑16;daf-­‐‑2;hif-­‐‑1  (HIF-­‐‑1  loss-­‐‑of-­‐‑function)  and  daf-­‐‑
16;daf-­‐‑2;aak-­‐‑2  (AMPK  loss-­‐‑of-­‐‑function)  and  measured  acdh-­‐‑1  mRNA  levels  by  qRT-­‐‑PCR.  
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As   already   demonstrated,   acdh-­‐‑1   expression   increased   in   wah-­‐‑1   (RNAi)   treated   daf-­‐‑
16;daf-­‐‑2  animals.  Interestingly,  the  additional  loss  of  hif-­‐‑1  or  aak-­‐‑2  function  suppressed  
the  acdh-­‐‑1  mRNA  increase  (Figure  3-­‐‑11  A)  and  reduced  expression  to  wild  type  levels.  
Therefore,  hif-­‐‑1  and  aak-­‐‑2  seem  to  play  an  important  role  for  the  metabolic  changes  in  
WAH-­‐‑1  deficient  IIS  mutants.  To  elucidate  the  role  of  autophagy  in  IIS-­‐‑mediated  acdh-­‐‑1  
expression,  I  decreased  autophagic  function  by  bec-­‐‑1  (RNAi)  in  the  daf-­‐‑16;daf-­‐‑2  mutant  
background  and  measured  acdh-­‐‑1  by  qRT-­‐‑PCR.  RNAi  solely  against  bec-­‐‑1  strongly  re-­‐‑
duced   acdh-­‐‑1   expression   levels   in   daf-­‐‑16;daf-­‐‑2   mutants   compared   to   control   levels  
(Figure  3-­‐‑11  B).  Further,  double  RNAi  against  wah-­‐‑1  and  bec-­‐‑1  reduced  the  strong  acdh-­‐‑
1  expression  by  wah-­‐‑1  alone.  Hence,  autophagy  seems  to  play  an  important  role  in  the  
metabolic  adaption  to  mitochondrial  stress  along  with  HIF-­‐‑1  and  AMPK.  
  
Figure  3-­‐‑11:  acdh-­‐‑1  mRNA  levels  are  dependent  on  hif-­‐‑1,  aak-­‐‑2  and  autophagy.  (A)  mRNA  of  
acdh-­‐‑1   measured   by   qRT-­‐‑PCR   in   wild   type   N2,   daf-­‐‑16(mu86);daf-­‐‑2(e1370),   daf-­‐‑16(mu86);daf-­‐‑
2(e1370);hif-­‐‑1(ia4)  and  daf-­‐‑16(mu86);daf-­‐‑2(e1370)aak-­‐‑2(ok524)  animals.  acdh-­‐‑1  mRNA  levels   in   (B)  
daf-­‐‑16(mu86);daf-­‐‑2(e1370)  and  (C)  AAK-­‐‑2  overexpressing  nematodes  treated  with  control,  wah-­‐‑1,  
bec-­‐‑1   and   wah-­‐‑1;bec-­‐‑1   (RNAi).   (C:   control,  W:  wah-­‐‑1   (RNAi),   B:   bec-­‐‑1   (RNAi),  W;B:  wah-­‐‑1;bec-­‐‑1  
(RNAi)  treatment.  Mean  ±  S.E.M.,  ***p<  0.001,  **p<  0.01,  *p<  0.05,  two-­‐‑tailed  Student’s  t  test)  
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AMPK   itself   has   been   demonstrated   to   be   a   key   regulator   of   metabolism   and  
showed  to  be  crucial  for  acdh-­‐‑1  expression  in  daf-­‐‑16;daf-­‐‑2;  wah-­‐‑1  (RNAi)  animals.  There-­‐‑
fore   I   asked  weather  overactivation  of  AMPK  was   sufficient   to   induce  acdh-­‐‑1   expres-­‐‑
sion.  To  this  end,  I  measured  acdh-­‐‑1  mRNA  levels   in  a  mutant  nematode  that  overex-­‐‑
presses  aak-­‐‑2  (aak-­‐‑2  OE).  Strikingly,  aak-­‐‑2  OE  increased  acdh-­‐‑1  levels  when  treated  with  
wah-­‐‑1   (RNAi)   similarly   to  daf-­‐‑16;daf-­‐‑2  mutants   (Figure   3-­‐‑11  C).  The   additional  down-­‐‑
regulation  of  autophagy  by  bec-­‐‑1  (RNAi)  suppressed  the  increase  in  acdh-­‐‑1  expression.    
In  summary,  acdh-­‐‑1  expression  levels  suggest  metabolic  rewiring  in  mitochondri-­‐‑
ally  impaired  IIS  mutants.  This  change  in  metabolism  was  dependent  on  the  activity  of  
HIF-­‐‑1  and  AMPK.  Interestingly,  AMPK  overexpression  was  sufficient  to  induce  acdh-­‐‑1  
expression.  Furthermore,  autophagy  seems   to  play  a  key   role   in   this  metabolic  adap-­‐‑
tion  and  was  required  for  acdh-­‐‑1  gene  expression.  
  3.7  HIF-­‐‑1  is  activated  by  wah-­‐‑1  (RNAi)  and  important  for  the  
lifespan  extension  by  daf-­‐‑16;daf-­‐‑2    
In   interaction   with   IIS/DAF-­‐‑2   signalling,   HIF-­‐‑1   is   an   important   mediator   of  
lifespan  (Chen  et  al.,  2009;  Leiser  &  Kaeberlein,  2010;  Zhang  et  al.,  2009)  and  shares  a  
subset   of   target  genes  with   the   transcription   factor  DAF-­‐‑16   (Hoogewijs   et   al.,   2007;  
McElwee  et  al.,  2004).  Although,  DAF-­‐‑16  is  dispensable  for  the  promotion  of  lifespan  
in  WAH-­‐‑1  deficient   animals   (Chapter   3.4   ),   active  HIF-­‐‑1  might  mediate   lifespan  ex-­‐‑
tension.   Furthermore,   acdh-­‐‑1   expression   levels   were   dependent   on   the   hypoxia-­‐‑
inducible   factor  HIF-­‐‑1   in   daf-­‐‑16;daf-­‐‑2  mutants  with   impaired  mitochondrial   respira-­‐‑
tion.  Therefore,  HIF-­‐‑1  might  play  an  important  role  in  metabolic  rewiring  reflected  by  
acdh-­‐‑1  expression  levels.  
To  address  HIF-­‐‑1  activity,  HIF-­‐‑1  protein  and  nhr-­‐‑57  mRNA  levels  were  meas-­‐‑
ured   by   western   blot   and   qRT-­‐‑PCR,   respectively.   In   line   with   the   effect   of   wah-­‐‑1  
downregulation  on   respiration   (Chapter  3.1   ),   an   increase   in  HIF-­‐‑1  protein   levels  as  
well   as   an   increase   in   the   expression   of   the  HIF-­‐‑1   target   nuclear   hormone   receptor  
nhr-­‐‑57  was  observed.  This  increase  occurred  in  both  wild  type  (Figure  3-­‐‑12  A-­‐‑B)  and  
insulin/IGF-­‐‑1  mutant  animals  (Figure  3-­‐‑12  C-­‐‑D).  To  test  the  involvement  of  hif-­‐‑1  in  the  
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animal’s  survival,  a  lifespan  analysis  was  performed  in  hif-­‐‑1  loss-­‐‑of-­‐‑function  mutants.  
hif-­‐‑1  did  not  affect  the  lifespan  of  wah-­‐‑1  (RNAi)  treated  worms  in  the  wild  type  back-­‐‑
ground   (Figure  3-­‐‑12  E).  However,  hif-­‐‑1   (RNAi)  abrogated   the   lifespan  extension  ob-­‐‑
served  in  wah-­‐‑1  (RNAi)  treated  daf-­‐‑16;daf-­‐‑2  mutants  (Figure  3-­‐‑12  F).  Therefore,  HIF-­‐‑1  
seems  to  play  an  important  role  in  IIS  dependent  lifespan  extension  of  OXPHOS  defi-­‐‑
cient  wah-­‐‑1  (RNAi)  animals.    
The  results  suggest   that   the   transcription   factor  HIF-­‐‑1  plays  an   important  role  
in  the  lifespan  extension  of  ETC-­‐‑impaired  IIS  mutants.  
  
  
Figure  3-­‐‑12:  Activation  of  Hypoxia-­‐‑Inducible  Factor  is  required  for  the  lifespan  extension  of  
WAH-­‐‑1  deficient  daf-­‐‑16;daf-­‐‑2  animals.  HIF-­‐‑1  protein  levels  measured  by  western  blot  and  nhr-­‐‑
57  mRNA  analysed  by  qRT-­‐‑PCR  in  (A-­‐‑B)  wild  type  animals  and  (C-­‐‑D)   insulin/IGF-­‐‑1  mutants.  
Lifespan   of   (E)   hif-­‐‑1(ia4)   mutants   treated   with   control   and   wah-­‐‑1   (RNAi)   and   (F)   daf-­‐‑
16(mu86);daf-­‐‑2(e1370)  mutants  treated  with  control,  wah-­‐‑1,  hif-­‐‑1  and  wah-­‐‑1;hif-­‐‑1  (RNAi).  (C:  con-­‐‑
















































































  3.8    The  lifespan  extension  of  WAH-­‐‑1  deficient  animals  is  
mediated  by  AMPK/AAK-­‐‑2  
Apart  from  the  activation  of  protective  pathways  under  hypoxic  conditions  by  
HIF-­‐‑1,   other   cellular   sensors   such   as   AMPK/AAK-­‐‑2   play   an   important   role   in   the  
maintenance  of  cellular  function  upon  mitochondrial  impairment.  AMPK/AAK-­‐‑2  is  a  
nutrient  sensor   that  monitors   the  energy  status  of   the  cell  and  tunes  metabolism  ac-­‐‑
cordingly.  Active   IIS  blocks   the  activation  of  AMPK/AAK-­‐‑2  and   the  nutrient   sensor  
has   been   found   to   be   required   for   the   long   lifespan   of   daf-­‐‑2   mutants   (Curtis   et   al.,  
2006)  and  animals  subjected  to  dietary  restriction  (DR)  (Greer  et  al.,  2007).    
As  impaired  OXPHOS  can  activate  AMPK/AAK-­‐‑2,  the  energy  sensor  might  also  
be   activated   by   the   consequences   of   wah-­‐‑1   (RNAi)-­‐‑induced  mitochondrial   dysfunc-­‐‑
tion.  However,   in  wild  type  animals,  active  IIS  might   inhibit  AMPK/AAK-­‐‑2.   In  con-­‐‑
trast,  IIS  is  inactive  in  daf-­‐‑16;daf-­‐‑2  mutants.  Consequently,  the  inhibition  of  the  energy  
sensor   might   be   abrogated   and   lead   to   AMPK/AAK-­‐‑2   activity.   Thereby,   active  
AMPK/AAK-­‐‑2  could  mediate  lifespan  extension  in  mutant  animals.  To  test  this,  I  first  
measured  phospho-­‐‑AMPK  (the  active  form  of  AMPK/AAK-­‐‑2)  protein  levels  by  west-­‐‑
ern  blot  analysis.  Indeed,  phospho-­‐‑AMPK  levels  were  increased  in  daf-­‐‑16;daf-­‐‑2  but  not  
in   wild   type   animals   subjected   to   wah-­‐‑1   (RNAi)   (Figure   3-­‐‑13   A).   To   test   whether  
AMPK/AAK-­‐‑2  activity  also  has  an   impact  on   the   lifespan  of  daf-­‐‑16;daf-­‐‑2  nematodes,  
the   mutants   were   crossed   with   a   aak-­‐‑2   loss-­‐‑of-­‐‑function   mutation   in   the   catalytic   α  
subunit  of  AMPK/AAK-­‐‑2.  Lifespan  analysis  of   these  animals  demonstrated   that   the  
increased   survival   of   daf-­‐‑16;daf-­‐‑2   animals   was   abolished   (Figure   3-­‐‑13   B).   Since  
AMPK/AAK-­‐‑2  activity  was  indispensable  for  the  lifespan  extension  of  daf-­‐‑16;daf-­‐‑2  an-­‐‑
imals,  it  is  possible  that  the  sole  overexpression  of  AAK-­‐‑2  was  sufficient  for  a  lifespan  
extension   in  wah-­‐‑1   (RNAi)   treated  nematodes.  To   test   this  hypothesis,  aak-­‐‑2  OE  ani-­‐‑
mals  were  fed  with  control  bacteria  and  wah-­‐‑1  (RNAi)  and  the  effect  on  lifespan  was  
observed.  In  contrast  to  the  lifespan  reduction  by  the  aak-­‐‑2  loss-­‐‑of-­‐‑function  mutation,  
the  overexpression  of  AAK-­‐‑2  was  sufficient  to   increase  the  lifespan  of  wah-­‐‑1   (RNAi)  
animals  (Figure  3-­‐‑13  C).  
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Figure  3-­‐‑13:  Lifespan  extension  requires  AMPK/AAK-­‐‑2  activity.   (A)  Western  Blot  analysis  of  
Phospho-­‐‑AMPK   in   wild   type   and   daf-­‐‑16;daf-­‐‑2   animals   treated   with   wah-­‐‑1   (RNAi).   Lifespan  
analysis  of  (B)  daf-­‐‑16;daf-­‐‑2;aak-­‐‑2  and  (C)  AAK-­‐‑2  overexpressing  animals.  (C:  control,  W:  wah-­‐‑1  
(RNAi)  treatment)  
Taken  together,   these  results  highlight  the  important  role  of  the  energy  sensor  
AMPK/AAK-­‐‑2  in  the  regulation  of  lifespan.  AMPK/AAK-­‐‑2  activity  was  indispensable  
for  the  lifespan  extension  of  daf-­‐‑16;daf-­‐‑2  mutant  worms  with  reduced  WAH-­‐‑1  levels.  
Moreover,   its   overexpression   was   even   sufficient   to   extend   the   lifespan   of   wah-­‐‑1  
(RNAi)  treated  wild  type  C.  elegans.  These  results  make  AMPK/AAK-­‐‑2  an  interesting  
target  for  potential  pharmacological  treatment  of  higher  organisms  suffering  from  mi-­‐‑









































  3.9  daf-­‐‑16;daf-­‐‑2  and  AAK-­‐‑2  mediated  lifespan  extension  requires  
autophagy  
Under  low  energy  conditions  and  upon  mitochondrial  damage,  AMPK/AAK-­‐‑2  
activates  autophagy  (Hardie,  2011a;  Salminen  &  Kaarniranta,  2012;  Zhang,  2013).  No-­‐‑
tably,  autophagy  has  been  reported  to  play  an  important  role  for  the  lifespan  exten-­‐‑
sion  under  various  conditions  and  is  also  linked  to  changes  in  metabolism  (Hansen  et  
al.,   2008;  Hars   et   al.,   2007;   Jia  &  Levine,   2007;  Lim   et   al.,   2014;  Melendez   et   al.,   2003;  
Toth   et   al.,   2008).   To   determine  whether   activated  AMPK/AAK-­‐‑2   also   led   to   an   in-­‐‑
creased  autophagic  flux  after  wah-­‐‑1  (RNAi)  treatment,  a  transgenic  daf-­‐‑2  line  express-­‐‑
ing  a  LGG-­‐‑1/LC3::GFP  reporter  under  the  control  of  the  lgg-­‐‑1  promoter  was  analysed  
for  the  number  of  GFP  puncta.  The  number  of  puncta  correlate  with  autophagic  activ-­‐‑
ity.  Fluorescent  puncta  in  the  hypodermal  seam  cells  were  increased  by  wah-­‐‑1  (RNAi)  
treatment   in   IIS  deficient  mutants   but   not   in  wild   type   animals   (Figure   3-­‐‑14  A).   To  
address  the  involvement  of  autophagy  in  the  lifespan  extension  by  daf-­‐‑16;daf-­‐‑2  muta-­‐‑
tion,  RNAi  for  bec-­‐‑1  was  used.  BEC-­‐‑1  is  a  crucial  protein  for  autophagic  function  and  
knockdown  blocks  autophagy.  Decreased  BEC-­‐‑1   levels  abolished  the   lifespan  exten-­‐‑
sion  of  daf-­‐‑16;daf-­‐‑2  mutants  subjected  to  wah-­‐‑1  (RNAi)  (Figure  3-­‐‑14  B).  This  means  that  
autophagy  was  necessary  for  the  lifespan  extension  of  wah-­‐‑1  (RNAi)  treated  animals  
by   the  mutations   in   IIS.   Furthermore,   autophagy  was   also   required   for   the   lifespan  
extension  by  aak-­‐‑2   overexpression.  The   simultaneous  decrease  of  wah-­‐‑1   and  bec-­‐‑1   in  
animals   overexpressing  AMPK/AAK-­‐‑2  diminished   the   lifespan   extension   compared  
to  the  exclusive  downregulation  of  wah-­‐‑1  (Figure  3-­‐‑14  C)  emphasising  the  importance  
of  autophagy  in  the  lifespan  extension  by  AMPK/AAK-­‐‑2.  
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Figure   3-­‐‑14:  Autophagy   is   required   for   lifespan  extension.   (A)  Microscopy  analysis  of  LGG-­‐‑
1::GFP  puncta  in  seam  cells  of  wild  type  and  daf-­‐‑2(e1370)  mutant  C.  elegans  as  a  marker  of  au-­‐‑
tophagy.  Lifespan  of  (B)  daf-­‐‑16(mu86);daf-­‐‑2(e1370)  and  (C)  AAK-­‐‑2  overexpressing  animals  treat-­‐‑
ed  with  bec-­‐‑1  (RNAi).  (C:  control,  W:  wah-­‐‑1  (RNAi)  treatment.  Mean  ±  S.E.M.,  ***p<  0.001,  ns:  not  
significant,  two-­‐‑tailed  Student’s  t  test)  
In  conclusion,  while  AMPK/AAK-­‐‑2  activation  in  wah-­‐‑1  (RNAi)  treated  animals  
induced  autophagy  and  increased  lifespan,  the  block  of  the  autophagic  pathway  abol-­‐‑
ished   this   lifespan   extension.   Therefore,   autophagy   plays   a   key   role   in   the   lifespan  
regulation  of  ETC  deficient  animals  in  IIS  mutants  and  AMPK/AAK-­‐‑2  overexpressing  
animals.  
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  4  Discussion  
Mitochondria  are  complex  organelles  that  execute  essential  functions  for  the  ac-­‐‑
tivity   and   survival   of   cells.   These   include   energy   and   ROS   production,   biosynthesis  
and  degradation  of  amino  acids,  fatty  acid  β-­‐‑oxidation,  calcium  homeostasis  and  apop-­‐‑
tosis.  Due  to  the  complex  nature  of  mitochondrial  architecture  and  mitochondrial  func-­‐‑
tion,  it  is  not  surprising  that  their  dysfunction  can  result  in  the  development  of  various  
pathological  conditions.  Inherited  and  spontaneous  mutations  in  many  different  nucle-­‐‑
ar  or  mitochondrial  DNA  genes  can  cause  severe  mitochondrial  dysfunction  and  result  
in   mitochondriopathies   and   neurodegenerative   diseases   (Koopman   et   al.,   2013).   Yet,  
cause  and  consequence  of  many  syndromes  are  difficult   to  diagnose  as  genotype  and  
phenotype   are   often   poorly   correlated,   resulting   in   inadequate   therapy   of  many   pa-­‐‑
tients  with  mitochondrial  disorders  (Chinnery,  2014).  The  heterogeneity  of  symptoms  
and  the  unique  character  of  mitochondrial  genomics  make  disease  management  further  
challenging.  Although,   the   underlying   genotype   can   be   highly   heterogeneous,  many  
mitochondrial   diseases   share   common   cellular   consequences   and   phenotypes.   Thus,  
understanding  common  pathways  downstream  of  ETC  dysfunction  could  result  in  the  
development  of  treatments  for  many  mitochondrial  disease  phenotypes.    
In   the   present   study,   I   induced  mitochondrial   dysfunction   by   reducing   the   ex-­‐‑
pression  of  AIF/WAH-­‐‑1  in  C.  elegans.  Furthermore,  I  explored  genetic  ways  to  protect  
the  organism  from  the  detrimental  consequences   (Figure  4-­‐‑1).  Low   levels  of  AIF  pro-­‐‑
tein  resulted  in  ETC  deficiency  and  OXPHOS  dysfunction  in  C.  elegans.  Mitochondrial  
ETC   complexes  were   destabilised   and   led   to   a   decrease   in   oxygen   consumption   and  
ATP   production.   Mitochondrial   morphology   was   affected   and   protective   stress   re-­‐‑
sponse  mechanisms  were   induced,   indicating  profound   impairment  of  mitochondrial  
function.   As   a   result,   the   lifespan   of   nematodes  was   significantly   reduced  when   fed  
with   bacteria   expressing  wah-­‐‑1   (RNAi).   However,   IIS/DAF-­‐‑2   signalling   has   been   re-­‐‑
ported  to  extend  the  lifespan  of  various  organisms  (Bartke,  2008).  In  WAH-­‐‑1  deficient  
nematodes,   impaired   IIS  did   revert   the   short   lifespan.   In   fact,   lifespan  of   the  animals  
was   further   increased.  This   effect  on   lifespan  extension  was   independent  of   the   tran-­‐‑
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scription  factor  DAF-­‐‑16  but  dependent  on  HIF-­‐‑1  and  AMPK/AAK-­‐‑2  as  well  as  the  cru-­‐‑
cial   cellular   process   of   autophagy.   Strikingly,   overexpression   of   AMPK/AAK-­‐‑2   was  
sufficient   to   increase   lifespan.   Interestingly,   levels   of   the  metabolic  marker   ACDH-­‐‑1  
showed  strong  correlation  with  the  lifespan  of  treated  animals.  
  
  
Figure  4-­‐‑1:  Effect  of  AIF/WAH-­‐‑1  decrease  and  impaired  insulin/IGF-­‐‑1  signalling  on  C.  elegans  
lifespan.  Wild   type   C.  elegans   (grey)   have   a   mean   lifespan   of   ~20  days.   Downregulation   of  
AIF/WAH-­‐‑1  protein   levels   (red)  affects  mitochondrial   function  and  decreases   their   lifespan  of  
~20  %.  However,  additional  decrease  of  insulin/IGF-­‐‑1  signalling  (green)  extends  the  lifespan  of  
the  animals  and  they  live  even  longer  than  wild  type  controls.  
  
In   summary,   I   present   evidence,   that   the  manipulation   of   ageing-­‐‑related   path-­‐‑
ways  can  counteract  the  detrimental  effects  of  mitochondrial  dysfunction  caused  by  an  
impaired  ETC  in  C.  elegans.  Furthermore,  the  results  promote  the  idea  of  a  convergent  
therapy  for  various  mitochondrial  diseases  that  affect  complex  I  and  presumably  other  
ETC  dependent  deficiencies.  Specifically,  AMPK  and  autophagy  might  serve  as  potent  
targets  that  could  contribute  to  health  in  patients.  
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  4.1  AIF/WAH-­‐‑1  downregulation  as  a  C.  elegans  model  of  
mitochondrial  deficiency    
To  mimic  the  situation  in  the  harlequin  mouse  and  patients  that  suffer  from  AIF  
dependent   mitochondrial   encephalomyopathy,   RNAi   against   wah-­‐‑1,   the   C.   elegans  
orthologue  of  human  AIFM1,  was  used.  wah-­‐‑1   (RNAi)   resulted   in   a  profound  down-­‐‑
regulation  of  mRNA  levels  to  about  40  %  compared  to  wild  type  levels.  Although,  AIF  
has  not   yet   been   shown   to  directly   interact  with   any  ETC   subunits,   there   is   growing  
evidence  that  the  flavoprotein  stabilises  the  ETC.  Accordingly,  reduced  AIF  levels  de-­‐‑
stabilise  the  ETC  and  compromise  OXPHOS  (Klein  et  al.,  2002;  Vahsen  et  al.,  2004).  My  
findings  revealed  that  AIF/WAH-­‐‑1  deficiency  disturbed  ETC  function  in  the  nematode  
C.   elegans.   This   resulted   in   reduced   respiration   rates   and   altered  mitochondrial  mor-­‐‑
phology.  Furthermore,  RNAi-­‐‑induced  mitochondrial  defects  decreased  ATP  levels,  re-­‐‑
duced  oxygen  consumption  and  altered  mitochondrial  morphology  in  C.  elegans.  Thus,  
the  function  of  AIF/WAH-­‐‑1  in  the  maintenance  of  the  ETC  and  cellular  respiration  ap-­‐‑
pears  to  be  evolutionarily  conserved.  Moreover,  decreased  WAH-­‐‑1  levels  shortened  the  
lifespan  of  wild  type  nematodes.  As  WAH-­‐‑1  deficiency  did  not   influence  the   lifespan  
of  mutants  that  already  carry  a  genetic  lesion  in  C  I  (i.e.  gas-­‐‑1(fc21)),  WAH-­‐‑1  likely  af-­‐‑
fects  lifespan  by  altering  mitochondrial  respiration.  This  observation  supports  the  hy-­‐‑
pothesis   that   distinctive   mitochondrial   mutations   can   affect   common   downstream  
pathways  that  ultimately  affect  the  function  of  the  cell.  
  4.2  ROS  levels  and  ETC  dysfunction  
Commonly,   mitochondrial   deficiencies   and   defects   in   OXPHOS   are   associated  
with  increased  levels  of  ROS  (Kirkinezos  &  Moraes,  2001).  Impaired  ETC  function  fails  
to   efficiently   process   oxygen   and   produces   free   electrons   that   eventually   lead   to   the  
generation  of  oxygen  radicals.  However,  cells  have  their  own  ROS  scavenging  mecha-­‐‑
nisms  that  are  required  for  cell  survival  under  stress  conditions  in  healthy  individuals  
(Melov   et   al.,   1998).  Notably,   it   has  been  demonstrated   that  under  normal   conditions  
incomplete   scavenging   results   in   approximately   1–3  %   of   remaining   ROS   (Boveris  &  
Chance,  1973;  Nohl  &  Hegner,  1978). Evidence  arises  that  ROS  are  not   just  a  toxic  by-­‐‑
Discussion   59  
product  of  mitochondrial   respiration,  but   function  as   important  physiological   regula-­‐‑
tors  of  a  myriad  of  cellular  signalling  pathways  (Finkel,  2011;  Reczek  &  Chandel,  2014).  
Mutations  in  ETC  subunits  that  decrease  C.  elegans  lifespan  commonly  lead  to  an  
increase   in   ROS.   Therefore,   it   is   surprising   that   ETC   dysfunction   induced   by  wah-­‐‑1  
(RNAi)  revealed  decreased  ROS  levels.  Nonetheless,  studies  of  impaired  AIF  function  
in   mice   also   demonstrate   contradictory   results   on   the   generation   of   ROS.   Whereas  
Klein   et   al.   (2002)   and  Apostolova   et   al.   (2006) report   an   increase   in   ROS,   Joza   et   al.  
(2005)  and  Pospisilik  et  al.  (2007) report  no  changes  in  ROS  levels.  On  the  contrary,  Ur-­‐‑
bano   et   al.   (2005)   find   ROS   levels   to   be   decreased.   Therefore,   the   concept   that   AIF  
serves  as  a  potential  antioxidant   through   its   cofactors  FAD  and  NAD   is   further   chal-­‐‑
lenged  by  the  decreased  ROS  levels  after  downregulation  of  AIF/WAH-­‐‑1  in  C.  elegans  
(Chen  et  al.,  2014;  Klein  et  al.,  2002;  Sevrioukova,  2011;  van  Empel  et  al.,  2005).  
In  accordance  with  studies  of  other  mitochondrial  deficiencies  (Ishii  et  al.,  1998),  
AIF/WAH-­‐‑1  loss  activated  transcription  factors  that  mediate  stress  response  such  as  the  
upregulation   of   genes   encoding   mitochondrial   chaperones   (HSP-­‐‑6   and   HSP-­‐‑60),   hy-­‐‑
poxia-­‐‑induced   proteins   (HIF-­‐‑1   targets)   and   antioxidant   proteins   (SOD-­‐‑3   and  GST-­‐‑4).  
This   activation   of   detoxification   pathways  may   ultimately   result   in   ROS   scavenging.  
Therefore,  the  relative  decrease  of  ROS  could  arise  from  increased  expression  of  antiox-­‐‑
idant  enzymes.   
  4.3  UPRmt  in  impaired  mitochondria  
The   stress   responses   elicited  by  detrimental  macromolecules  have  been   charac-­‐‑
terised  as  mechanisms  to  prevent  imbalance  of  cellular  homeostasis.  Furthermore,  they  
play   an   important   role   in   the   lifespan   extension   of   long-­‐‑lived  mutants,   such   as   daf-­‐‑2  
and   eat-­‐‑2   (Durieux   et   al.,   2011).  Moreover,   RNAi   knockdown   of  UPRmt   components  
can  suppress  the  lifespan  extension  from  mutations  in  isp-­‐‑1  or  clk-­‐‑1.  However,  cellular  
stress  response  is  insufficient  to  protect  from  abnormal  insults  and  the  activation  of  the  
UPRmt  is  neither  sufficient  for  lifespan  extension  nor  a  predictor  of  longevity  in  C.  ele-­‐‑
gans  (Bennett  et  al.,  2014).  
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The  expression  of  heat   shock  proteins   in  nematodes   lacking  AIF   is   a  marker  of  
induced  mitochondrial   stress.  However,   this   expression  was   independent   of   the  UP-­‐‑
Rmt  signalling  molecules  DVE-­‐‑1  and  UBL-­‐‑5  (Benedetti  et  al,  2006).  Instead,  the  results  
of  this  study  support  the  role  of  ATFS-­‐‑1  as  the  main  regulator  of  the  UPRmt  that  can  
act   independently  of  DVE-­‐‑1/UBL-­‐‑5  (Bennett   et  al.,  2014).  Nevertheless,  different  kinds  
of   mitochondrial   insults   might   activate   different   UPRmt   signalling   molecules.   Some  
insults  might  primarily  activate  ATFS-­‐‑1,  whereas  others  result  in  DVE-­‐‑1/UBL-­‐‑5  activa-­‐‑
tion.  For  example,  detriments  that  directly  affect  mitochondrial  membrane  potential  or  
mitochondrial  import  mechanisms  but  do  not  have  an  acute  effect  on  matrix  homeosta-­‐‑
sis   could   induce  UPRmt  via  ATFS-­‐‑1   independently  of  DVE-­‐‑1/UBL-­‐‑5.   In   this   scenario,  
import  deficiency  of  ATFS-­‐‑1   into   the  mitochondria  would  result   in  nuclear   transloca-­‐‑
tion  and   induce  heat  shock  protein  gene  expression.  Protein   folding   in   the  mitochon-­‐‑
drial  matrix  would  not  (yet)  be  directly  affected.  Thereby,   low  CLPP  activity  resulted  
in   little   production   of   peptide   products   and   export   through  HAF-­‐‑1.   In   this  way,   the  
DVE-­‐‑1/UBL-­‐‑5  node  of  action  would  be  bypassed.  For  instance,  the  downregulation  of  
ubl-­‐‑5  by  RNAi  did  not  affect  the  lifespan  in  various  long-­‐‑lived  mutants  but  suppressed  
the  lifespan  extension  in  isp-­‐‑1  (C  III  subunit)  and  clk-­‐‑1  (necessary  for  coenzyme  Q  syn-­‐‑
thesis),  exclusively  (Durieux  et  al.,  2011).  Additionally,  the  partial  effect  of  ubl-­‐‑5  (RNAi)  
on  the  lifespan  extension  from  knockdown  of  cco-­‐‑1  (Cyt  c  oxidase  subunit  Vb)  (Bennett  
et  al.,  2014)  indicates  that  induction  of  the  UPRmt  plays  a  causal  role  in  lifespan  exten-­‐‑
sion   from  ETC  inhibition.  Nevertheless,  a  broader  and  more  systemic  adaption   to  or-­‐‑
ganelle-­‐‑induced   stress   that   exceeds   the  UPRmt   could   increase   the   chance   for   cellular  
protection  from  adverse  insults.  
  4.4  Insulin/IGF-­‐‑1  signalling,  AMPK  and  HIF-­‐‑1  correlation  
For  more  than  20  years,  impaired  IIS  has  been  the  single  most  effective  mutation  
for  lifespan  extension  in  C.  elegans.  In  wah-­‐‑1  deficient  nematodes,  daf-­‐‑2  loss-­‐‑of-­‐‑function  
also  prolonged  lifespan  (Figure  4-­‐‑2).   Importantly,   this  effect  was  not  specific   to  wah-­‐‑1  
(RNAi)  but  daf-­‐‑2  mutation  also  extended  the   lifespan  of   the  ETC  mutant  gas-­‐‑1.  Taken  
together,  ETC  deficiencies  that  decrease  C.  elegans  lifespan  showed  a  lifespan  extension  
upon  impaired  IIS.  A  central  protein  for  increased  survival  through  IIS  is  the  transcrip-­‐‑
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tion  factor  DAF-­‐‑16.  However,  in  OXPHOS  impaired  animals,  the  protective  properties  
of   IIS  were   independent   of   DAF-­‐‑16.   This   suggests   other   regulatory   factors   being   re-­‐‑
sponsible   for   the   lifespan   extension   in  daf-­‐‑16;daf-­‐‑2   nematodes.  Nonetheless,   the  DAF-­‐‑
16-­‐‑independent  protection  of  wah-­‐‑1  (RNAi)  animals  does  not  principally  understate  the  
importance  of  the  transcription  factor  DAF-­‐‑16  for  lifespan.  The  overall  lifespan  of  daf-­‐‑
16;daf-­‐‑2;  wah-­‐‑1   (RNAi)  animals  was  considerably   shorter   compared   to   the   long   life  of  
daf-­‐‑2;  wah-­‐‑1  (RNAi)  animals  with  active  DAF-­‐‑16  transcription.  This  finding  enforces  the  
importance   of  DAF-­‐‑16   as   the  most   potent  mediator   of   lifespan   extension   and  under-­‐‑
lines   the   orchestrated   and   cooperative   function   of   DAF-­‐‑2   downstream   transcription  
factors.  Nevertheless,  DAF-­‐‑16   does   not   seem   to   play   a   role   in   the   cellular   protection  
from  the  detrimental  consequences  of  ETC  dysfunction.  
  
  
Figure  4-­‐‑2:  Proposed  model  for  the  molecular  mechanisms  involved  in  the  lifespan  extension  
of  nematodes  carrying  impaired  OXPHOS.  (A)  In  wild  type  animals,  mitochondrial  OXPHOS  
produces   sufficient  energy   for   cellular   function  and  maintenance.  Active   Insulin/IGF-­‐‑1   signal-­‐‑
ling  inhibits  stress  response  mechanisms.  (B)  Loss  of  AIF/WAH-­‐‑1  leads  to  impaired  mitochon-­‐‑
drial   function  and  energy  production.  Despite   the   inhibitory   effect   of   the   active   insulin/IGF-­‐‑1  
signalling   cascade,   OXPHOS   impairment   results   in   stress-­‐‑mediated   activation   of   HIF-­‐‑1.   The  
nuclear  translocation  of  the  transcription  factor  elicits  a  stress  response,  which  is  not  sufficient  
to  promote  lifespan  extension.  (C)  Under  condition  of  low  insulin/IGF-­‐‑1  signalling,  the  metabol-­‐‑
ic  sensor  AMPK  is  activated  along  with  HIF-­‐‑1.  The  enhanced  catabolism  and  the  engagement  of  
the  autophagic  machinery  ultimately   increase  stress   resistance  and  survival.  All   three  compo-­‐‑
nents  –  nuclear-­‐‑encoded  gene  expression,  AMPK  and  autophagy  –  are  required  for  the  lifespan  




HIF-­‐‑1,  along  with  AMPK,  is  likely  to  be  a  key  player  in  the  regulation  of  metabo-­‐‑
lism  and   lifespan  extension   in  wah-­‐‑1   (RNAi)   treated  worms.  HIF-­‐‑1   is  activated  under  
hypoxic  conditions  or  reduced  mitochondrial  respiration  and  signals  to  the  nucleus  to  
express   genes   encoding   for   protective   proteins   (Lee   et   al.,   2010).   Furthermore,  HIF-­‐‑1  
acts  as  a  metabolic  switch  (Kim  et  al.,  2006)  and  could  mediate  its  protective  effect  by  
mitochondrial  and  mitochondria-­‐‑to-­‐‑nucleus  signalling  (Ristow  &  Zarse,  2010).  For  ex-­‐‑
ample,  HIF-­‐‑1  directly  stimulates  the  glycolytic  flux  to  pyruvate  (Lee  et  al.,  2010)  as  de-­‐‑
tected  in  wah-­‐‑1  (RNAi)  animals  by  increased  gpd-­‐‑3  mRNA  levels.  However,  HIF-­‐‑1  was  
activated   in  wild   type   and   IIS  mutant   animals   and   the   effect   on   glycolysis  was   con-­‐‑
sistent  in  both  backgrounds.  Furthermore,  it  has  been  reported  that  HIF-­‐‑1  can  upregu-­‐‑
late  mitochondrial   autophagy   (Zhang   et   al.,   2008)   and  macroautophagy   (Bellot   et   al.,  
2009;  Tracy  et  al.,  2007;  Wilkinson  &  Ryan,  2009).  In  fact,  autophagy  plays  a  crucial  role  
in  the  lifespan  extension  of  mitochondrially-­‐‑impaired  nematodes  (Chapter  4.5  ).  Inter-­‐‑
estingly,  it  has  been  reported  that  AMPK  is  required  for  the  activation  of  HIF-­‐‑1  under  
hypoxic  conditions  in  human  prostate  carcinoma  cells  (Lee  et  al.,  2003).  The  activation  
of  both   regulators  might   also  be   connected   in  WAH-­‐‑1  deficient  worms.  Hwang   et   al.  
(2014)  recently  reported  a  common  HIF-­‐‑1/AMPK  feedback  loop  activation  by  elevated  
levels  of  reactive  oxygen  species  in  isp-­‐‑1(qm150)  (complex  III)  mutants.  Although,  ROS  
levels  were   decreased   in   the  AIF/WAH-­‐‑1  model   of  mitochondrial   deficiency   in   both  
wild   type   and  daf-­‐‑16;daf-­‐‑2   background,  HIF-­‐‑1   and  AMPK  were   similarly   activated   as  
demonstrated  in  isp-­‐‑1(qm150)  mutants.  Importantly,  the  mutation  in  isp-­‐‑1  results  in  an  
extension  of  wild  type  animal  lifespan  whereas  wah-­‐‑1  (RNAi)  reduced  survival.  Hence,  
HIF-­‐‑1   and   AMPK   are   hypothetically   activated   by   different   OXPHOS   deficiencies  
through   common   pathways   that   are   controlled   by   distinct   regulators.   Notably,   I  
demonstrated   that  HIF-­‐‑1  was   activated   in  wild   type   as  well   as   in   IIS  mutant   nema-­‐‑
todes.  AMPK  on  the  other  hand  was  only  activated  in  the  mutant  background.  
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For  the  development  of  disease  treatments  or  the  amelioration  of  phenotypes,  a  
rather   focused   node   of   action   is   desirable,   emphasising   HIF-­‐‑1   or   more   importantly  
AMPK/AAK-­‐‑2  as  potential  targets.  The  activation  of  the  nutrient  sensor  AMPK/AAK-­‐‑2  
was  crucial   for   the   lifespan  extension  of  wah-­‐‑1   (RNAi)   treated  daf-­‐‑16;daf-­‐‑2  mutants.  A  
loss-­‐‑of-­‐‑function  mutation   in   aak-­‐‑2   completely   abolished   the   prolonged   survival.   Fur-­‐‑
thermore,  overexpression  of  aak-­‐‑2  was  enough  to  reverse  the  effects  of  WAH-­‐‑1  loss  in  
wild  type  animals  and  extended  their  lifespan.  This  makes  AMPK  a  key  player  in  the  
lifespan  extension  of  AIF/WAH-­‐‑1-­‐‑impaired  animals  by  inactive  IIS.  Therefore,  it  could  
potentially   serve   as   a   target   for   the   treatment   of  mitochondrial   deficiencies.   Further-­‐‑
more,  AMPK  is  an  interesting  target  as  various  chemical  activators  of  the  nutrient  sen-­‐‑
sor  are  available.  Some  of  them  are  already  in  clinical  use  for  the  treatment  of  other  pa-­‐‑
thologies.   AICAR   (5-­‐‑amino-­‐‑1-­‐‑β-­‐‑D-­‐‑ribofuranosyl-­‐‑imidazole-­‐‑4-­‐‑carboxamide)   is   an   ana-­‐‑
logue  of  AMP  and  a  potent  activator  of  endogenous  AMPK/AAK-­‐‑2.  Strikingly,  exper-­‐‑
iments   in   our   laboratory   recently   demonstrated   that   pharmacologic   activation   by  
AICAR  was   sufficient   to   extend   the   lifespan  of   treated  wild   type  animals  after  wah-­‐‑1  
downregulation.   Based   on   the   finding   that   daf-­‐‑16;daf-­‐‑2-­‐‑induced   lifespan   extension  
might  not  be  restricted  to  mitochondrial  dysfunction  caused  by  AIF/WAH-­‐‑1  deficiency  
but  might  also  counteract  ETC  deficiency  induced  by  other  mutations,  boosting  AMPK  
activity  might  also  be  a  putative  treatment  for  other  mitochondrial  diseases.  These  re-­‐‑
sults  make  AMPK/AAK-­‐‑2  an  interesting  target  for  potential  pharmacological  treatment  
of  higher  organisms  suffering  from  mitochondrial  impairment.  
  4.5  Involvement  of  autophagy  
Autophagy  is  a  process  that  has  the  capability  to  rejuvenate  cells  by  recycling  cel-­‐‑
lular  components  and  organelles.  Autophagy  plays  a  central  role  in  the  protective  ca-­‐‑
pacities   of   insulin/IGF-­‐‑1   and   AMPK/AAK-­‐‑2   signalling,   as   it   is   necessary   for   the  
OXPHOS  deficiency-­‐‑induced  lifespan  extension  by  wah-­‐‑1  (RNAi).  In  support  of  a  pro-­‐‑
tective  effect  of  autophagy,  several  studies  demonstrate  that  genetic  or  extrinsic  inter-­‐‑
ventions  that  up-­‐‑regulate  autophagy  can  extend  the  lifespan  of  the  organism  (Bjedov  et  
al.,   2010;   Eisenberg   et   al.,   2009;  Hansen   et   al.,   2008;   Schiavi   et   al.,   2013).  Accordingly,  
block   of   autophagy   in   various   long-­‐‑lived  mutants   reduces   their   lifespan   (Toth   et   al.,  
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2008).   Nevertheless,   how   could   autophagy   mediate   lifespan   extension   under   condi-­‐‑
tions  of  mitochondrial  dysfunction?  Autophagy  is  an  evolutionarily  conserved  catabol-­‐‑
ic  process   that   eliminates   and   recycles  macromolecules   and  organelles,   such  as  dam-­‐‑
aged  mitochondria.  Lack  of  autophagy  is  associated  with  an  increased  number  of   im-­‐‑
paired  organelles  that  can  affect  cellular  function.  For  example,  the  deregulation  of  au-­‐‑
tophagy  in  cells  with  high  energy  demand,  like  neurons,  results  in  the  loss  of  synapses  
and  culminates  in  apoptosis  (Levine  &  Kroemer,  2008).  In  ETC  deficient  nematodes  it  is  
plausible  that  a  compensatory  increase  of  mitochondria,  despite  their  intrinsic  damage,  
might  act  as  a  reservoir  for  the  autophagic  pathway.  They  supply  material  essential  for  
the  progression  of  catabolic  processes  (Hailey  et  al.,  2010).  Nevertheless,   it   is  not  clear  
how  autophagy  and  other   stress   response  mechanisms  could   interact   to  protect   from  
the  detrimental  consequences  of  impaired  OXPHOS.  
A  recent  study  by  Papa  and  Germain  (2014)  in  a  breast  cancer  cell  line  elucidates  
an  important  crosstalk  between  various  mechanisms  involved  in  lifespan  extension:  
Accumulation  of  misfolded  and  unfolded  proteins  in  mitochondria  induces  proteotoxic  
stress   and   increases   ROS   levels.   Consequently,  UPRmt   is   activated   to   counteract   the  
negative  effects  of  unfolded  proteins.  In  parallel,  autophagy  is  activated  to  clear  the  cell  
from  molecular  debris  and  defective  organelles.  When  ROS  is  inhibited  by  the  antioxi-­‐‑
dant  NAC,   the   increase   in  LC3BII   levels   (formation  of  autophagosomes)   is  abolished.  
Also,  the  block  of  autophagy  by  ATG9  siRNA  abolished  the  increase  in  LC3BII  and  led  
to  a  40  %  reduction  in  viability.  Therefore,  the  activation  of  autophagy  is  required  for  
the  maintenance  of  cellular  viability.  
Although,  in  C.  elegans,  wah-­‐‑1  (RNAi)  leads  to  a  decrease  in  ROS  instead  of  an  in-­‐‑
crease,   the  UPRmt   is   still   activated   and   chaperones   are   expressed.  Nevertheless,   the  
induction  of  the  UPRmt  alone  is  insufficient  to  protect  the  organism  from  a  decrease  in  
lifespan.  Just  upon  activation  of  AMPK/AAK-­‐‑2  and  subsequent  induction  of  autopha-­‐‑
gy,  survival  could  be  enhanced.  This  is  another  indication  of  the  importance  of  active  
autophagy  in  cell  survival.  
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  4.6  Autophagy  and  metabolism  
Recent  studies  on  the  important  role  of  autophagy  during  stressful  conditions  il-­‐‑
lustrate  the  relationship  between  autophagy  and  systemic  metabolism  (Lim  et  al.,  2014).  
In  mammals,   Atg7   is   an   essential   autophagy   gene   in   skeletal   muscle   and   liver.   The  
cross  of  haploinsufficient  mice   for  Atg7  with  ob/ob  mice   that   eat   excessively  and  be-­‐‑
come  obese  does  not  alter  the  metabolic  profile  of  the  animals.  Nevertheless,  they  fail  
to  adapt  to  the  metabolic  load  and  develop  diabetes  and  aggravated  insulin  resistance  
(Lim   et   al.,   2014).   Subsequent   induction   of   autophagy   by   the   chemical   enhancer  
Imatinib   was   sufficient   to   ameliorate   the   adverse   affects   of   Atg7   haploinsufficiency.  
Despite  the  different  model  and  disease  in  my  study,  these  data  support  that  autopha-­‐‑
gy   is   a   crucial  mechanism   in   the   adaption   to  metabolic   changes   and  protection   from  
detrimental   organelle  dysfunctions.   Furthermore,   it   provides   the   identification  of   an-­‐‑
other  potential   target   for   treatment  of  mitochondrial  dysfunction  with  chemical   com-­‐‑
pounds.    
Regarding  the  potential  for  therapy,  autophagy  provides  an  important  advantage  
over   the   targeting  of   transcription   factors.  At   least   in   lower  model  organisms,   tissue-­‐‑
specific  regulation  of  DAF-­‐‑2  signalling  and  daf-­‐‑16  expression  levels  have  been  demon-­‐‑
strated   to   signal   to   other   tissues.   Feedback   regulation   of   insulin/IGF-­‐‑1   and  other  un-­‐‑
known   effects   of   daf-­‐‑16   gene   expression   ultimately   affect   all   tissues   in   C.  elegans  
(Kenyon,  2005;  Murphy   et   al.,   2007).  Also,   tissue  specific   insulin/IGF-­‐‑1  dysfunction   in  
mice  can  affect   the  whole  organism.  This  cell  non-­‐‑autonomous  gene  regulation   is  not  
specific  for  DAF-­‐‑16  but  applies  to  other  transcription  factors  including  HIF-­‐‑1  (Bishop  &  
Guarente,  2007).  Autophagy,  however,  is  regulated  in  a  tissue-­‐‑specific  manner,  provid-­‐‑
ing  the  option  of  site-­‐‑specific  modulation  of  the  autophagic  flux,  ameliorating  potential  
side   effects.   Therefore,   even   organ-­‐‑specific   pathologies   of  mitochondrial   dysfunction  
could  be  targeted  by  techniques  that  precisely  regulate  autophagy  in  the  respective  tis-­‐‑
sue.  
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  4.7  Involvement  of  ACDH-­‐‑1  and  metabolism  
HIF-­‐‑1   and   AMPK/AAK-­‐‑2   sense   metabolic   perturbations   caused   by   impaired  
OXPHOS  and  stimulate  alternative  pathways.  The  adaption  of  metabolism  by  the  pro-­‐‑
teins  involved  in  IIS  eventually  led  to  an  induction  of  acdh-­‐‑1  expression.  ACDH-­‐‑1  is  an  
important   metabolic   sensor   that   plays   an   active   role   in   metabolic   reprogramming  
through  fatty  acid  β-­‐‑oxidation  and  BCAA  breakdown  (Watson   et  al.,  2013).  However,  
the  activation  of  acdh-­‐‑1  by  AIF/WAH-­‐‑1  downregulation  in  IIS  mutants  did  not  have  an  
immediate  effect  on  BCAA  levels.  Furthermore,   the  block  of  acdh-­‐‑1  by  RNAi  was  not  
sufficient  to  abolish  the  lifespan  extension  of  wah-­‐‑1  (RNAi)  treated  daf-­‐‑16;daf-­‐‑2  mutants.  
However,  a  minimum  of  13  acyl-­‐‑CoA  dehydrogenase  genes  has  been  identified  for  C.  
elegans  that  could  compensate  for  the  loss  of  a  single  isoform.  Additionally,  such  as  IIS  
is  a   complex  process,  metabolism   is  an   intricate   interplay  of  hundreds  of  metabolites  
and  other  co-­‐‑factors  could  be  involved.    
However,   if   metabolism   plays   a   critical   role   in   lifespan,   why  where   no   differ-­‐‑
ences  in  important  metabolites  and  key  metabolic  pathways  between  wild  type  and  IIS  
mutant  animals  detected?    
The  majority  of  scientific  studies  that  demonstrate  the  critical  role  of  metabolic  changes  
for  cellular  homeostasis  have  been  conducted  in  cell  lines.  For  example,  absence  of  glu-­‐‑
cose,  amino  acids  or  other  nutrients   induces  autophagy   in  vitro   (Galluzzi   et  al.,  2014).  
However,  such  drastic  alterations  in  the  abundance  of  extracellular  supplies  do  not  oc-­‐‑
cur  in  vivo.  Food-­‐‑restriction  in  mice  for  24–48  hours  leads  to  a  reduction  of  10  %  –  20  %  
in   body   weight   and   induces   autophagy   in   close-­‐‑to-­‐‑all   nucleated   cells   of   the   body  
(Mizushima,  2009a;  Mizushima,  2009b).  However,  a  major  depletion  in  amino  acid  lev-­‐‑
els  or  massive,  life-­‐‑threatening  hypoglycemia  was  not  observed.  The  authors  speculate  
that  this  might  be  due  to  the  autophagy-­‐‑dependent  mobilisation  of  cellular  stores  and  
the  systemic  response  to  starvation  (He  et  al.,  2012;  Kuma  et  al.,  2004).  Although,  C.  ele-­‐‑
gans   is  a  significantly   less  complex  organism,  the  composition  of   the  extracellular  mi-­‐‑
lieu  in  multicellular  eukaryotes  is  preserved  by  multiple  homeostatic  circuits  (Galluzzi  
et   al.,   2014).  Moreover,   the   cellular   availability   of   nutrients   is   not  mainly  dictated   by  
their  abundance  but,  rather,  by  the  regulation  of  their  uptake  via  specific  transporters  
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(Wieman   et   al.,   2007).   Therefore,   the  metabolic   analysis   of  C.  elegans   whole   body   ex-­‐‑
tracts  might  not  reflect  the  metabolic  state  of  the  cells  inside  the  organism.  
However,   the   involvement   of   the   metabolic   regulators   HIF-­‐‑1,   AMPK   and   au-­‐‑
tophagy  as  well   as   the   expression  of   the  metabolic   sensor  acdh-­‐‑1   strongly   suggest   an  
involvement  of  metabolism  in  the  regulation  of  lifespan  under  conditions  of  impaired  
ETC  function.  acdh-­‐‑1  expression  levels  strongly  correlated  with  the  lifespan  of  animals.  
The  reduction  of  aak-­‐‑2  and  hif-­‐‑1  in  daf-­‐‑16;daf-­‐‑2  animals  abolished  lifespan  extension  by  
wah-­‐‑1  (RNAi)  and  strongly  suppressed  acdh-­‐‑1  expression.  The  increased  lifespan  of  aak-­‐‑
2  OE  animals  when  treated  with  wah-­‐‑1   (RNAi)  also  displayed  increased  acdh-­‐‑1   levels.  
Strikingly,   acdh-­‐‑1   expression   levels   also   resembled   the   changes   in   lifespan   caused  by  
impaired  autophagy  (bec-­‐‑1  (RNAi))  on  both  daf-­‐‑16;daf-­‐‑2  mutants  and  aak-­‐‑2  OE  animals.  
The  reduction  of  bec-­‐‑1  in  wah-­‐‑1  deficient  animals  resulted  in  a  loss  of  the  lifespan  exten-­‐‑
sion  and  decreased  acdh-­‐‑1  expression  levels  approximately  to  control  levels.  
  Taken  together,  acdh-­‐‑1  expression  levels  changed  along  with  the  effect  of  hif-­‐‑1  
and  aak-­‐‑2  on  the  lifespan  of  C.  elegans.  Furthermore,  acdh-­‐‑1  levels  also  correlated  with  
the   influence   of   autophagy   on   lifespan   in   the   various   backgrounds   and   treatments.  
Thus,  acdh-­‐‑1  might  serve  as  a  marker  of  lifespan  in  OXPHOS  deficient  animals.     
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  4.8  Concluding  remarks  
In   conclusion,   this   study   demonstrates   the   evolutionarily   conserved   role   of  
AIF/WAH-­‐‑1  in  the  maintenance  of  the  ETC  and  mitochondrial  OXPHOS.  Furthermore,  
I  identified  a  new  model  of  disease  related  to  mitochondrial  deficiency  in  the  nematode  
C.   elegans.   Based   on   these   findings,  WAH-­‐‑1   deficiency   engages   a   series   of  molecular  
mechanisms   that   recapitulate  detrimental   effects   of   impaired  mitochondrial   function.  
Importantly,   reduced   insulin/IGF-­‐‑1   signalling   can   protect   from   OXPHOS   deficiency  
and  activate  programs  that  lead  to  lifespan  extension  in  C.  elegans.  The  response  to  in-­‐‑
sufficient   AIF/WAH-­‐‑1   by   impaired   IIS   represents   an   important   link   between   mito-­‐‑
chondrial   function,   stress   response   and   metabolism.   In   animals   with   OXPHOS   im-­‐‑
pairment,   the  reduction  of   IIS   leads   to   the  activation  of   the   transcription   factor  HIF-­‐‑1  
and   the  nutrient   sensor  AMPK/AAK-­‐‑2.  This   in   turn,  upregulates   autophagy   that   can  
prevent  the  accumulation  of  damaged  molecules  and  organelles  and  controls  metabolic  
reprogramming.  Thus,  AMPK  kinase  and  autophagy  may   represent  attractive   targets  
for   the  development  of  new   therapeutic   strategies   for   the   treatment  of  mitochondrial  
diseases.  Furthermore,  ACDH-­‐‑1  was  identified  as  a  metabolic  marker  that  reflects  the  
effect  of  signalling  pathways  that  promote  C.  elegans   lifespan.  Although,  the  effects  of  
IIS,  HIF-­‐‑1,  AMPK  and  autophagy  in  wah-­‐‑1  deficient  nematodes  on  metabolism  remain  
largely  elusive,  the  results  highlight  the  role  of  metabolic  genes  as  regulators  of  cellular  
health,  disease  and  longevity.  
Finally,   further   studies   are   indispensable   to   identify   the   underlying   processes  
that  ultimately  induce  AMPK  and  autophagy.  Furthermore,  the  protective  functions  of  
these  factors  need  to  be  established  for  other  ETC  deficiencies  that  are  independent  of  
AIF/WAH-­‐‑1.  Various  mitochondrial  dysfunctions  and  pathologies  that  share  common  
symptoms  might  also  share  common  disease  pathways.  With  focus  on  the  treatment  of  
patients  these  common  pathways  might  provide  the  option  of  collective  therapies.  Im-­‐‑
portantly,  FDA  approved  drugs  that  activate  AMPK  and  autophagy  are  available  and  
already  in  clinical  use.  For  example,  AICAR  is  used  to  stimulate  AMPK  activity  to  treat  
and  protect  against  cardiac  ischemic  injury  (Mentzer  et  al.,  1988).  Conversely,  autopha-­‐‑
gy   can   be   induced   by   the   inhibition   of  mTOR.  Most   prominently,   rapamycin   (siroli-­‐‑
mus)  has  been  shown   to  prolong   the   life  of  mice   (Harrison   et   al.,   2009)  and  might  be  
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useful  in  the  treatment  of  mitochondrial  deficiencies.  Although  mitochondrial  diseases  
are   rather  poorly  understood  and   require   extensive   research,   the   chance  of   collective  
treatment   and   the   availability   of   potentially   beneficial   drugs   emphasise   the  develop-­‐‑
ment  of  future  therapies  for  patients.  
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  5  Materials  and  Methods  
  5.1  Caenorhabditis  elegans  procedures  
  5.1.1  Strains  
C.  elegans  strains  were  obtained  from  the  Caenorhabditis  Genetics  Centre  (CGC,  
University  of  Minnesota).  Strains  used  in  this  study:  
N2   (ancestral,   wild   type,   Bristol   isolate),   AGD731   uthEx299[aak-­‐‑2(aa1-­‐‑
aa321)::GFP::unc-­‐‑54   3'ʹUTR,   myo-­‐‑2p::tdTomato],   BAN-­‐‑1   daf-­‐‑2(e1370)III,   BAN-­‐‑41   daf-­‐‑
2(e1370)III;   Ex[lgg-­‐‑1p::lgg-­‐‑1::gfp],   BAN-­‐‑57   daf-­‐‑16(mu86)I;   daf-­‐‑2(e1370)III;   gas-­‐‑1(fc21)X,  
BAN-­‐‑61   aak-­‐‑2(ok524)X;   daf-­‐‑16(mu86)I;   daf-­‐‑2(e1370)III,   CF1553   muls84[pAD76(sod-­‐‑
3::GFP)],   CL2166   dvls19[pAF15(gst-­‐‑4::GFP::NLS)],   CW152   gas-­‐‑1(fc21)X,   jrIs1   [Prpl-­‐‑
17::HyPer],   jrIs2   [Prpl-­‐‑17::Grx-­‐‑1-­‐‑roGFP2],   RB867   haf-­‐‑1(ok705)IV,   SJ4100   zcls13[hsp-­‐‑
6::GFP],   SJ4103   zcls14[myo-­‐‑3p::GFP(mit)],   SJ4151   zcIs19[ubl-­‐‑5p::ubl-­‐‑5::GFP],   SJ4197  
zcIs39[dve-­‐‑1p::dve-­‐‑1::GFP],  TK22  mev-­‐‑1(kn-­‐‑1)III,  VC1026  rab-­‐‑10(ok1494),  ZG31  hif-­‐‑1(ia4)V.  
  5.1.2  Crossing  of  mutant  and  transgenic  worm  strains  
In  order   to  obtain  C.  elegans   strains  with  more   than  one  mutation  or   to   express  
transgenes  in  mutant  nematodes,  worms  were  crossed  with  other  C.  elegans  strains.  In  
general,  C.  elegans  males  are  only  observed  at  a  frequency  of  ~0.02  %  in  the  nematode  
population.  To  increase  the  frequency  of  males  in  the  population,  about  30  late  L4  her-­‐‑
maphrodites   were   heat   shocked   at   31   °C   for   ~5   hours   and   subsequently   transferred  
back  to  20  °C.  For  the  cross,  four  to  six  male  L4s  were  mated  with  one  hermaphrodites  
of   the  desired   strain,   keeping   the   ratio   in   favour  of  male  worms.  After   24  hours,   the  
crossed   hermaphrodites   were   transferred   onto   individual   55  mm   NGM   plates.   The  
newly  hatched  progeny  was  singled  out  on  individual  NGM  plates  and  after  animals  
had   laid   eggs   the  parental  worms  were  used   for  genotyping.  This   step  was   repeated  
until  homozygous  worms  were  obtained.  
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  5.1.3  C.  elegans  maintenance  
Nematode   growth   medium   (NGM)   plates   seeded   with   E.   coli   OP50   bacteria  
(  5.1.4.1  )  were  used  as  standard  maintenance  plates  for  C.  elegans.  In  case  of  contamina-­‐‑
tion,  worms  were   treated  with   hypochlorite   bleaching   solution   and   eggs  were   trans-­‐‑
ferred  to  fresh  plates  (  5.1.6  ).  Before  each  experiment,  animals  were  kept  on  sufficient  
food  supply  for  at  least  two  generations  to  prevent  developmental  effects  and  adverse  
gene  expression  caused  by  starvation  response  mechanisms.  
  5.1.4  Preparation  of  NGM  plates  
Nematodes  were  maintained  at  20  °C  on  NGM  as  described  (Brenner,  1974),  un-­‐‑
less   stated   otherwise.   NGM   agar   plates   were   prepared   by   an   automated   peristaltic  
pouring  system  (Mediajet,  Integra)  using  90x20  mm  and  55x20  mm  petri  dishes  (nerbe  
plus).  Plates  were   left  at  room  temperature  (RT)  for  at   least   two  days  before  use.  The  
Escherichia   coli   strain   OP50   was   used   as   a   food   source   for   standard   maintenance  
(   5.1.4.1   );   HT115   bacteria   were   used   for   RNA   interference   (RNAi)   experiments  
(  5.1.4.2  ).  For  experiments  that  included  treatment  of  C.  elegans  with  ethidium  bromide,  
the   chemical   compound  was  added  at   a   final   concentration  of   50  µμg/ml   to   the  NGM  
after  autoclaving,  before  pouring  the  media.  
  5.1.4.1  Maintenance  plates  –  E.  coli  OP50  
To  generate  E.   coli  OP  50   starter   colonies   a   90  mm  LB  pate  was  pre-­‐‑warmed   to  
37  °C  in  an  incubator  and  bacteria  were  grown  by  streaking  of  a  glycerol  stock  on  the  
LB  plate   and   incubation  over  night   (O/N)   at   37  °C.  The  next  day,  LB  was   aseptically  
inoculated  with  an  OP  50  starter  colony  picked  from  the  streaked  LB  agar  plate.  A  liq-­‐‑
uid  culture  of  100  ml  was  allowed   to  grow   for  5-­‐‑8  h  at  37  °C  on  a   shaker  at  160  rpm.  
Subsequently,  NGM  plates  were  seeded  with  1  ml  (90  mm  dish)  or  100  µμl  (50  mm  dish)  
of  OP  50   solution  per  plate,   evenly  distributed  over   the   agar   surface.  Residual  OP  50  
liquid  culture  was  stored  at  4  °C  to  be  used  for  up  to  three  days.  The  distributed  bacte-­‐‑
rial  lawn  was  allowed  to  dry  and  grow  O/N  at  RT.  Plates  were  then  stored  at  4  °C.    
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  5.1.4.2  RNAi  plates  –  E.  coli  HT115  
E.  coli  HT115  (DH3)  strains  were  taken  from  the  Ahringer  library  (Source  BioSci-­‐‑
ence).   The   bacteria   express   stable   dsDNA   for   RNAi   induction   in   C.   elegans.   RNAi  
strains  for  genes  that  were  not  available  from  the  library  were  individually  generated.  
Therefore,  the  desired  RNAi  fragment  was  cloned  into  the  pL4440  vector  construct  and  
subsequently  transformed  into  competent  HT115  bacteria.  HT115  transformed  with  the  
empty  pL4440  vector  were  used  as  a  control.  Bacteria  carrying  control  pL4440  vector  or  
RNAi-­‐‑encoding   plasmids   were   streaked   out   on   pre-­‐‑warmed   (37  °C)   LB   plates   with  
100  µμg/ml   ampicillin   and   12.5  µμg/ml   tetracycline   and   incubated  O/N   at   37  °C.   Single  
HT115  colonies  were  used  to   inoculate  3  ml  of  LB  supplemented  ampicillin  and  incu-­‐‑
bated  O/N  at  37  °C  on  a  shaker  at  160  rpm.  The  next  day,  an  over  day  culture  was  pre-­‐‑
pared  by   inoculation  of  LB   +   ampicillin  with   the   fresh  O/N   culture   (ratio   ~1:25).  The  
culture  was  grown   for   5-­‐‑8  hours   and  used   to   seed  NGM  plates.   For   the   induction  of  
double   stranded   RNA   expression   in   the   HT115   bacteria,   Isopropyl-­‐‑β-­‐‑D-­‐‑1-­‐‑
thiogalactopyranoside  (IPTG)  was  added  to  the  bacteria  suspension  at  a   final  concen-­‐‑
tration  of  1  mM  before  seeding  of  NGM  plates.  Seeded  bacteria  were  allowed  to  grow  
O/N  at  RT.  
  5.1.5  Generation  of  RNAi  constructs  
  5.1.5.1  Plasmid  DNA  isolation  
4  ml  of  inoculated  LB  medium  supplemented  with  ampicillin  were  centrifuged  at  
3,000  g  for  10  min  after  incubation  O/N  at  37  °C.  Supernatant  was  discarded  and  Plas-­‐‑
mid   DNA  was   isolated   and   purified   using   the   Jetquick   Plasmid  Mini   Spin   Kit   (Ge-­‐‑
nomed).  The  protocol  was  followed  according  to  the  manufacturer’s  users  manual  pro-­‐‑
vided.  Plasmid  DNA  was  resuspended  in  40  µμl  of  sterile  water.  
  5.1.5.2  DNA  extraction  from  C.  elegans    
C.  elegans  genomic  DNA  for  cloning  purposes  was  extracted  using  the  Illustra  tis-­‐‑
sue  &  cells  genomicPrep  Spin  Kit   (GE  Healthcare).  Approximately  1,000  worms  were  
grown  to  adulthood  on  standard  NGM  plates  with  OP50  bacteria.  Worms  where  rinsed  
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off  of  the  plates  with  M9  buffer  and  thoroughly  washed  free  from  remaining  bacteria.  
Worms  were   left   in   fresh  M9  buffer   for  15  min  to  get  rid  of  remaining  bacteria   in   the  
animal’s   intestine.   Subsequently,   the   supernatant   was   discarded   and   the   animals  
cleaned   another   time.   Afterwards,   DNA  was   extracted   following   the  manufacturer’s  
protocol.  
  5.1.5.3  RNAi  construct  cloning  
The  mixing  of  two  bacterial  strains  carrying  individual  RNAi  results  in  low  gene  
regulation  efficiency.  To  prevent  the  dilution  effect,  bec-­‐‑1  RNAi  was  cloned  into  the  ex-­‐‑
isting  wah-­‐‑1-­‐‑pL4440  RNAi  construct.  For  this  purpose,  the  wah-­‐‑1  plasmid  was  extracted  
from  a   4  ml  O/N   culture   in  LB  medium.  The   bec-­‐‑1   RNAi   sequence  was   amplified   by  
PCR   from   genomic   C.  elegans   DNA.   The   two   primers   contained   restriction   sites   for  
XhoI  5’  and  KpnI  3’,  respectively.  Then,  DNA  was  purified  and  cloned  by  T4  ligation  
after  restriction  digest  for  2  h.  Vector  was  then  transformed  into  HT115  bacteria.  Bacte-­‐‑
ria  colonies  were  checked  for  the  bec-­‐‑1  insert  by  PCR.  Positive  clones  were  sent  for  se-­‐‑
quence  analysis  (GATC  biotech)  and  subsequently  used  for  RNAi  experiments.  
  5.1.5.4  Transformation  of  E.  coli  HT115  
RNAi  clones  were  transformed  into  E.  coli  HT115.  To  this  end,  25  µμl  of  competent  
HT115   bacteria   solution  were   slowly   thawed   on   ice   and   50-­‐‑100  ng   of   plasmid   DNA  
were  added  to  the  bacteria  and  incubated  on  ice  for  30  min.  Transformation  was  then  
promoted  by  heat  shock  in  a  heating  block  at  42  °C  for  45  s  and  bacteria  were  immedi-­‐‑
ately  chilled  on  ice  for  1  min.  Subsequently,  500  µμl  of  Super  Optimal  broth  with  Catab-­‐‑
olite   repression   (SOC,   Invitrogen)  were   added   to   the  bacteria   and   incubated  at   37  °C  
for  1  h  at  200  rpm.  In  the  meantime,  LB  plates  supplemented  with  100  µμg/ml  ampicillin  
where  allowed  to  pre-­‐‑warm  to  37  °C  in  an  incubator.  Between  25-­‐‑150  µμl  of  bacteria  so-­‐‑
lution  were   distributed   on   LB-­‐‑plates   and   clones  were   grown   at   37°C  O/N.   The   next  
day,   single   colonies  were   isolated   and   transferred   to   6  µμl   of   fresh   LB.   Subsequently,  
2  µμl  of  the  solution  were  used  for  single  clone  analysis  by  PCR  and  the  residual  4  µμl  of  
the  bacteria  were   transferred   to  3  ml  LB  medium  with  ampicillin  and  grown  O/N  for  
subsequent  plasmid  extraction  (  5.1.5.1  ).  
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  5.1.6  Synchronisation  of  C.  elegans  
Synchronous   nematode  populations   obtained   by   bleaching  using   a   sodium  hy-­‐‑
pochlorite/NaOH  solution.  Incubation  of  nematodes  with  hypochlorite  bleaching  solu-­‐‑
tion  results  in  the  lysis  of  C.  elegans  tissue,  while  eggs  survive  the  treatment  for  an  ex-­‐‑
tended  period  of   time.  Gravid  hermaphrodites  carrying  fertilized  eggs  were  collected  
with  M9  buffer  and   transferred   to  a  1.5  µμl   reaction   tube.  Animals  were  washed   three  
times  with  M9  buffer  and  supernatant  containing  bacteria  and  young  larvae  was  aspi-­‐‑
rated.  Worms  were   resuspended   in   200  µμl   of   double-­‐‑distilled  water   (ddH2O).   Subse-­‐‑
quently,  600  µμl  of  freshly  prepared  sodium  hypochlorite  solution  were  added.  Follow-­‐‑
ing  this,  the  suspension  was  thoroughly  mixed  for  approximately  5  min  in  a  vortex  un-­‐‑
til  animals  were  dissociated.  To  avoid  extensive  sodium  hypochlorite  treatment,  500  µμl  
of  M9  were   added   and   eggs  were   immediately   spun   down   at   9,000  g   for   30  s.   Eggs  
were   then  washed   three   times  with   1  ml   of  M9,  mixed   and   resuspended   thoroughly  
and  spun  down  at  9,000  g   for  30  s  between  each  washing  step.  After   the   last  washing  
cycle   all   eggs   were   resuspended   in  M9   buffer   and   distributed   to   fresh   NGM   plates  
seeded  with  HT115  (DH3)  or  OP50  bacteria  for  RNAi  experiments  or  maintenance,  re-­‐‑
spectively.  
  5.1.7  Lifespan  assays  
Synchronous  nematode  populations  were  established  by  hypochlorite  treatment  
of  gravid  adults  to  obtain  synchronised  embryos  as  described  (  5.1.6  ).  The  HT115  bac-­‐‑
teria  were   transformed  with   either   control  pL4440  vector   or  RNAi-­‐‑encoding  plasmid  
(  5.1.4.2  ).  Bleached  C.  elegans  progeny  was  grown  at  20  °C  unless  noted  otherwise,  and  
transferred  to  fresh  HT115-­‐‑seeded  plates  every  other  day  after  they  reached  adulthood.  
Lifespans  were  performed  at  groups  of  30-­‐‑50  nematodes  per  plate  for  a  total  number  of  
120-­‐‑150  individuals  per  experiment.  The  day  of  hatching  was  defined  as  t=0.  Animals  
were   examined   every   second   day   for   touch-­‐‑provoked   movement   and   pharyngeal  
pumping.  The  mean  lifespan  is  defined  as  the  time  point  when  50  %  of  the  animals  are  
still   alive.  Worms  which   died   abnormally   due   to   internally   hatched   eggs,   protruded  
vulva  or  dried  on  the  edge  of  the  plates  were  considered  censored.  The  survival  curves  
were  generated  using  the  method  of  Kaplan  and  Meier  with  the  GraphPad  Prism  Soft-­‐‑
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ware  package  (GraphPad  Software  Inc.,  San  Diego,  USA).  Lifespans  were  performed  at  
least   three   times   and   the   figures   report   representative   experiments.   p   values   for   the  
evaluation  of  the  differences  were  determined  using  the  log-­‐‑rank  (Mantel-­‐‑Cox)  test.    
  5.2  Molecular  Biology  
  5.2.1  Quantitative  real-­‐‑time  PCR  
  5.2.1.1  RNA  isolation  
At  adulthood,  200  worms  were  collected  from  NGM  plates  and  cleaned  from  the  
bacteria.  Then,  nematodes  were   frozen  and  stored  at   -­‐‑80  °C.  Total  RNA  isolation  was  
performed  using  QIAshredder  (Qiagen)  for  disruption  of  nematode  tissue  and  RNeasy  
RNA  isolation  kit  (Qiagen)  according  to  the  manual.  RNA  isolation  was  carried  out  in  
an  automated  QIAcube  system  (Qiagen)  including  an  on  column  DNAse  digest.  Brief-­‐‑
ly,  600  µl  RLT  lysis  buffer  were  added  to  the  frozen  nematodes  and  samples  were  vor-­‐‑
texed  for  5  min.  Lysates  were  frozen  and  vortexed  for  a  second  cycle.  In  the  meantime,  
the  QIAcube  was  loaded  and  buffers  for  RNA  extraction  were  prepared  and  provided  
in   the   designated   compartments.   Dependent   on   the   number   of   samples,   respective  
amounts  of  RNAse  free  DNAse  (Qiagen)  was  diluted  in  RDD  buffer  in  a  2  ml  reaction  
tube  and  loaded  to  the  machine.  RNA  was  collected  from  the  column  in  35  µl  RNAse  
free  dH2O.  After   isolation,  RNA  concentration  was  determined  using   the  NanoDrop  
2000c/2000  UV-­‐‑Vis  Spectrophotometer  (Thermo  Scientific).  
  5.2.1.2  Quantitative  real-­‐‑time  PCR  (qRT-­‐‑PCR)  
Gene  expression  analysis  in  C.  elegans  was  assessed  by  quantitative  real  time  PCR  
(qRT-­‐‑PCR).  Furthermore,  qRT-­‐‑PCR  was  used  to  validate  the  downregulation  of  target  
genes  by  RNAi  for  each  experiment.    
(A)   Equimolar   amounts   of   RNA  were   transcribed   into   cDNA   by   reverse   tran-­‐‑
scription.   Isolated  RNA   (   5.2.1.1   )  was   translated   into   cDNA   in   a   thermal   cycler   (Bi-­‐‑
ometra   TProfessional   Trio)   by   the   qScript   cDNA  Synthesis  Kit   (Quanta   Bioscciences)  
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according  to  the  manufacturer’s  protocol.  cDNA  was  analysed  by  real-­‐‑time  PCR  analy-­‐‑
sis.  
(B)  The  real-­‐‑time  PCR  reaction  was  carried  out  in  a  Step  One  Plus  Real  time  PCR  
System  (Applied  Biosystems)  using  the  Fast  SYBR  Green  Master  Mix  (Applied  Biosys-­‐‑
tems).  The  following  cycling  conditions  were  used:   Initial  AmpliTaq  Polymerase  acti-­‐‑
vation  at   95  °C   for   20  s   followed  by  40   cycles  of  denaturation   (95  °C   for   3  s)   and  An-­‐‑
nealing/Extension   (60  °C   for   30  s).   Data   was   analysed   using   the   comparative   ΔΔCt  
method  (Livak  &  Schmittgen,  2001).  An  average  of  at  least  3  technical  repeats  was  used  
for  each  sample.  
  
Table  5-­‐‑1:  Primers  used  for  qRT-­‐‑PCR  
beta-­‐‑actin   5´-­‐‑tgtgatgccagatcttctccat-­‐‑3´                          and                      5´-­‐‑gagcacggtatcgtcaccaa-­‐‑3´    
wah-­‐‑1   5´-­‐‑gctgatgctgtcgaggaga-­‐‑3´                              and                      5´-­‐‑tggtggtgttctcttctgtaga-­‐‑3´  
hsp-­‐‑6   5’-­‐‑aaccggaaaggaacaacagat-­‐‑3’                    and                      5’-­‐‑tctcgatttggtccttggaa-­‐‑3’  
hsp-­‐‑16.2   5’-­‐‑tgcagaatctctccatctgagt-­‐‑3’                          and                      5’-­‐‑tggtttaaactgtgagacgttga-­‐‑3’  
dve-­‐‑1   5’-­‐‑gcattcagcacccactca-­‐‑3’                                        and                    5’-­‐‑gagtgggtcgaacatcagg-­‐‑3’  
nhr-­‐‑57   5´-­‐‑tcggaatgaatccggaagt-­‐‑3´                                and                    5´-­‐‑atgcaggggaagatgaacag-­‐‑3´  
bec-­‐‑1   5´-­‐‑tgcagctctaggacaaattgtttt-­‐‑3´                    and                    5´-­‐‑gggcatcagttcgtgatgttg-­‐‑3´  
acdh-­‐‑1   5´-­‐‑gttcgtgtccacaaatcagc-­‐‑3´                                and                    5´-­‐‑caatggcaattctacctgcat-­‐‑3´  
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  5.2.2  Western  Blot  
  5.2.2.1  SDS-­‐‑PAGE  
C.  elegans   proteins   were   separated   by   SDS   polyacrylamide   gel   electrophoresis  
(SDS-­‐‑PAGE)   and   blotted   on   nitrocellulose  membranes   for   immunoreaction  with   pri-­‐‑
mary   antibodies.  To   this   end,   200  worms  were   collected   from  NGM  plates   and   thor-­‐‑
oughly  cleaned  from  bacteria  with  M9  buffer.  Supernatant  was  discarded  and  the  sam-­‐‑
ples   were   frozen   and   stored   at   -­‐‑80  °C.   After   thawing   of   the   samples,   40  µl   of   2x  
Laemmli  buffer  were  added  and  the  nematodes  were  disrupted  by  ultra-­‐‑sonication  at  
an  amplitude  of  11  µm  (23  kHz)  for  30  s  (MSE  Soniprep  150  plus).  Proteins  were  dena-­‐‑
tured   at   95  °C   for   5  min   and   immediately   transferred   to   ice.   After   the   samples  were  
cooled  down,   the   lysates  were   centrifuged  at  10,000  g   for  10  min   to   spin  down   tissue  
remains.  Next,  20  µl  of   the  prepared  samples  were   loaded  onto  12  –  15  %  polyacryla-­‐‑
mide  gels  and  allowed  to  penetrate  the  stacking  gel  at  a  voltage  of  80  mV  for  20  min.  
Subsequently,   the  voltage  was  increased  to  130  mV  to  separate  the  proteins  until  bro-­‐‑
mophenol  blue   in  the   loading  buffer  reached  the  desired  distance   in  the  gel.  The  gels  
were  subsequently  used  for  western  blotting.    
  5.2.2.2  Western  Blot  transfer  
Separated   proteins   were   transferred   to   a   nitrocellulose   membrane   by   wet-­‐‑
blotting   (Bio-­‐‑Rad)   for   85  min   at   300  mA.  Following,  membranes  were  briefly  washed  
with  TBST  buffer  (15.3  mM  Tris/HCl,  140  mM  NaCl,  pH  7.6,  0,1  %  Tween).  Blocking  of  
the  membrane  with  5  %  non-­‐‑fat  milk  powder  in  TBST-­‐‑buffer  for  30  minutes  prevented  
unspecific  binding.  Primary  antibodies  were  diluted  in  5  %  milk  in  TBST  and  incubated  
O/N   at   4  °C   or   for   2   h   at   RT.   After   incubation,   the   antibody   was   removed   and   the  
membrane  was  washed  with  TBST  buffer  3  times  for  10  min.  The  conjugated  secondary  
antibody  (horseradish  peroxidase  conjugated,  HRP)  was  diluted  1:10,000  in  5  %  milk  in  
TBST  and   incubated   for  1  h.  Membranes  were  washed  3   times  with  TBST  and   finally  
developed   with   peroxidase   substrate   for   enhanced   chemiluminescence   (Pierce   ECL  
Western  Blotting  Substrate,  Thermo  Scientific)  according  to  the  manufacturer´s  instruc-­‐‑
tions.  The  chemiluminescent  detection  was  performed  using  the  ChemiDoc  XRS+  Gel  
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documentation  system  (BioRad).  Protein  bands  were  quantified  by  densiometric  analy-­‐‑
sis.  Figures  show  one  representative  experiment.  
Table  5-­‐‑2:  Primary  antibodies  used  for  immunoblotting  
Anti-­‐‑ATP  synthase  subunit  alpha   Mouse  monoclonal   MitoSciences,  MS507  
Anti-­‐‑Ndufs3  (Complex  I)   Mouse  monoclonal   MitoSciences,  MS112  
Anti-­‐‑MT-­‐‑CO1  (Complex  IV)   Mouse  monoclonal   MitoSciences,  MS404  
Anti-­‐‑COXIV  (nuclear  encoded)   Rabbit  polyclonal   Cell  Signaling  
Anti-­‐‑Pyruvate  dehydrogenase  
(PDH)  subunit  E1  alpha  
Rabbit  monoclonal   MitoSciences,  MSP07  
Phospho-­‐‑AMPK   Rabbit  monoclonal   Cell  Signaling  
  5.3  Imaging  and  stress-­‐‑response  analysis  
  5.3.1  STED  microscopy  
Super  resolution  microscopy  of  mitochondria  in  the  muscle  was  performed  with  
a  Leica  TCS  SP8  gated  stimulated  emission  depletion  (STED)  microscope.  The  inverted  
microscope   (Leica  DMI6000  CS)  was  equipped  with  a  100x-­‐‑oil-­‐‑objective,  and  a  White  
Light  Laser  (WLL).  Images  were  taken  with  a  resolution  of  about  50  nm  at  488  nm  fol-­‐‑
lowing  laser  depletion  at  a  wavelength  of  592  nm.  
  5.3.2  ROS  quantification  by  H2DCF-­‐‑DA  and  2-­‐‑NDBG  staining  
6-­‐‑carboxy-­‐‑2'ʹ,7'ʹ-­‐‑dichlorodihydrofluorescein   diacetate   (DCF-­‐‑DA)   and   2-­‐‑(N-­‐‑(7-­‐‑
Nitrobenz-­‐‑2-­‐‑oxa-­‐‑1,3-­‐‑diazol-­‐‑4-­‐‑yl)Amino)-­‐‑2-­‐‑Deoxyglucose   (2-­‐‑NBDG)   are   fluorescent  
dyes  that  have  been  used  to  monitor  reactive  oxygen  species  (ROS)  and  glucose  uptake  
in   live  cells,   respectively.  Staining  with   the   fluorescent  compounds  was  performed   in  
vivo  in  C.  elegans  and  protocols  were  adapted  from  Klapper  et  al.  (2010)  and  Schulz  et  al.  
(2007).  Young  adult  nematodes  were  washed  off  of  RNAi  plates  and   rinsed  with  M9  
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buffer  three  times.  After  cleaning,  worms  were  resuspended  in  950  µμl  M9.  To  prevent  
starvation  during  incubation,  50  µμl  of  concentrated  control  and  wah-­‐‑1   (RNAi)  bacteria  
were  added.  Subsequently,  2  µμl  of  a  0.1  mM  DCF-­‐‑DA  (Life  Technologies)  or  4  µμl  of  a  
0.1  mM  2-­‐‑NBDG   (Life  Technologies)   stock   solution   in  DMSO  were  added   to   the   sus-­‐‑
pension  to  obtain  a  final  concentration  of  200  µμM  or  400  µμM,  respectively.  Worms  were  
then  incubated  for  5  h  at  20  °C  on  a  shaking  incubator  at  200  rpm.  After  staining,  ani-­‐‑
mals  were   briefly   centrifuged   and  washed   three   times  with   1  ml   fresh  M9  buffer   for  
5  min  to  prevent  unspecific  fluorescence  from  DCF-­‐‑DA  or  2-­‐‑NBDG-­‐‑stained  HT115  bac-­‐‑
teria  in  the  nematodes  intestine  and  remove  all  dye  that  was  not  incorporated.  Nema-­‐‑
todes  were  resuspended  in  M9  and  analysed  using  the  COPAS  Biosort  (Union  Biomet-­‐‑
rica).   Fluorescence  was  measured   at   an   excitation  wavelength   of   488  nm   and   a   GFP  
emission  filter.  
  5.3.3  Hyper  and  roGFP  ROS  analysis  
Quantification   of  H2O2   levels   in   jrIs1   [Prpl-­‐‑17::Hyper]  and  GSSG/2GSH   ratios   in  
jrIs2  [Prpl-­‐‑17::Grx-­‐‑1-­‐‑roGFP2]  animals  was  performed  by  spinning  disc  microscopy.  The  
setup   consisted   of   a   fully  motorised   inverted  microscope   (Nikon)   equipped  with   an  
auto   focus   stage   in  association  with  a  Yokogawa  Spinning  Disk   connected   to  a  back-­‐‑
illuminated   EM-­‐‑CCD   camera   (Andor   iXON   DU-­‐‑897,   512   x   512   pixels,   16   bit,   35  
frames/s).   This   setup  was   equipped  with   a   60x   and   100x-­‐‑oil-­‐‑immersion   lens   (Nikon).  
Treated  animals  at  4  or  7  days  of  age  were  paralysed  with  25  mM  levamisole   (Appli-­‐‑
Chem)   in  M9   buffer,  mounted   on   2  %   agarose   pads   on   glass   slides   and   closed  with  
cover   slips.   Nematodes   were   then   imaged   with   488  nm   (oxidised   Hyper,   reduced  
roGFP2)   and   405  nm   (reduced   Hyper,   oxidised   GroGFP2)   excitation   lasers   and   a  
525  nm  emission  filter.  Regions  of  interest  (ROIs)  were  analysed  by  using  Fiji  software  
and  oxidised/reduced  ratios  were  calculated.  GraphPad  (Prism)  software  was  used  for  
statistical  analysis.  
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  5.3.4  Analysis  of  fusion-­‐‑GFP  strains  
GFP   expression   in   fusion-­‐‑GFP   worm   strains   (i.e.   hsp-­‐‑6::GFP,   hsp-­‐‑60::GFP,   ubl-­‐‑
5p::GFP,  dve-­‐‑1p::dve-­‐‑1::GFP,  gst-­‐‑4::GFP,  sod-­‐‑3::GFP,  acdh-­‐‑1::GFP)  was  analysed  with  the  
Complex  Object  Parametric  Analyzer  and  Sorter  (COPAS)  Biosort  (Union  Biometrica).  
A  minimum  of  200  animals  were  analysed  for  each  experiment  and  treatment.  Fluores-­‐‑
cence  was  measured  at  an  excitation  wavelength  of  488  nm  and  a  GFP  emission  filter.  
Laser  intensity  and  gain  settings  were  individually  adjusted  to  GFP  expression  signals  
of  each  strain  and  kept  consistent  for  all  the  experiments.  The  LGG-­‐‑1/LC3::GFP  report-­‐‑
er   strain   has   been   widely   used   for   the   estimation   of   autophagosomes   in   C.   elegans  
(Melendez  et  al.,  2003).  Autophagic  activity  was  analysed  by  quantification  of  fluores-­‐‑
cent  puncta  in  the  hypodermal  seam  cells  under  a  fluorescence  stereoscope.  
  5.4  Metabolite  analyses  
  5.4.1  Oxygen  consumption  rates  
Oxygen  consumption  rates  were  analysed  with  the  XF24  Extracellular  Flux  Ana-­‐‑
lyzer  (Seahorse  Bioscience).  The  day  before  the  assay  was  performed,  a  XF24  FluxPak  
sensor  cartridge   (XF24  extracellular   flux  assay  kit,  Seahorse  Bioscience)  was  hydrated  
in  1  ml  calibrant  solution  at  37  °C  O/N  in  an  incubator  without  CO2.  The  next  day,  cali-­‐‑
bration   of   the   cartridge  was   performed   at   20  °C.   Young   adult  worms  were   collected  
from  NGM  plates  in  M9  buffer  and  washed  three  times.  Subsequently,  50  animals  per  
well  were   transferred   into   a   24-­‐‑well   XF24  microplate   in   quadruplicates   or   quintupli-­‐‑
cates  per  genotype  and  treatment.  The  volume  was  brought  up  to  500  µμl/well  with  M9  
buffer.   For   the   background   correction,   empty   wells   were   filled   with   500  µμl   of   M9.  
Measurement  was  performed  at  20  °C  with  a  repetition  of  ten  cycles.  
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  5.4.2  ATP  content  
ATP   levels   were   measured   with   the   Luminescent   ATP   Detection   Assay   Kit  
(abcam).   The   lysis   buffer   provided   in   the   kit   irreversibly   inactivates   ATP   degrading  
enzymes.  The  ATP  content  in  the  cells/tissue  is  then  quantified  by  ATP  dependent  lu-­‐‑
ciferase  activation  and  analysed  by   fluorescence  detection.  A  synchronised  nematode  
population  was  grown  to  adulthood  on  NGM  plates  seeded  with  HT115  E.  coli  bacteria  
containing  control  or  RNAi  plasmid.  200  worms  were  collected  in  a  1.5  ml  sample  tube  
and  washed  with  M9  buffer  three  times.  Animals  were  centrifuged  and  the  supernatant  
was   discarded.   To   inactivate   ATPases,   50  µμl   of   the   detergent   provided   with   the   kit  
were   added   and  worms  were   immediately  homogenised  with   a  motor-­‐‑driven  pestle.  
After  homogenisation,  150  µμl  of  dH2O  were  added  to  the  sample.  The  homogenate  was  
centrifuged   at   4  °C   for   10  min   at   10  000  g.   Samples  were  measured   in   triplicates   at   a  
volume  of  50  µμl  in  a  black  96-­‐‑well  plate  according  to  the  assay  kit’s  protocol.  Lumines-­‐‑
cent  signals  were  detected  by  an  EnVision®  Multilabel  plate  reader  (Perkin  Elmer).  
  5.4.3  Lactate  Dehydrogenase  activity  
Lactate  Dehydrogenase  (LDH,  EC  1.1.1.27)  activity  was  measured  by  the  reduc-­‐‑
tion   of  NAD   to  NADH  with   the   Lactate  Dehydrogenase  Assay  Kit   (abcam).   For   the  
analysis,   200   young   adult  worms   of   a   synchronised   nematode   population   grown   on  
control   and  RNAi  NGM  plates  were   collected   in   a   1.5  ml   tube   and  washed  with  M9  
buffer   three   times.   Animals   were   centrifuged   and   the   supernatant   was   discarded.  
Nematode  bodies  were  cracked  by  a  freeze-­‐‑thaw  cycle,  resuspended  in  500  µμl  cold  as-­‐‑
say   buffer   and  mechanically   homogenised  with   a  motor-­‐‑driven   pestle.   The   homoge-­‐‑
nate  was  centrifuged  for  15  min  at  10,000  g  at  4  °C.  For  the  assay,  50  µμl  of  the  superna-­‐‑
tant  was  used  in  triplicates  in  a  clear  96-­‐‑well  plate  (Brand)  according  to  the  assay  pro-­‐‑
tocol.  Optical  density  at  450  nm  was  measured  kinetically  every  30  min  using  an  EnVi-­‐‑
sion®  Multilabel  plate  reader   (Perkin  Elmer).  Data  analysis  was  performed  on  values  
of  time  point  T2-­‐‑T1.  
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  5.4.4  Fumarate  levels  
Fumarate   levels  were  measured  using  the  Fumarate  Detection  Kit   (Abcam).  For  
the  analysis,  200  young  adult  worms  were  collected  in  a  1.5  ml  tube  and  washed  with  
M9  buffer   three  times.  Animals  were  centrifuged  and  the  supernatant  was  discarded.  
Nematode  bodies  were  cracked  by  a  freeze-­‐‑thaw  cycle,  resuspended  in  200  µμl  cold  as-­‐‑
say   buffer   and  mechanically   homogenised   with   a   motor-­‐‑driven   pestle.   Homogenate  
was  centrifuged  for  10  min  at  13,000  g.  For  the  assay  50  µμl  of  the  supernatant  was  used  
in  triplicates  in  a  clear  96-­‐‑well  plate  (Brand)  according  to  the  assay  protocol.  Fumarate  
specific   substrate   reaction   was   measured   at   450  nm   using   an   EnVision®   Multilabel  
plate  reader  (Perkin  Elmer).  
  5.4.5  Branched  Chain  Amino  Acid  Levels  
BCAAs  were  detected  by  oxidative  deamination  and  measurement  of  the  subse-­‐‑
quently   produced   NADH   with   the   BCAA   Assay   Kit   (abcam).   For   the   analysis,  
200  young   adult  worms  were   collected   in   a   1.5  ml   tube   and  washed  with  M9   buffer  
three  times.  Animals  were  centrifuged  and  the  supernatant  was  discarded.  Nematode  
bodies  were   cracked   by   a   freeze-­‐‑thaw   cycle,   resuspended   in   100  µμl   assay   buffer   and  
mechanically  homogenised  with  a  motor-­‐‑driven  pestle.  Homogenate  was  centrifuged  
for  10  min  at  15,000  g.  For  the  assay  25  µμl  of  the  supernatant  was  used  in  triplicates  in  a  
clear  96-­‐‑well  plate  (Brand)  and  brought  to  50  µμl  with  Assay  Buffer.  BCAA  specific  en-­‐‑
zyme   reaction  was  measured   at   450  nm   using   an   EnVision®  Multilabel   plate   reader  
(Perkin  Elmer).     
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  5.5  Materials  
LB  (1  l)  
10  g  tryptone  (Sigma);  5  g  Bacto-­‐‑yeast  (Sigma);  5  g  NaCl  (Sigma);  made  up  to  1  l  with  
dH2O;  adjusted  to  pH  7.0  using  1  M  NaOH  (Roth)  
  
NGM  agar  (1  l)  
3  g  NaCl   (Sigma);  17  g  agar   (Sigma);  2.5  g  peptone   (Sigma);  1  ml  Cholesterol   (Sigma);  
made  up  to  1  l  with  dH2O  
autoclave  
add  1  ml  of  1  M  CaCl2  (Sigma);  1  ml  of  1  M  MgSO4  (Sigma);  25  ml  of  1  M  KPO4  (pH  6)  
(Sigma)  
  
S-­‐‑medium  (1  l)  
1  l  S-­‐‑basal    
5.5  g  NaCl  (Sigma);  1  g  K2HPO4  (Sigma);  6  g  KH2PO4  (Sigma);  5  mg  cholesterol  (Sigma);  
dH2O  to  1  l  
   autoclave    
10  ml  1  M  potassium  citrate  (Sigma)  
10  ml  trace  metals  solution    
1.86  g  disodium  EDTA  (Sigma);  0.69  g  FeSO4•7  H2O  (Sigma);  0.2  g  MnCl2•4  H2O  (Sig-­‐‑
ma);  0.29  g  ZnSO4•7  H2O  (Sigma);  0.025  g  CuSO4•5  H2O  (Sigma);  H2O  to  1  l  
   autoclave  
3  ml  1  M  CaCl2  (Sigma);  3  ml  1  M  MgSO4  (Sigma)  
  
Sodium  hypochlorite  solution  (6  ml)  
1  ml  10  M  NaOH  (Roth);  2  ml  5  %  sodium  hypochlorite  (GPR  rectapur);  2.4  ml  ddH2O  
  
M9  (1  l)  
3  g  KH2PO4  (Sigma);  6  g  Na2HPO4  (Sigma);  5  g  NaCl  (Sigma);  1  ml  1M  MgSO4  (Sigma);  
made  up  to  1  l  with  dH2O  
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Worm  DNA  lysis  buffer  
20  mM  Tris   pH   7.5   (Sigma);   50  mM  EDTA   (Roth);   200  mM  NaCl   (Sigma);   0.5%   SDS  
(Sigma)  
  
Western  Blot  Buffers  
separation  gel  buffer  
1.5  M  Tris-­‐‑Base;  0.4  %  SDS;  pH  8.8  
stacking  gel  buffer  
   1  M  Tris-­‐‑Base;  0.4  %  SDS;  pH  6.8  
running  buffer  
25  mM  Tris-­‐‑Base;  192  mM  glycine;  0.1  %  SDS  
transfer  buffer  
25  mM  Tris;  192  mM  glycine;  20  %  methanol  
blocking  buffer  
5%  w/v  non-­‐‑fat  dried  milk  in  TBS-­‐‑Tween  0.05%  
  
Laemmli  Buffer  (4x)  
250  mM   Tris/HCl   pH  6.8   (Sigma);   8  %   SDS   (Sigma);   40  %   glycerol   (Sigma);   20  %   β-­‐‑
mercaptoethanol  (Sigma);  1  mg/ml  bromophenol  blue  (Applichem)  
  
TBS  (10x)  
153  mM  Tris-­‐‑HCl  (Sigma);  1.4  M  NaCl  pH  7.6  (Sigma)  
  
TBST  (1  l)  
15.3  mM  Tris/HCl  (Sigma);  140  mM  NaCl  (Sigma);  pH  7.6;  0.1%  Tween  20  (Calbiochem)  
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